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ABSTRACT 
Nature has provided scientists with numerous bioactive molecules with great potential as 
therapeutic agents for a range of human and animal diseases. Exploring terrestrial and marine 
environments for macro- and microorganisms capable of producing these valuable secondary 
metabolites remains an important source of new drug-leads. Unfortunately, the development of 
many natural products into full-fledged pharmaceutical products is frequently hindered by the 
inability of the natural source to provide sufficient quantities to support clinical evaluation.  
 
To address the supply issue hindering the development of many terpenes, a heterologous 
expression platform capable of high-level production of bioactive terpenes was developed. The 
metabolic profile of Streptomyces lividans TK24 was first improved by genetically disrupting 
the production of actinorhodin and undecylprodigiosin via markerless deletions. This removed 
any interference from these metabolites during biological and chemical assays and eliminated 
competition for common biosynthetic precursors. Terpentecin biosynthetic genes were then 
expressed in the genetically modified S. lividans host under the control of a constitutive 
promoter, though no detectable yield of the diterpene were present in the heterologous host.  
 
This work led to the identification of two new glucosylated polyketides, satosporin A and 
B, isolated from the strain Kitasatospora griseola MF730-N6. Structure elucidation and 
stereochemical assignments were performed using spectroscopic analyses, computational 
methods and chemical derivatizations. Satosporins possess an unprecedented tricyclic ring 
system comprising an oxo-decalin unit fused to an 8-membered lactone and 11 chiral centers. 
The aglycone, satosporin C, was selectively obtained by enzymatic deglucosylation of satosporin 
A using β-glucosidase from almonds.  
  
The satosporing biosynthetic gene cluster was identified from the K. griseola genome via 
a combination of degenerate primers and Illumina
®
 and Pacific Biosciences
®
 sequencing 
technologies. The DNA sequences were analyzed by antiSMASH and BLAST
®
 and revealed a 
67 kb region that putatively encoded  a cytochrome P450 monoxygenase, two large 
multimodular polyketide synthases, a unique fused ketosynthase-cytochrome P450 
monoxygenase, a glycosyltransferase as well as regulatory and self-resistance genes. A knock-
out experiment within module 1 of a polyketide synthase (satB) confirmed the involvement of 
this gene cluster in satosporin biosynthesis as production ceased following gene disruption.  
 
The Pacific Biosciences
®
 sequencing data along with closure of gaps by sequencing 
overlapping amplicons led to the draft genome of K. griseola in 8 contigs totalling 7,966,157 bp 
and an overall G + C content of 72.7%. Annotation using RAST revealed 9 complete + 5 
incomplete rRNA operons and 7,226 protein encoding sequences. The K. griseola genome was 
similar to other kitasatosporae and streptomycetes in terms of developmental and regulatory 
genes and antiSMASH analysis revealed 23 secondary metabolite biosynthetic gene clusters, 15 
of which had unknown products.  
 
Over 75% of the bioactive metabolites produced by actinomycete bacteria are from 
members of the genus Streptomyces. There is, however, a growing interest in bioprospecting 
from “rare” or non-streptomyces actinomycetes such as kitasatosporae. Twelve kitasatosporae 
were thus cultured in two media and metabolomic analysis using principal component analysis 
was used to rapidly identify putatively new natural products. Through collaborative work with 
MMS student Krista Gill, cystargamide and cystargolide A and B were identified as new 
compounds.    
   
v 
 
ACKNOWLEDGEMENTS 
I would like to start by thanking Dr Russell Kerr for having taken me on as a graduate 
student back in 2009. Throughout the years, you have given me a great deal of flexibility and 
independence and you have entertained many reseach ideas that, although unplanned, have 
yielded great results; without these leaps of faith, I would not have learned as much about so 
many research areas as I have while under your supervision. To my research manager, Bradley 
Haltli, I thank you for sharing your knowledge and skills and always being available to 
troubleshoot and brainstorm with me. Your passion and enthusiasm for quality scientific 
research has helped shape me into the scientist I am today and has, in the process, made me fall 
in love with bacterial genetics and molecular biology. 
We are very fortunate in the Kerr laboratory to have access to excellent research managers 
with distinct areas of expertise and a strong desire to help and teach. To Fabrice Berrué, I thank 
you for being patient with me as I learned numerous new skills related to chemistry. You were 
always available when I had questions and always made sure I understood the concept fully 
before sending me off, even if that meant you had to repeat yourself a few times. Thanks to 
David Overy and Martin Lanteigne for performing the antimicrobial assays for our lab and being 
available to answer any questions related to them as well. Thanks to all the lab members who, 
thoughout the years, have become great friends. To my officemates and pseudo-officemates 
(Becca, Veronica, Erin, Stacey, Alyssa, Ghada, and Amanda), I have become especially close to 
you and want to thank you for all the talks we have had over the year, science related or not and 
for all the fun times we shared together.    
I would like to acknowledge my current supervisory committee (Dr Russ Kerr, Dr 
Spencer Greenwood, Dr John Burka, Dr Rick Cawthorn and Dr Jason McCallum) as well as past 
members (Dr Byeong Hwa Jeon and Dr Junzen Zhang) for showing interest in my research and 
providing valuable feedback throughout my degree and regarding this thesis.  
This research would not have been possible if not for financial support (stipend and 
research funds) from the Atlantic Veterinary College and Department of Biomedical Sciences 
(graduate student scholarship and other awards/grants), the Natural Sciences and Engineering 
Reserch Council of Canada, the Atlantic Innovation Fund, the Canada Research Chair Program 
and the Lévesque Foundation.   
Furthermore, I would like to acknowledge Tricia Boland for running LCMS experiments, 
Dr Nathan Magarvey for the Illumina
®
 sequencing data, Genome Québec for PacBio sequencing 
services, Dr Alison Thompson for providing circular dichroism spectra and Dr Jason Peason for 
collaborating with us and sharing his computational chemistry expertise. A sincere thank you to 
the staff in biomedical sciences, Debbie Gallant, Suzette Acorn and Sherri Pineau, for always 
being eager to help and for the cheerfulness you bring to the department.  
I would like to thank my parents for shaping me into the person I have become and 
allowing and supporting me in the pursuit of my dreams eventhough they have taken me further 
away from home. Thank you for believing in me; I strive to make you proud. To my brother, 
thank you for keeping me spontaneous and teaching me that winging it every once in a while is 
good for me. Thanks to all of my extended family for always being interested as to what I am 
working on and thanks for traveling to PEI so I could share the wonders of this amazing island 
with you. Thank you to my mother-in-law for raising a wonderful man, for welcoming me into 
your life and for supporting us throughout our studies.   
To my close friends from childhood, high school, college and university, thank you for 
your support and encouragements throughout my seemingly never ending studies. No matter the 
distance, I forever cherish our friendships.  
Finally, to my husband, how can I put in words how grateful I am for everything you give 
me... You are my best friend, my support system, my sidekick and my daily source of love, 
laughter and aww. Thank you for marrying me.     
vi 
 
DEDICATION 
 
 
 
 
 
 
To my family… 
 
 
 
…the one I was fortunate to be 
born into and the one I chose 
to marry into. 
  
vii 
 
TABLE OF CONTENTS 
 
HETEROLOGOUS PRODUCTION OF BIOACTIVE TERPENES AND 
DISCOVERY OF NOVEL NATURAL PRODUCTS FROM MEMBERS OF THE 
GENUS KITASATOSPORA ..................................................................................................... I 
Thesis/dissertation non-exclusive license ............................................................................ II 
Certification of thesis work ................................................................................................... III 
Abstract ..................................................................................................................................... IV 
Acknowledgements ................................................................................................................... V 
Dedication ................................................................................................................................. VI 
Table of contents ..................................................................................................................... VII 
List of tables................................................................................................................................ X 
List of figures ............................................................................................................................ XI 
List of abbreviations ............................................................................................................ XIV 
CHAPTER 1 – AN INTRODUCTION TO NATURAL PRODUCTS- CURRENT 
CHALLENGES AND THESIS RESEARCH GOALS .................................................... 1 
1.1 Natural products and their biosynthesis ......................................................................................... 2 
1.2 Strategies to discover novel natural products ................................................................................. 5 
1.3 Sequencing reveals numerous cryptic biosynthetic pathways within bacterial genomes .............. 6 
1.4 The supply issue can limit the development of natural products into commercial products ......... 9 
1.5 The use of heterologous hosts to produce important natural products ........................................ 10 
1.6 Thesis research .............................................................................................................................. 12 
CHAPTER 2-HETEROLOGOUS EXPRESSION OF TERPENTECIN IN A 
METABOLICALLY SIMPLIFIED STRAIN OF STREMPTOMYCES LIVIDANS
 .................................................................................................................................................... 14 
2.1 INTRODUCTION ......................................................................................................................... 15 
2.2 MATERIALS AND METHODS .................................................................................................. 17 
2.2.1 Construction of S. lividans TK24 ΔactΔred ................................................................................... 17 
2.2.2 Construction of pTERP_1: The terpentecin biosynthetic gene cluster construct ........................... 32 
2.2.3 Heterologous expression of terpentecin in S. lividans TK24 ΔactΔred ......................................... 42 
2.2.4 Generation of two knock-out strains: K. griseola Δbaf and K. griseola Δterp .............................. 44 
2.2.5 Reassessing terpentecin production in S. lividans TK24 ΔactΔred::pTERP_1. ............................. 48 
2.3 RESULTS AND DISCUSSION .................................................................................................... 48 
2.3.1 Construction of S. lividans TK24 ΔactΔred ................................................................................... 48 
2.3.2 Construction of pTERP_1: The terpentecin biosynthetic gene cluster construct ........................... 56 
2.3.3 Heterologous expression of terpentecin in S. lividans TK24 ΔactΔred ......................................... 65 
2.3.4 Generation of two knock-out strains: K. griseola Δbaf and K. griseola Δterp .............................. 80 
2.2.5 Reassessing terpentecin production in S. lividans TK24 ΔactΔred::pTERP_1. ............................. 94 
2.4 CONCLUSION ............................................................................................................................. 98 
CHAPTER 3 - ISOLATION AND STRUCTURE ELUCIDATION OF 
SATOSPORIN A AND B: NEW POLYKETIDES FROM THE ACTINOMYCETE 
KITASATOSPORA GRISEOLA ........................................................................................ 101 
3.1 INTRODUCTION ........................................................................................................................102 
3.2 MATERIALS AND METHODS .................................................................................................103 
3.2.1 Fermentation of Kitasatospora griseola MF730-N6 ................................................................... 103 
viii 
 
3.2.2 Isolation of satosporins from K. griseola fermentation ................................................................ 105 
3.2.3 Structure elucidation of satosporins ............................................................................................. 107 
3.2.4 Determining the relative and absolute stereochemistry by computational modeling ................... 107 
3.2.5 Determining the absolute configuration at C16 by the modified Mosher’s reaction ................... 108 
3.2.6 Determining the stereochemistry of the carbohydrate moiety of satosporin A by the modified 
Tanaka’s derivatization ......................................................................................................................... 108 
3.2.7 Searching for satosporins in other Kitasatospora strains ............................................................. 109 
3.2.8 Biological activity of satosporins ................................................................................................. 109 
3.3 RESULTS AND DISCUSSION ...................................................................................................111 
3.3.1 Fermentation of Kitasatospora griseola MF730-N6 ................................................................... 111 
3.3.2 Isolation and structure elucidation of satosporins from K. griseola fermentation ....................... 111 
3.3.3 Determining the relative and absolute stereochemistry of satosporins ........................................ 121 
3.3.4 Determining the absolute configuration at C16 by the modified Mosher’s reaction ................... 127 
3.3.5 Determining the stereochemistry of the carbohydrate moiety of satosporin A by the modified 
Tanaka’s derivatization ......................................................................................................................... 129 
3.3.6 Searching for satosporins in other Kitasatospora strains ............................................................. 132 
3.3.7 Biological activity of satosporins ................................................................................................. 132 
3.4 CONCLUSION ............................................................................................................................133 
CHAPTER 4 - ORGANIZATION OF THE SATOSPORIN BIOSYNTHETIC 
GENE CLUSTER IN KITASATOSPORA GRISEOLA ............................................... 134 
4.1 INTRODUCTION ........................................................................................................................135 
4.2 MATERIALS AND METHODS .................................................................................................137 
4.2.1 Fermentation of Kitasatospora griseola and chemical extraction ............................................... 137 
4.2.2 Sequencing of the sat cluster ....................................................................................................... 137 
4.2.3 Insertional inactivation of module 1 ............................................................................................ 140 
4.2.4 Sequence analysis of the sat cluster ............................................................................................. 141 
4.3 RESULTS AND DISCUSSION ...................................................................................................141 
4.3.1 Fermentation of Kitasatospora griseola and chemical extraction ............................................... 141 
4.3.2 Sequencing of the sat cluster ........................................................................................................ 142 
4.3.3 Insertional inactivation of module 1 to generate K. griseola ∆sat ............................................... 153 
4.3.4 Sequence analysis of the sat cluster and revised proposed biosynthesis ...................................... 156 
4.4 CONCLUSION ............................................................................................................................173 
CHAPTER 5 - DRAFT GENOME SEQUENCE OF KITASATOSPORA 
GRISEOLA MF730-N6 AND INSIGHTS INTO THE POTENTIAL FOR 
SECONDARY METABOLITE PRODUCTION ......................................................... 174 
5.1 INTRODUCTION ........................................................................................................................175 
5.2 MATERIALS AND METHODS .................................................................................................176 
5.2.1 Strain information ........................................................................................................................ 176 
5.2.2 Genome sequencing and assembly .............................................................................................. 176 
5.2.3 Genome annotation and analysis .................................................................................................. 177 
5.2.4 Accession numbers ...................................................................................................................... 177 
5.3 RESULTS AND DISCUSSION ...................................................................................................177 
5.3.1 Sequencing and assembly ............................................................................................................ 177 
5.3.2 General features of the K. griseola MF730-N6 genome .............................................................. 183 
5.3.3 Genes involved in developmental regulation ............................................................................... 193 
5.3.4 Genes involved in secondary metabolism .................................................................................... 199 
5.4 CONCLUSION ............................................................................................................................210 
 
ix 
 
CHAPTER 6 - DISCOVERY OF NEW NATURAL PRODUCTS FROM 
MEMBERS OF THE GENUS KITASATOSPORA BY METABOLOMIC 
PROFILING .......................................................................................................................... 212 
6.1 INTRODUCTION ........................................................................................................................213 
6.2 MATERIALS AND METHODS .................................................................................................213 
6.2.1 Fermentation and extraction of 12 kitasatosporae........................................................................ 213 
6.2.2 Data processing and statistical analysis ....................................................................................... 214 
6.2.3 Biological assay ........................................................................................................................... 215 
6.2.4 Purification of compounds of interest and structure elucidation .................................................. 215 
6.3 RESULTS AND DISCUSSION ...................................................................................................215 
6.3.1 General results ............................................................................................................................. 215 
6.3.2 Hits based on chemical novelty ................................................................................................... 221 
6.3.3 Hits based on biological activity .................................................................................................. 225 
6.4 CONCLUSION ............................................................................................................................231 
CHAPTER 7 - GENERAL CONCLUSIONS AND FUTURE DIRECTIONS ...... 232 
7.1 Development of a metabolically simplified strain of Streptomyces lividans TK24 unable to 
heterologously produce the antibacterial terpene terpentecin. .........................................................233 
7.2 Satosporin A and B are new polyketide natural products from K. griseola MF730-N6 with an 
unprecedented tricyclic ring system and unusual sugar moieties. ....................................................234 
7.3 The satosporin biosynthetic gene cluster involves genes encoding multimodular type I polyketide 
synthases, a cytochrome P450, a glycosyltransferase, a unique fused KS-P450 as well as regulatory 
and self-resistance genes. ...................................................................................................................235 
7.4 The genome of K. griseola MF730-N6 has similar developmental regulatory genes to other 
kitasatosporae and contains 23 putative secondary metabolite biosynthetic gene clusters. .............237 
7.5 Principal component analysis of the metabolomes of twelve kitasatosporae allowed the rapid 
detection of novel natural products ...................................................................................................238 
7.6 Concluding remarks.....................................................................................................................240 
REFERENCES ..................................................................................................................... 241 
APPENDIX A - Supporting information regarding the structure elucidation of 
satosporin a-c (chapter 3) ................................................................................................... 256 
 
  
x 
 
LIST OF TABLES 
Table 2.1. Plasmids used and constructed throughout this study. ............................................... 19 
Table 2.2. Sequences of primers used in this study ..................................................................... 20 
Table 2.3. Recipes for selected media used in this study. ........................................................... 24 
Table 2.4. Polymerase chain reaction conditions used throughout this study ............................. 27 
Table 2.5. Sequencing of 13 regions with discrepancy with the terpentecin gene cluster .......... 36 
Table 2.6. Formation of the terpentecin biosynthetic gene cluster construct .............................. 41 
Table 2.7. Ions present in extracts from S. lividans TK24 ∆act∆red::pTERP_1 clone 9 ............ 79 
Table 2.8. Ions absent from fermentations of K. griseola ∆terp ................................................. 89 
Table 3.1. Species of Kitasatospora used in the study .............................................................. 110 
Table 3.2. NMR table for satosporin A (1) ............................................................................... 114 
Table 3.3. NMR table for satosporin B (2) ................................................................................ 117 
Table 3.4. NMR table for satosporin C (3) ................................................................................ 120 
Table 3.5. Comparison of predicted and experimental proton interatomic distances ............... 126 
Table 4.1. Primers and plasmids used during this study. .......................................................... 139 
Table 4.2. Preliminary dereplication of each KS-AT amplicon using degenerate primers ....... 144 
Table 4.3. Contigs generated from 58 KS-AT clone amplicons ............................................... 145 
Table 4.4. KS-AT clones and associated modules of the bafilomycin gene cluster .................. 147 
Table 4.5. Biosynthetic genes in nodes and contigs generated from Illumina
®
 sequencing ..... 149 
Table 4.6. Alignment between previous hits and the 15 PacBio contigs .................................. 152 
Table 4.7. BLAST
®
p results for each open reading frame within the sat cluster ...................... 158 
Table 4.8. Deduced function of each open reading frame ......................................................... 159 
Table 5.1. Primers and PCR conditions to close gaps within genome assembly ...................... 178 
Table 5.2. Sequencing primers used to confirm gap closure amplicons ................................... 179 
Table 5.3. Read data generated from each of the eight SMRT
®
 cells ....................................... 182 
Table 5.4. General features of K. griseola MF730-N6 and other kitasatosporae genomes ....... 185 
Table 5.5. Aerial mycelia orthologous genes identified in K. griseola ..................................... 194 
Table 5.6. Whi and ssgA-like protein orthologous genes located in Kitasatospora griseola .... 198 
Table 5.7. Known secondary metabolite biosynthetic gene clusters in K. griseola. ................. 201 
Table 5.8. Unknown secondary metabolite biosynthetic gene clusters in K. griseola .............. 202 
 
 
  
xi 
 
LIST OF FIGURES 
Figure 1.1. Two biosynthetic routes for the production of IPP and DMAPP ............................... 3 
Figure 1.2. Secondary metabolite biosynthetic gene clusters in S. coelicolor genome................. 8 
Figure 2.1. Strategy to heterologously express terpentecin ........................................................ 18 
Figure 2.2. Maps of plasmids used in this study ......................................................................... 23 
Figure 2.3. Structures and biosynthetic gene clusters for actinorhodin and undecylprodigiosin 25 
Figure 2.4. Representation and annotation of the terpentecin biosynthetic gene cluster ............ 33 
Figure 2.5. Design of the efficient promoter ............................................................................... 37 
Figure 2.6. Sequence of PErmE*_actII-ORF4_JC ..................................................................... 37 
Figure 2.7. Vector maps for pSET152 and pWEB ...................................................................... 39 
Figure 2.8. Arrangement of the bafilomycin and terpentecin biosynthetic gene clusters ........... 45 
Figure 2.9. Predicted and experimental restriction map of pKC1139_act_KO .......................... 50 
Figure 2.10. Predicted and experimental restriction map of pKC1139_red_KO ........................ 50 
Figure 2.11. Colony PCR to identify act and red knock-out strains ........................................... 52 
Figure 2.12. Culture pigmentation and pH change in act and red knock-out strains .................. 52 
Figure 2.13. Spectrophotometric measurements of act and red .................................................. 54 
Figure 2.14. PCR amplification of each terpentecin segment ..................................................... 57 
Figure 2.15. Predicted and experimental restriction fragments of pSEGMENT1 DNA ............. 57 
Figure 2.16. Predicted and experimental restriction fragments of pSEGMENT2 DNA ............. 58 
Figure 2.17. Predicted and experimental restriction fragments of pSEGMENT3 DNA ............. 60 
Figure 2.18. Assembly of reference and sequencing results of terpentecin segments ................ 61 
Figure 2.19. Various steps towards the construction of pUC57::PErmE*_actII-ORF4_JC ....... 63 
Figure 2.20. Predicted and observed pJC001 DNA fragments following digestion. .................. 64 
Figure 2.21. Colony PCR for terpentecin segments in E. coli  ................................................... 66 
Figure 2.22. Map of pTERP_1 .................................................................................................... 67 
Figure 2.23. Assembly between the reference and amplicons for pTERP_1 .............................. 68 
Figure 2.24. Predicted and observed fragments of pTERP_1 pDNA ......................................... 69 
Figure 2.25. PCR screen for terpentecin genes in S. lividans TK24 ΔactΔred::pTERP_1 ......... 71 
Figure 2.26. Monitoring the expression of terpentecin genes by RT-PCR ................................. 72 
Figure 2.27. Differences between crude extracts from recombinant and control strains ............ 75 
Figure 2.28. Mass spectra for recombinant and control strains at 2.60 and 2.88 min ................. 76 
Figure 2.29. Monitoring ions 365.1959±5 ppm in native, recombinant and control strains ....... 78 
Figure 2.30. PCR screen and restriction digest of E. coli pBAFKO ........................................... 81 
Figure 2.31. Restriction digest of pTERPKO ............................................................................. 83 
Figure 2.32. PCR identification of bafilomycin and terpentecin mutants ................................... 84 
Figure 2.33. LC-HRMS and inhibition assay for K. griseola MF730-N6 and knock-out strain K. 
griseola ∆baf. ....................................................................................................................... 86 
Figure 2.34. LC-HRMS and inhibition assay for K. griseola MF730-N6 and knock-out strain K. 
griseola ∆terp ....................................................................................................................... 88 
Figure 2.35. Structures of terpentecin and related compounds ................................................... 91 
Figure 2.36. Principal component analysis of wild-type and terpentecin knock-out strains. ...... 93 
Figure 2.37. Principal component analysis using both media ..................................................... 96 
Figure 2.38. Screening for metabolites in recombinant and control strains ................................ 97 
Figure 3.1. Structures of satosporins A-C. ................................................................................ 104 
xii 
 
Figure 3.2. Purification scheme  of satosporin A-B .................................................................. 113 
Figure 3.3 Key COSY and HMBC correlations of satosporin A. ............................................. 115 
Figure 3.4. Enzymatic deglucosylation of satosporin A ........................................................... 119 
Figure 3.5. LCMS and corresponding mass spectrum for satosporin A-C ............................... 119 
Figure 3.6. Key NOESY correlations of satosporin C. ............................................................. 122 
Figure 3.7. Diagnostic proton distances (Å) for each stereoisomer of satosporin C ................. 124 
Figure 3.8. Calculated  and experimetnal ECD spectra for satosporin C .................................. 128 
Figure 3.9. Modified Mosher reaction on satosporin C ............................................................ 130 
Figure 3.10. Sugar derivatization of satosporin A  ................................................................... 131 
Figure 3.11. LCMS of standard and satosporin sugars following derivatization ...................... 131 
Figure 4.1. Structure of satosporins A and B from K. griseola MF730-N6. ............................. 136 
Figure 4.2. Proposed satosporin biosynthetic scheme............................................................... 136 
Figure 4.3. HRMS of satosporins in K. griseola  extract .......................................................... 143 
Figure 4.4. Restriction patterns of KS-AT insert amplicons ..................................................... 144 
Figure 4.5. Possible orientations of the KS-AT amplicon during cloning ................................ 147 
Figure 4.6. Colony PCR and HRMS of K. griseola and knock-out strain ................................ 154 
Figure 4.7. Proposed biosynthesis of satosporins based on sat cluster ..................................... 157 
Figure 4.8. Diels-Alder cyclization reaction mechanism proposed in satosporin biosynthesis 165 
Figure 4.9. Partial alignment of the cytochrome P450 sequences in the sat cluster ................. 167 
Figure 4.10. π-bond oxidation reactions by P450 monoxygenases ........................................... 169 
Figure 4.11. Second proposed mechanism to afford the satosporin ketone at C9 .................... 169 
Figure 4.12. Betaenone B biosynthesis ..................................................................................... 169 
Figure 5.1. Geneious assembly using 13 of the 15 contigs ....................................................... 182 
Figure 5.2. Alignment of the 3' end of Quiver_34 with Quiver _43 ......................................... 184 
Figure 5.3. Evidence that contigs Quiver_42 and Quiver_34 are adjacent on the genome ...... 184 
Figure 5.4. Distribution of rRNA operons and tRNA genes within the genome ...................... 185 
Figure 5.5. Number of CDS in each subsystem category by RAST ......................................... 186 
Figure 5.6. Genome synteny between K. griseola and other kitasatosporae............................. 188 
Figure 5.7. Alignment of the putative oriC regions from five kitasatosporae genomes ........... 190 
Figure 5.8. Distribution of “strong” DnaA box sequences within the genome ......................... 190 
Figure 5.9. Amino acid and nucleotide alignments of SsgB protein ......................................... 192 
Figure 5.10. Gene synteny of the ram cluster and predicted lantipeptide ................................. 196 
Figure 5.11. Sporulation in streptomycetes ............................................................................... 197 
Figure 5.12. Gene synteny between kitasatosporae for ssgR and ssgA ..................................... 200 
Figure 5.13. Distribution of secondary metabolite biosynthetic gene clusters ......................... 204 
Figure 5.14. Synteny surrounding lantipepide synthetases ....................................................... 205 
Figure 5.15. Unknown siderophore biosynthetic gene clusters 1 and 14 .................................. 209 
Figure 6.1. Bucket condensation and matrix generated during metabolomic analysis ............. 217 
Figure 6.2. Principal component analysis of kitasatosporae metabolomes ............................... 219 
Figure 6.3. Buckets responsible for separation of K. mediocidica and K. cystarginea ............. 220 
Figure 6.4. ELSD chromatogram and HRMS of K. cystarginea extracts and structure of 
cystargamide. ..................................................................................................................... 223 
Figure 6.5. ELSD chromatograms of K. mediocidica extract and structure of pepstatin A ...... 224 
Figure 6.6. ELSD chromatograms of K. kifunensis extract and structure of naphthomycin A. 227 
xiii 
 
Figure 6.7. Buckets responsible for the separation of K. griseola NRRL B-16229 .................. 229 
Figure 6.8. ELSD chromatograms of K. griseola NRRL B-16229 extract ............................... 230 
Figure A.1. HRMS of satosporin A. ......................................................................................... 257 
Figure A.2. HRMS of satosporin B. .......................................................................................... 257 
Figure A.3. HRMS of satosporin C. .......................................................................................... 258 
Figure A.4. 
1
H NMR spectrum (600 MHz, CD3OD) of satosporin A. ..................................... 258 
Figure A.5.
 13
C NMR spectrum (150 MHz, CD3OD) of satosporin A. ..................................... 259 
Figure A.6. COSY spectrum of satosporin A. .......................................................................... 259 
Figure A.7. HSQC spectrum of satosporin A. .......................................................................... 260 
Figure A.8. HMBC spectrum (600 MHz, CD3OD) of satosporin A. ........................................ 260 
Figure A.9. ROESY spectrum (600 MHz, CD3OD) of satosporin A. ....................................... 261 
Figure A.10. 
1
H NMR spectrum (600 MHz, CD3OD) of satosporin B. .................................... 261 
Figure A.11. COSY spectrum of satosporin B. ......................................................................... 262 
Figure A.12. HSQC spectrum (600 MHz, CD3OD) of satosporin B. ....................................... 262 
Figure A.13. HMBC spectrum (600 MHz, CD3OD) of satosporin B. ...................................... 263 
Figure A.14. ROESY spectrum of satosporin B. ...................................................................... 263 
Figure A.15. 
1
H NMR spectrum (600 MHz, CD3OD) of satosporin C. .................................... 264 
Figure A.16. COSY spectrum of satosporin C. ......................................................................... 264 
Figure A.17. HSQC spectrum of satosporin C. ......................................................................... 265 
Figure A.18. HMBC spectrum of satosporin C. ........................................................................ 265 
Figure A.19. NOESY spectrum of satosporin C. ...................................................................... 266 
Figure A.20. Infrared spectra (IR) recorded at 25°C in methanol for satosporin A-C .............. 267 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
LIST OF ABBREVIATIONS 
A   absorbance 
A   adenylation 
Å   angstrom 
ABC   ATP-binding cassette 
ACN   acetonitrile 
ACP   acyl-carrier protein 
ACT   actinorhodin 
ANOVA  analysis of variance 
antiSMASH  antibiotic and secondary metabolites analysis shell 
ARS   Agriculture Research Service  
AT   acyltransferase 
BLAST
®  
Basic Local Alignment Search Tool 
bp   base pair 
C   condensation  
C18   octadecylsilane 
CCS   circular consensus sequence 
CD3OD   deuterated methanol 
cDNA   complementary deoxyribonucleic acid 
CDS   coding sequences 
CLR   continuous long read 
CoA    coenzyme A  
COSY   correlation spectroscopy 
DAP   diaminopimelic acid  
DCM   dichloromethane 
DH   dehydratase 
Dha   dehydroalanine 
Dhb    dehydrobutyrine 
DMAP   4-dimethylaminopyridine 
DMAPP   dimethylallyl diphosphate 
DMSO   dimethyl sulfoxide 
DNA   deoxyribonucleic acid  
DXP    1-deoxy-D-xylulose 5-phosphate  
ε   extinction coefficients  
ECD   electronic circular dichroism 
ED50   median effective dose  
ELSD   evaporative light scattering detector  
eq   equivalents 
ER   enoyl reductase  
ESI   electrospray ionization  
EtOAc   ethyl acetate  
FPP   farnesyl diphosphase  
gDNA   genomic deoxyribonucleic acid 
GGPP    geranylgeranyl diphosphate  
xv 
 
GPP   geranyl diphosphate  
HGAP2  Hierarchical Genome Assembly Process 2 
HMBC   heteronuclear multiple bond correlation 
HMG-CoA  3-hydroxy-3-methyl-glutaryl-CoA  
HPLC   high performance liquid chromatography 
HRESIMS  high resolution electrospray ionization mass spectrometry 
HRMS   high resolution mass spectrometry 
HSQC   heteronuclear single quantum coherence  
Ɩ   path length 
IC50   half maximal inhibitory concentration 
IPA   isopropyl alcohol 
IPOD   International Patent Organism Depositary 
IPP    isopentenyl diphosphate 
ISP3   international Streptomyces project medium 3 
J   coupling constant 
kb   kilobase pair 
KO   knock-out 
KR   ketoreductase  
KS   ketosynthase 
LB   Luria-Bertani 
LC   liquid chromatography 
LC-HRMS  liquid chromatography-high resolution mass spectrometry 
m/z   mass to charge ratio 
Mb   megabase pair 
MeOH   methanol 
MEP    2-C-methyl-D-erythritol 4-phosphate  
MEV   mevalonate 
MIBiG   minimal information about a biosynthetic gene cluster 
MIC   minimum inhibitory concentration  
MMS   molecular and macromolecular sciences 
MPA   methoxyphenylacetic acid 
MRSA   methicillin-resistant Staphylococcus aureus 
MS   mass spectrometry 
MS
n
   tandem mass spectrometry  
MYM   maltose-yeast extract-malt extract 
N50   minimum fragment length to generate half of the genome assembly  
nanoDESI   nanospray desorption ionization 
NCBI   national center for biotechnology information 
NEB   New England Biolabs 
NMPDR  National Microbial Pathogen Data Resource  
NMR   nuclear magnetic resonance 
NOE   nuclear overhauser effect 
NOESY  nuclear overhauser effect spectroscopy 
NRP   nonribosomal peptide 
xvi 
 
NRPS   nonribosomal peptide synthase 
nt   nucleotide 
ORF   open reading frame 
OSMAC  one strain/many compounds 
PacBio   Pacific Biosciences
®
  
PCA   principal component analysis 
PCM   polarizable continuum solvent model 
PCP   peptidyl carrier protein 
PCR   polymerase chain reaction 
PDA   photodiode array detector  
pDNA   plasmid deoxyribonucleic acid 
PEG   protein coding sequence 
PK   polyketide 
PKS   polyketide synthase 
R   rectus 
RAST   rapid annotation using subsystem technology 
RBS   ribosome binding site 
RED   undecylprodigiosin 
RiPPs   ribosomally synthesized and post-translationally modified peptides 
RNA   ribonucleic acid  
ROESY  rotating frame overhauser effect spectroscopy 
rpm   revolutions per minute 
rRNA   ribosomal ribonucleic acid  
RT-PCR  reverse transcription-polymerase chain reaction 
S   sinister 
SALP   SsgA-like protein 
SBSPKS  structure based sequence analysis of polyketide synthases 
SMRT
®   
single molecule real-time  
SPE   solid phase extraction  
TBME   tert-butyl methyl ether 
TCA   tricarboxilic acid 
TDDFT  time-dependent density functional theory 
TFA   trifluoroacetic acid 
tR   retention time 
tRNA   transfer ribonucleic acid 
TSB   tryptic soy broth 
UV   ultraviolet 
νmax    wavenumber absorption maxima 
VRE   vancomycin-resistant Enterococcus 
WT   wild-type 
YEME   yeast extract-malt extract  
ZMW   zero-mode waveguide
1 
 
 
 
 
 
 
CHAPTER 1 – AN INTRODUCTION TO 
NATURAL PRODUCTS- CURRENT 
CHALLENGES AND THESIS RESEARCH 
GOALS 
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1.1 Natural products and their biosynthesis 
Natural products, or secondary metabolites, are non-essential compounds of tremendous 
structural diversity biosynthesized by various organisms that are believed to provide a selective 
advantage to the producer
1, 2
. The compounds fall into the following classes based on their 
biosynthetic origin and structural composition: terpenes, polyketides, nonribosomal peptides, 
alkaloids, shikimic acid derivative and others.  
Terpene (or isoprenoid) natural products include compounds such as artemisinin, 
geosmin, paclitaxel, terpentecin, eleutherobin and pseudopterosins. They are biosynthesized 
from consecutive head-to-tail condensation of two universal isoprene precursors, isopentenyl 
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), to give rise to mono- (C10), sesqui- 
(C15) and diterpenes (C20) via geranyl diphosphate (GPP), farnesyl diphosphase (FPP) and 
geranylgeranyl diphosphate (GGPP) linear intermediates
3
. IPP and DMAPP are produced via 
one of two biosynthetic routes, the mevalonate (MEV) and the non-mevalonate pathways. The 
mevalonate pathway is present in eukaryotes including all mammals, the cytosol and 
mitochondria of plants and fungi, archae and a few bacteria. It converts 3 molecules of acetyl-
coenzyme A (CoA) into IPP via a mevalonate intermediate
4
 (Figure 1.1). In contrast, the non-
mevalonate pathway (also referred to as the 2-C-methyl-D-erythritol 4-phosphate (MEP) and 1-
deoxy-D-xylulose 5-phosphate (DXP) pathways) is found mainly in bacteria, cyanobacteria, 
green algae, and in the plastid of plants and converts pyruvate and glyceraldehyde-3-phosphate 
into IPP and DMAPP via a methylerythritol phosphate intermediate
4
 (Figure 1.1). The great 
structural diversity of terpenes is then achieved by reactions such as cyclization, methylation, 
hydroxylation, epoxidation and glycosylation
4
. Actinomycetes such as Kitasatospora griseola 
MF730-N6, Streptomyces sp. CL 190, Streptomyces sp. KO-3988 and Actinoplanes sp. A40644 
have been reported to utilize both pathways, where mevalonate biosynthetic genes were usually 
clustered with other terpene biosynthetic genes
5
. 
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Figure 1.1. Two biosynthetic routes, the mevalonate and non-mevalonate pathways, leading to 
the production of the two isoprene precursor units which are then condensed by 
prenyltransferases to form the basic skeleton of all terpenes; IPP: isopentenyl diphosphate, 
DMAPP: dimethylallyl diphosphate, GPP: geranyl diphosphate, FPP: farnesyl diphosphase, 
GGPP: geranylgeranyl diphosphate. Reproduced, with permission, from Kirby and Keasling, 
2008
6
.  
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Polyketide natural products include compounds such as erythromycin, rapamycin, 
lovastatin and actinorhodin that are biosynthesized via the condensation of a starter unit (usually 
acetyl-CoA and propionyl-CoA) with extender units such as malonyl-CoA and methylmalonyl-
CoA
7
. The enzymes involved in polyketide assembly are polyketide synthases (PKSs) and are 
generally categorized as a type I if it is a large multimodular polypeptide containing modules 
that are each responsible for a single chain extension step as in erythromycin biosynthesis, or as 
type II if the group of polypeptides are reused for each chain elongation as is the case in 
actinorhodin biosynthesis
8
. During polyketide biosynthesis, the extender unit is selected and 
tethered to the acyl-carrier protein (ACP) by the acyltransferase (AT) following which it is 
condensed with the previous ketide by the ketosynthase (KS), resulting in a two-carbon 
extension of the ketide. The presence of one or more of the β-processing enzymes ketoreductase 
(KR), dehydratase (DH) and enoyl reductase (ER) will reduce the β-carbonyl group to an 
alcohol, alkene or alkane, respectively; along with post-PKS tailoring enzymes, they contribute 
to the incredible structural diversity observed in polyketides
9
.  
Nonribosomal peptides are biosynthesized similarly to polyketides, though using amino 
acids as building blocks and nonribosomal peptide synthases (NRPSs) and adenylation (A), 
condensation (C) and peptidyl carrier protein (PCP) as the core domains and epimerases, 
cyclases, oxidases and methyltransferases as tailoring enzymes
10
. Alkaloids are nitrogen 
containing natural products often biosynthesized from ornithine, lysine, tyrosine and tryptophan, 
but where the nitrogen atom may also arise from other sources
11
. Shikimic acid derivatives, as 
the name implies, are compounds derived from shikimic acid and can lead to phenolic natural 
products
11
. Other natural products include ribosomally synthesized and post-translationally 
modified peptides (RiPPs)
12
.  
Secondary metabolites are produced by diverse organisms such as bacteria, fungi, plants, 
and invertebrates of both terrestrial and marine habitats and can provide functional roles in 
defense (and offense) and communication
1, 13
; the production of secondary metabolites can also 
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play important roles in symbiotic relationships
13
. It is becoming increasingly evident that 
bacterial symbionts can be responsible for the production of secondary metabolites that were 
initially thought to be produced by invertebrates. Such has been the case for bryostatin, 
onnamide/peredin, psymberin, patellamides, cyanobactins and ET-743
14-16
. Though many more 
natural products are suspected to be produced by a microbial symbiont, challenges in culturing 
these symbionts have made it difficult to unequivocally identify the true producers and instead, 
genetic techniques must be used to provide supporting evidence for microbial biosynthesis
17
.  
Although the link between the natural product and its ecological importance is often 
unknown, numerous compounds have biological properties that can be exploited by humans
1
. 
We have indeed benefited from natural products for thousands of years, beginning with the use 
of ethnobotanical remedies
18
 and more recently with the isolation of pure bioactive compounds 
by the pharmaceutical industry for use as antimicrobial, anticancer, antiviral, anti-inflammatory 
and anti-hypertensive agents
19, 20
. Natural product drug discovery is a lengthy and costly process 
which includes the discovery of novel compounds with promising biological activity, followed 
by preclinical and clinical trials (Phase I, II and III)
21
. Although challenges may be encountered 
at every step, focus on challenges pertaining to the early steps of the process will be discussed 
here as this constitutes the focus of the research within the Kerr laboratory: to identify new 
natural products with potential uses as human and animal therapeutics. The main challenges 
faced are the high occurrence of compound rediscovery (including the difficulty of discovering 
novel natural products) and the inability to provide required amounts of the natural product, also 
referred to as the supply issue
22
.  
1.2 Strategies to discover novel natural products 
To discover new secondary metabolites, one must first be able to rapidly identify which 
compounds in an extract are known, a process known as chemical dereplication. This important 
step ensures minimal time and resources are allocated to the purification and structure 
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elucidation of known compounds. Numerous strategies have been developed to enable chemical 
dereplication and usually rely on a combination of chromatographic methods (such as liquid 
chromatography (LC) and solid phase extraction (SPE)) coupled with spectrometric and 
spectroscopic techniques (such as mass spectrometry (MS) and nuclear magnetic resonance 
(NMR)) along with searchable databases (such as AntiBase, Marinlit, AntiMarin and the 
Dictionary of Natural Products)
23
. While advances in analytical techniques have allowed for 
reduced preparation times and higher instrument sensitivity (tandem mass spectrometry (MS
n
), 
nanospray desorption ionization (nanoDESI) MS, high resolution MS, two-dimentional NMR)
22
, 
advances in computerized methodologies have enabled the organization of the plethora of 
information in a meaningful way
24, 25
; together, they have enabled the efficient dereplication of 
large natural product extract libraries. In addition to the rapid identification of known 
compounds, metabolic profiling of natural product extracts can also be used to dereplicate 
bacterial samples in order to compile an organism library based on unique metabolic profiles 
rather than 16S ribosomal ribonucleic acid (rRNA)-based phylogenetic analysis
24
.  
In addition to discarding known metabolites, researchers can improve the likelihood of 
discovering new natural products by collecting organisms from unique environments and 
applying selection methods to remove common species and/or select for unique species within 
the community assemblage as commonly isolated organisms will likely lead to the isolation of 
known compounds
26-28
.  
1.3 Sequencing reveals numerous cryptic biosynthetic pathways within bacterial genomes 
Even when care is taken to study underexplored organisms from unique habitats, natural 
product discovery is hindered by the organism’s secondary metabolite regulatory network and 
the inability of culturing conditions to trigger the production of numerous biosynthetic pathways. 
It is now apparent that numerous microorganisms, especially actinomycetes, have the potential 
to produce many more natural products than reported using traditional fermentation and 
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extraction techniques
29
. A well understood example is that of the model organism Streptomyces 
coelicolor (Figure 1.2), which was believed to produce only a handful of compounds until its 
genome was sequenced in 2002, revealing over 20 secondary metabolite biosynthetic gene 
clusters
30
; as a result of genome mining, 10 additional compounds have now been described 
from this organism
31
.  
Strategies to access these cryptic natural products include both fermentation techniques 
and genetic manipulations to specifically or globally enhance secondary metabolite production
31
. 
Manipulating culture conditions such as media composition, nutrient availability, temperature, 
osmotic pressure and exposure to antibiotics, small molecules and other organisms to trigger an 
increase in production using the one strain/many compounds (OSMAC) approach has proven 
successful but results tend to be unpredictable and are difficult to interpret genetically
29
. On the 
other hand, genetic approaches are more tractable but are more laborious; they include the 
activation/overexpression of global or pathway specific regulators, inactivation of repressors, 
improvements to precursor availability by metabolic engineering and finally heterologous 
expression of the natural product
31
.  
A recent example of a formerly cryptic natural product whose production was triggered 
due to variation in culture condition is that of coelichelin in S. coelicolor. Since genome mining 
revealed that a putative siderophore (encoded by an NRPS) would sequester iron due to the 
presence of hydroxamic acid groups; fermentation of S. coelicolor in low iron conditions led to 
detectable yields of the new compound coelichelin
32
. An example of using genetic manipulations 
to activate cryptic genes has been exemplified by kitasetaline, where genome mining of 
Kitasatospora setae revealed paralogs of a γ-butyrolactone autoregulator which had been 
previously shown to regulate secondary metabolite production
33
; the inactivation of one of the 
paralog, ksbC, led to detectable levels of the new compound kitasetaline
34
. 
With the reduced costs and improved capabilities of sequencing technologies (Illumina
®
, 
Ion Torrent™, Pacific Biosciences® (PacBio) and nanopore sequencing35-37), as well as 
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Figure 1.2. Secondary metabolites biosynthetic gene clusters along the S. coelicolor genome; gene clusters of known metabolites are shown in 
black while those with unknown products are represented by a white vertical line. Reproduced, with permission, from Craney et al.
31
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improvements in genome annotation and secondary metabolite gene prediction software such as 
the antibiotic and secondary metabolites analysis shell (antiSMASH)
38
 and eventually the 
minimal information about a biosynthetic gene cluster (MIBiG, unpublished), genome mining is 
sure to continue to provide numerous opportunities to enhance production of low-yield or cryptic 
natural products from various producers.  
1.4 The supply issue can limit the development of natural products into commercial 
products  
As mentioned previously, natural products can sometimes be difficult to purify due to 
their cryptic nature and low yields. In order to progress through the drug development pipeline, 
large amounts (~100 g) of the compounds are necessary to begin clinical trials
19
. Since natural 
products usually comprise less than 1% by weight of the crude extract
22
, the supply issue is a 
common obstacle in drug discovery programs, especially when the source of the natural product 
cannot be readily cultured
39
.  
Pseudopterosins and eleutherobin are two glycosylated diterpenes isolated from corals of 
the genera Antillogorgia (previously Pseudopterogorgia) and Eleutherobia, with promising anti-
inflammatory
40
 and antitumor activities
41
, respectively. Even though pseudopterosins constitute 
up to 5% of the coral crude extract
42
, their supply for the cosmetic industry and clinical trials 
continues to be a challenge
43
. Similarly, the very low yields of eleutherobin (0.01%) in crude 
extracts of the coral
41
 has prevented even preclinical evaluations of the compound as an 
anticancer drug with similar potency to the currently used drug Taxol
®44, 45
. 
Strategies to overcome the supply issue include large scale collections of the producing 
organism, total and semisyntheses, searching for an alternative producer of bacterial origin, 
metabolic engineering or random mutagenesis of the producing organism to eliminate competing 
pathways and bottlenecks and finally expression of the biosynthetic genes in a heterologous 
host
46, 47
. Though the Kerr laboratory investigates a number of these strategies, a portion of the 
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following thesis will focus on the use of heterologous expression to achieve sustainable 
production of natural products.  
1.5 The use of heterologous hosts to produce important natural products 
Heterologous expression involves the incorporation of appropriate biosynthetic genes 
from the producing organism into a surrogate (heterologous) host that does not normally produce 
the natural product of interest
48
. Parameters to consider when choosing the heterologous host 
include ease of culturing (rapid growth in inexpensive medium), well developed and tractable 
genetic methods for incorporating and expressing foreign deoxyribonucleic acid (DNA), the 
presence of the necessary precursors and cofactors and finally a comprehensive understanding of 
the organism’s regulatory networks and secondary metabolite production (both isolated and 
cryptic)
49
.  
The use of heterologous expression is a valuable tool in characterizing natural product 
biosynthetic pathways
49
 and is often used to express a newly elucidated biosynthetic gene cluster 
as additional evidence that the genes reported are in fact responsible for the biosynthesis of the 
compound
50-55
. Most heterologous expression experiments to date have used Escherichia coli 
and Saccharomyces cerevisiae as hosts due to their rapid growth rates and the availability of 
molecular techniques developed specifically for these organisms
48
. For experiments where the 
objective is to characterize biosynthetic pathways and only detectable levels of the natural 
product are required, these model organisms may serve as ideal hosts. However, if the purpose is 
to have an economic and renewable source of a valuable natural product, alternative hosts may 
provide superior yields without requiring decades of pathway engineering and fermentation 
optimization.  
Although the development of a single host for the high-level production of all natural 
product classes is unlikely, class-specific heterologous hosts hold potential due to the common 
biosynthetic origins of compounds within a class
49
. Since all terpenes share the same the two 
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universal precursors (IPP and DMAPP), a heterologous host capable of producing the two 
compounds in elevated amounts holds great promise for producing an array of terpenes in high 
yield.  
Previous work attempting to optimize the production of high-value, complex terpenes in 
heterologous hosts has focused mainly on artemisinin and paclitaxel in E. coli and S. cerevisiae 
hosts. Successful yield increases have been achieved via an increase in copy number of genes 
involved in rate limiting steps within the MEV and MEP pathways, especially when combined 
with a high flux towards downstream steps as some accumulating intermediates were proven to 
be toxic
56, 57
. The use of exogenous, engineered and codon-optimized genes have provided 
enzymes with increased activity and, along with eliminating competing pathways
58
, have also 
resulted in increased terpene yields
56, 59
. Combining these engineering steps with fermentation, 
extraction and processing optimization have, for example, finally resulted in yields of 25 g/L of 
artemisinic acid, the target yield for economic production of semisynthetic artemisinin
60
.  
Although sufficient yields of heterologous artemisinic acid were eventually obtained, 
decades of contribution from numerous research groups were necessary to achieve these results. 
An alternative approach to this lengthy process involves the use of mutagenic agents to generate 
the desired genotype via random mutations, a process that has been used since the 1940s to 
provide overproducing strains to the pharmaceutical industry
61
.  
Successful random mutagenesis as an approach to increase terpene titers is not conducive 
to high-throughput screening as it relies on lengthy chemical extractions and expensive 
analytical techniques. Given the low probability of obtaining the desired phenotype, numerous 
rounds of mutagenesis and thousands, if not hundreds of thousands, of colonies must be 
screened
62
; a rapid method to identify terpene overproducing mutants is thus essential. The use 
of growth inhibition zones in a soft-agar overlay assay to estimate the production of the 
antibacterial compound has been used in traditional strain improvement programs
61
 and, thus, its 
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use as a rapid terpene screening method would permit the generation of a new platform host for 
the high-level production of terpenes via random mutagenesis.  
Streptomycetes represent promising hosts due to their innate ability to produce numerous 
natural products of various classes including terpenes; the appropriate precursors and cofactors 
required for terpene biosynthesis may thus already be present
63
. Streptomycete hosts have 
previously been used for the heterologous production of bacterial terpenes such as platencin, 
phenalinolactone, terpentecin, cyclooctadin and pentalenolactone
50, 53, 55, 64, 65
 for the purpose of 
pathway characterization, demonstrating that streptomycetes make adequate hosts for the 
production of bacterial terpenes.  
As there is a need for inexpensive, environmentally friendly and sustainable terpene 
production methods, a portion of this thesis will focus on the development of a streptomycete 
heterologous host to circumvent the supply issue as it pertains to the production of terpenes 
specifically. 
1.6 Thesis research  
The general objective within the Kerr laboratory is to discover new natural products for 
applications in human and animal wellness. Members within the lab employ a variety of 
strategies to achieve this goal such as exploring bacterial and fungal communities in various 
environments, using molecular techniques to identify potential producers of secondary 
metabolites, developing new analogues of known compounds via synthetic routes, and using 
metabolomic analyses to identify potentially new natural products. 
One primary objective of my thesis work was to use molecular engineering and strain 
improvement methods to develop a new streptomycete heterologous host that could be used to 
provide a more efficient production of known natural products (Chapter 2). As actinomycetes are 
known to be prolific producers of natural products, special attention was given to the extracts 
from such organisms used during this research and as a result, a new natural product (satosporin) 
was isolated and characterized (Chapter 3). Further examination into the biosynthesis of this new 
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compound was accomplished by sequencing the genome of the producing organism, allowing 
for the description of the satosporin biosynthetic gene cluster (Chapter 4). Simultaneously, this 
data also allowed genomic comparisons to be made with the few kitasatosporae genomes 
previously available and the assessment of secondary metabolite production potential of the 
organism (Chapter 5). Finally, a study was undertaken to compare the metabolomes of numerous 
kitasatosporae and principal component analysis was used to rapidly identify potentially novel 
natural products (Chapter 6).  
 
The specific thesis objectives are:  
Objective 1: To develop a general platform host for the production of bioactive terpenes. 
Objective 2: To discover new natural products from actinomycetes of the genus 
Kitasatospora. 
Objective 3: To investigate the genetic origin of satosporins. 
Objective 4: To describe the genome of Kitasatospora griseola. 
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CHAPTER 2-HETEROLOGOUS EXPRESSION 
OF TERPENTECIN IN A METABOLICALLY 
SIMPLIFIED STRAIN OF STREMPTOMYCES 
LIVIDANS 
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2.1 INTRODUCTION 
Terpene natural products exhibit promising antimicrobial, antiviral, anti-hypertensive, 
anti-inflammatory, antiparasitic and anticancer activities and have been isolated from a variety 
of organisms including corals, sponges, algae, bacteria, plants and fungi from both terrestrial and 
marine environments
3
. Their development into commercially available pharmaceutical products 
is often hindered by insufficient yields produced by the native host, commonly referred to as the 
supply issue. Eleutherobin, for example, is a promising diterpene with potent anticancer activity 
but represents only 0.01% of the crude extracts of the coral Eleutherobia sp.
41
 Due to the 
structural and stereochemical complexities of these compounds, chemical synthesis rarely 
provides a financially feasible alternative production method and large-scale harvest of terpene 
producing marine invertebrates can have devastating effects on marine ecosystems such as coral 
reefs
66
. Consequently, there is pressing need for inexpensive, environmentally friendly and 
sustainable terpene production methods.  
Heterologous host expression provides such a solution. In this approach, a well 
characterized and genetically malleable microorganism is used as an alternative host to produce 
these bioactive natural products via the incorporation of the terpene biosynthetic genes from the 
native producer. Since all terpenes are biosynthesized from the same two precursors: IPP and 
DMAPP, the development of a universal host capable of producing these two metabolites in 
high-yields is an attractive proposal towards achieving high yields of various bioactive terpenes. 
Heterologous hosts such as Escherichia coli, Saccharomyces cerevisiae, Streptomyces 
avermitilis, Streptomyces coelicolor and Streptomyces lividans have been used for terpene 
production with limited success
63
. Recently, however, heterologous amorphadiene production in 
S. cerevisiae has finally reached respectable yields, following 11 years of optimization, where 
the necessary artemisinic acid yield of 25 g/L to supply the world with the antimalarial drug 
artemisinin was achieved in 2013
58
. This long and laborious metabolic engineering process could 
be circumvented by the use of the traditionally used random mutagenesis, where random 
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mutation(s) are generated by iterative exposures to mutagenic chemicals or ultraviolet (UV) 
radiation. This method has been extensively employed in strain development of antibiotic 
producing microorganisms since the discovery of penicillin, where production yields were 
improved in Penicillium chrysogenum from 60 mg/L to 1.8 g/L
62
. Although successful, random 
mutagenesis as an approach to increase terpene titers is not conducive to high-throughput 
screening and given that the probability of identifying improved mutants varies between one in 
1000 to one in 100,000
62
, a rapid method to identify terpene overproducing mutants is essential. 
Since antibiotic production can be rapidly estimated based on growth inhibition zones in an agar 
based assay, the production of an antibacterial terpene in the heterologous host would allow the 
detection of high terpene producing mutants. Terpentecin is a diterpene isolated from the 
actinomycete Kitasatospora griseola MF730-N6 (previously Kitasatosporia griseola and 
Streptomyces griseolosporeus) from soils of Nara Prefecture, Japan
67
. The compound showed 
antimicrobial activity against Gram-positive and Gram-negative bacteria including 
Staphylococcus aureus (minimum inhibitory concentration (MIC) <0.05 µg/mL) and Bacillus 
subtilis NRRL B-558 (MIC <0.05 µg/mL)
67
 and the gene cluster responsible for terpentecin 
biosynthesis in K. griseola was elucidated in 2001
64
. The production of terpentecin in the 
heterologous host would thus allow a rapid antibacterial agar-based assay to track increases in 
terpene production following each round of mutagenesis. 
The objective of this research was to develop a strain of Streptomyces lividans TK24 
capable of producing high yields of terpenes. To this end, the strain was first genetically 
modified to eliminate the production of two native secondary metabolites: actinorhodin and 
undecylprodigionsin. This eliminated any interference from these metabolites during biological 
and chemical assays and eliminated competition for common biosynthetic precursors. Diterpene 
biosynthetic genes responsible for the production of the antibacterial natural product terpentecin 
were then cloned from Kitasatospora griseola and expressed into the newly developed host 
under the control of a constitutive promoter using a newly developed vector and its production in 
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the heterologous host was assessed. An overview of the strategy to heterologously produce 
terpentecin is graphically represented in Figure 2.1. 
2.2 MATERIALS AND METHODS 
Restriction enzymes, T4 DNA ligase, Antarctic Phosphatase and competent Escherichia 
coli 5α and 10β were purchased from New England Biolabs (NEB, Whitby, ON). KOD Hot Start 
DNA Polymerase (TOYOBO), EconoTaq
®
 PLUS GREEN 2X Master Mix (Lucigen) and 
E.Z.N.A.
®
 plasmid mini kit (Omega Bio-Tek) were from VWR (Missassauga, ON). Chemical 
reagents were from Sigma-Aldrich (Oakville, ON). Gel electrophoresis was performed using 1% 
agarose, TAE buffer and 0.05 μg/mL ethidium bromide. Column and gel purifications were 
performed using EZ-10 Spin Column DNA Gel Extraction Kit (Bio Basic) from VWR. General 
procedures were performed according to Sambrook et al.
68
 Chemically competent cells were 
prepared following the rubidium chloride method (published under NEB protocols and modified 
by Joseph Utermohlen). A list of plasmids and primers used and constructed is listed in Table 
2.1 and Table 2.2 and illustrated in Figure 2.2. Media recipes are listed in Table 2.3. 
Liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis was 
performed at various steps using Thermo Scientific™ (Waltham, USA) LTQ Exactive™ 
equipment with a Core Shell Kinetex
®
 1.7 µm C18, 50 X 2.1 mm and 100 Å column, photodiode 
array detector (PDA), SEDEX 80 Sedere LT-ELSD evaporative light scattering detector (ELSD) 
and a Finnigan LXQ ion trap mass spectrometer in positive mode equipped with an electrospray 
ionization source (ESI) detecting m/z between 190 and 2000. Chromatographic separation was 
achieved with a 4.8 min gradient of 95:5 water (H2O):acetonitrile (ACN) to 100% ACN, 3.2 min 
of 100% ACN and finally a return to starting conditions over 3 min; solvents contained 0.1% 
formic acid and a flow rate of 500 µL/min was used.  
2.2.1 Construction of S. lividans TK24 ΔactΔred 
To eliminate the production of actinorhodin (ACT) (1) and undecylprodigiosin (RED) (2) 
(Figure 2.3 (A)) in S. lividans TK24, a portion of the act and the entire red biosynthetic gene  
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Figure 2.1. Schematic representation of the strategy to heterologously express terpentecin: host 
improvement strategy by knock-out of the actinorhodin (act) and undecylprodigiosin (red) 
biosynthetic gene clusters (A); design of the integrating vector containing the biosynthetic genes 
and promoter (B); introduction of the integrating vector into the genetically simplified host via 
conjugation (C). 
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Table 2.1. Plasmids used and constructed throughout this study, Terp: terpentecin , Baf: 
bafilomycin, Apr: apramycin, Amp: ampicillin, Th: thiostrepton, Neo: neomycin. 
Plasmid/strain Relevant characteristics/comments Source/ 
reference 
pKC1139 Apr
R
, rep
UC
, rep
ts
, oriT, lacZα, MCS, Streptomyces 
replicating cloning vector 
69
 
pKC1139_act_KO pKC1139 with act homologous arms, Actinorhodin 
deletion plasmid 
This work 
pKC1139_red_KO pKC1139 with red homologous arms, 
Undecylprodigiosin deletion plasmid 
This work 
pSET152 Apr
R
, rep
UC
, oriT, int
ΦC31
, attP, lacZα, MCS, 
Streptomyces integrating cloning vector 
69
 
pSEGMENT1 pSET152 with terp ORF8-13 This work 
pSEGMENT2 pSET152 with terp ORF13-1 This work 
pSEGMENT3 pSET152 with terp ORF1-7 This work 
pWEB Amp
R
, ori
Co lE1
, cos, ori
SV40
, Neo
R
  Epicentre
®
 
pUC57 Amp
R
, rep
(pMB1)
, lacZ, MCS, cloning vector Bio Basic 
pJC003 Apr
R
, oriT, int
ΦC31
, attP, amp
R
, ori
Co lE1
, cos This work 
pTERP_1 pJC003 with terp cluster and promoter This work 
pSET151 Th
R
, Apr
R
, XylE+, rep
UC
, oriT, lacZα, MCS, 
Streptomyces non-replicating cloning vector 
69
 
pBAFKO pSET151 with homologous arms and aa(3)IV, 
bafilomycin suicide plasmid 
This work 
pTERPKO pSET151 with homologous arms and aa(3)IV, 
terpentecin suicide plasmid 
This work 
E. coli 5α/10β High-efficiency chemically competent host for 
cloning 
New England 
Biolabs 
E. coli ET12567:: 
pUZ8002 
Donor strain during intergeneric conjugation 70 
K. griseola MF730-
N6 
Native terpentecin producer 
67
 
S. lividans TK24 str-6, SLP2
-
, SLP3
-
 John Innes 
Centre
71
 
S. lividans TK24 
ΔactΔred 
Act
-
, Red
-
 This work 
S. lividans TK24 
ΔactΔred::pTERP1 
S. lividans TK24 ΔactΔred with terp gene cluster 
under PErmE*_actII-ORF4_JC 
This work 
S. lividans TK24 
ΔactΔred::pJC003 
S. lividans TK24 ΔactΔred with vector backbone 
only 
This work 
K. griseola ∆baf Terp+, Baf- This work 
K. griseola ∆terp Terp-, Baf+ This work 
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Table 2.2. Sequences of primers used in this study, annealing location in sequence of pTERP_1, 
a
annealing location refers to GenBank accession numbers AL939122, GG657756.1 and 
AP010968.1 for act, red and bafilomycin, respectively and according to the constructed plasmid 
pTerp_1 for terpentecin related primers, engineered restriction sites are underlined. 
Primer Sequence (5′3′), restriction sites underlined Anneals ata 
M13F TGTAAAACGACGGCCAGT N/A 
M13R CAGGAAACAGCTATGACC N/A 
act_left_F GGAAGCTTGCCGGAAATCCAGCGTATGC 158804 
act_left_R GCGTCCATGGCACCCCATCTCCCTTCGACC 159801 
act_right_F GTACCCATGGGATCAGCTCGCGGAGGATGT 165131 
act_right_R GCGTGGATCCGAACGTCCGCCTGGTCGAGA 166213 
act_nested_F GTCACCAGTGCGACTTCGGA 159679 
act_nested _R GACATCCTCCGCGAGCTGATC 165151 
red_left_F CTGGAAGCTTGCGACCGCGCACAGGACCTT 2045009 
red_left_R GCGTCTCGAGCTGGAGAACGTGCCGGCCGA 2046531 
red_right_F GCGTCTCGAGAAACGAAGCACCCCACCGGG 2078660 
red_right_R GTACGGATCCGGAGCGTCCCGTCAGAGCGT 2080181 
TERP-SEG 1-F GTCATATGGGATCCCGAGGAGGGAGCGA 9293 
TERP-SEG 1-R ATGTCGCAGCCGACTCCCAT 16062 
TERP-SEG 2-F ATGCTCCCGTCGTTCAGCCA 15901 
TERP-SEG 2-R GTACTAGTATCCAGGAATGTGCTAGGCG 18925 
TERP-SEG 3-F CTGGCCGACTATGTCGCTTT 18863 
TERP-SEG 3-R GTACTAGTGGCTGCTCCGGTCAGCACGC 25433 
SEQTERP-1-d1-F GGTGTTCGTGGCGGGAGTCG 9799 
SEQTERP-1-d2-F GCGATGATCTCGACCTTCTT 10400 
SEQTERP-1-d3-F GGGCGAGCACCGTCCGACCG 10995 
SEQTERP-1-d4-F CCAGTGCAGACGAGTGGCGA 11602 
SEQTERP-1-d5-F GACATCGCGTATCCGCTGCC 12203 
SEQTERP-1-d6-F ACCACCTCGCTTTCGCCACC 12801 
SEQTERP-1-d7-F ACTGAGCGAGGTGCTGCAGC 13397 
SEQTERP-1-d8-F GGAGCAAACACCCTCGGAGA 14006 
SEQTERP-1-d9-F CGGCCTACAGCTCCATCATT 14607 
SEQTERP-1-d10-F TACTACTCGTGGGGCCGGGAGAAG 15203 
SEQTERP-1-d11-F GTGAGTGACGCGGACAAGTT 15809 
SEQTERP-1-d1-R GAAGAGGTGGCAGTGCTCAT 15582 
SEQTERP-1-d2-R TGGCGCGCTTGATCTCGTGG 14965 
SEQTERP-1-d3-R ATATCGCCGCCGCACACTCCTC 14388 
SEQTERP-1-d4-R GCACCCAGAGCACCTCGAAG 13779 
SEQTERP-1-d5-R AACCCGACCGATCCCCACAG 13204 
SEQTERP-1-d6-R CTCCAGCTGATCAGGGTGAT 12577 
SEQTERP-1-d7-R TATGCCCTGTGTCAGGTTGG 11980 
SEQTERP-1-d8-R CACACTGATCGGCCTGGTCC 11376 
SEQTERP-1-d9-R CCACCTCCTGCATGGTCTGC 10778 
SEQTERP-1-d10-R TCGCGCCCGGCAGGTCGAGG 10175 
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Table 2.2 Sequences of primers used in this study (continued) 
SEQTERP-1-d11-R ACGTGCGTGGCAAGTCGGCA 9575 
SEQTERP-2-d1-F TGCTACGAACTGGCCCGGCA 16433 
SEQTERP-2-d2-F TGCCTGATCTCTGCCGCCGA 17037 
SEQTERP-2-d3-F AGGCTCGCCGTCCGTTACGA 17635 
SEQTERP-2-d4-F CGATTCTGGCCGGCGACGTT 18234 
SEQTERP-2-d5-F CTCACCGAGGAGCAGCGCCG 18830 
SEQTERP-2-d1-R TCGCAGGCGCAGCTCAGCAG 18456 
SEQTERP-2-d2-R ACAAGAAGTGCCCCTTTGCC 17852 
SEQTERP-2-d3-R TCAGGTCCCCACGTCTTGCG 17258 
SEQTERP-2-d4-R TCCTTCGGAATGGCGTAGCC 16656 
SEQTERP-2-d5-R TCGCAGCCGACTCCCATGAC 16059 
SEQTERP-3-d1-F ACGCACGAGCGATCATCCTC 19357 
SEQTERP-3-d2-F GAACAGCCGTCAACCCTGCT 19978 
SEQTERP-3-d3-F TGGTGGTCGCGGTGGTCAGC 20555 
SEQTERP-3-d4-F ACCCGGTGTCGTCGTCTCCT 21155 
SEQTERP-3-d5-F TCGTGGACGCCGCAGTCATC 21778 
SEQTERP-3-d6-F CTTTTTCAGGGACCCCTCCT 22387 
SEQTERP-3-d7-F ACAGATCTCCACCTGGCTGG 22987 
SEQTERP-3-d8-F ACATGGCGACCCTGGCTTCC 23591 
SEQTERP-3-d9-F GATGCGTGCGCATGTCCAAC 24192 
SEQTERP-3-d10-F CCGTCGACGTCATGGACTTC 24794 
SEQTERP-3-d11-F CCACAAGCGCCTCTACCGAG 25395 
SEQTERP-3-d1-R GCTGGTGGTAGCAGAACGCG 24961 
SEQTERP-3-d2-R GTGGTACTTGCCGATCTCGG 24360 
SEQTERP-3-d3-R TTCAGGACGTCGGCCACCAC 23783 
SEQTERP-3-d4-R AACGGATGTCGGCGGAGCTG 23165 
SEQTERP-3-d5-R GTCTCCTGCGCCGTGTTCAG 22560 
SEQTERP-3-d6-R CCCCGAGGGCTTGGCCGCGC 21962 
SEQTERP-3-d7-R AACTTCCGGCCGTCCTCGTG 21358 
SEQTERP-3-d8-R GCCGAGGGCGTTGCGCTCCG 20748 
SEQTERP-3-d9-R GCGAGCTGGACCCGGGTGGT 20156 
SEQTERP-3-d10-R AGCCGATGTCCAGCGCCTGT 19529 
SEQTERP-3-d11-R GAGACCGCATCGTCAGGAAT 18943 
PROMOT-B-F GACCGGTTCAGATTCCGCTGGTCGCACCCGTCA 9156 
PROMOT-B-R TGCGTCGACTCTAGAGATATCGCATGCCATATG
ATCTCCCTTCGACCGCCGCT 
9287 
PROMOT-B-F-Con GATTCCGCTGGTCGCACCCGTCA 9156 
PROMOT-B-R-Con ATCTCCCTTCGACCGCCGCT 9287 
PROMOT-1-R ATAAGTTGAATCTCACCACC 8391 
VEC-pSET-F P-CCGACTATTTGCAACAGTGC 6415 
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Table 2.2 Sequences of primers used in this study (continued) 
VEC-pSET-R P-CTTCCCGGGTGTCTCGCTAC 2361 
TERP_ORF9_F CGGGCGTACTCCTCGATCAT 11076 
TERP_GGPPS_F CCGATCGTCGGGTACCACTT 17978 
TERP_GGPPS_R AAGCGACATAGTCGGCCAGC 18881 
TERP_HMG_coA_Red_F CATCTCGGGAAACGTCGCCA 23244 
TERP_HMG_coA_Red_R CATGCGCACGCATCAGTTCG 24205 
HrdB_F CTCGAGGAAGAGGGTGTGAC N/A 
HrdB_R TGCCGATCTGCTTGAGGTAG N/A 
bafKO_left_F GCTTCGGAATTCGGGCGACCAGCTCCCGTTTG 8335543 
bafKO_left_R  GTAGCATGCCCGCCCGGCGGCTGGACGTG 8336661 
bafKO_right_F GTAGCATGCTGGCTGGACACCGACCTCGA 8407725 
bafKO_right_R  GACTGCAAGCTTGACGAGCTGGCGATCTGGAG 8408740 
terpKO_left_F GCTTCGGAATTCAGCAAGAGGAATTGGAGCCG 12000 
terpKO_left_R  GTAGCATGCACAGGGCCGCTATCCGATCG 13025 
terpKO_right_F  GTAGCATGCCCGAATCGGCCTACAGCTCC 14601 
terpKO_right_R GACTGCAAGCTTGTGACGGAGCCGGTGACGCT 15584 
pJV177_aprR_F CTAGCATGCAGCGTACGGCCCACAGAATG N/A 
pJV177_aprR_R TTCGGCATGCTCATGAGCTCAGCCAATCGAC N/A 
TERP_602_F CGACCTGATGCCGGGTGCGG 12595 
TERP_1660_R GCCGAGGAGAAGTACCTGCC N/A 
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Figure 2.2. Maps of plasmids used in this study: pKC1139, pSET152, pWEB, pUC57 and 
pSET15; reproduced with permission from Keiser et al.
71
, Epicentre
®
 pWEB user manual and 
www.genscript.com/gsfiles/techfiles/GenScript_pUC57-Simple_Plasmid_Map.pdf.  
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Table 2.3. Recipes for selected media used in this study. 
Medium 
Components  
(per L of diH2O,  
unless specified otherwise) 
Seed medium 
10 g glucose 
10 g yeast extract 
Maltose-yeast-malt (MYM) 
 
4 g maltose 
4 g yeast 
10 g malt extract 
 
Mannitol-soy 
20 g mannitol 
20 g soy flour 
tap water 
 
Lean medium  
0.4 g glucose 
0.8 g galactose 
0.8 g maltose 
1.6 g dextrin 
0.8 g Bacto™-Soytone 
0.3 g (NH4)2SO4 
 
Yeast extract-malt extract 
(YEME) + 34% sucrose + 
0.5% glycine 
3 g yeast extract 
3 g Bacto™-Peptone 
3 g malt extract 
10 g glucose 
340 g sucrose 
5 mM (final) MgCl2∙6H2O 
0.5% (final) glycine 
 
International Streptomyces 
project medium 3 (ISP3) 
20 g oatmeal (boiled in 1 L diH2O for 20 min 
and filtered) 
1 mL trace element solution
a
 
Tryptic soy broth (TSB) 
 
17 g pancreatic digest of casein (tryptone) 
3 g Bacto™-Soytone 
5 g NaCl 
2.5 g K2HPO4  
2.5 g dextrose 
 
a
Trace element solution  
1 g FeSO4∙7H2O 
1 g MnCl2∙4H2O 
1 g ZnSO4∙7H2O 
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Figure 2.3. Structures of actinorhodin (1) and undecylprodigiosin (2), two endogenous 
compounds produced by S. lividans TK24 (A) and arrangement of the biosynthetic gene cluster 
of the actinorhodin and undecylprodigiosin in the closely related bacterium, Streptomyces 
coelicolor A3(2). Homologous arms and regions removed are shown in dotted and black boxes, 
respectively, modified from Okamoto et al.
72
 and Cerdeno et al.
73
 (B). 
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clusters were deleted from the genome using a double-crossover gene replacement strategy
71
. 
Act deletion plasmid construction 
To delete a 5.33 kilobase pair (kb) region of the act cluster containing act I ORF1-3, 
actVII and actIV (Figure 2.3 (B)), a 997 base pair (bp) fragment upstream of actI-ORF1 from 
bases 158,804 to 159,801 and a 1082 bp fragment downstream of actVB from bases 165,131 to 
166,213 were amplified by polymerase chain reaction (PCR) using S. lividans TK24 genomic 
DNA (gDNA) as template, KOD Hot Start DNA Polymerase and primer pairs 
act_left_F/act_left_R and act_right_F/act_right_R, respectively according to the conditions 
listed in Table 2.4. The act_left and act_right amplicons were restricted with HindIII/NcoI and 
NcoI/BamHI, respectively and purified from agarose gels following electrophoresis. The arms 
were cloned into the E. coli/Streptomyces shuttle vector, pKC1139 (digested with 
HindIII/BamHI), in a three-way ligation. Ligation was performed using T4 DNA ligase 
according to the manufacturer’s instructions and a 3:1 insert to vector ratio, giving the plasmid 
pKC1139_act_KO.  
A portion of the ligation was used to transform E. coli 5α and recombinant colonies were 
selected using Luria-Bertani (LB) agar containing 50 μg/ml apramycin according to standard 
protocols
68
. Transformants were screened for the presence of the desired plasmid by colony 
PCR. Briefly, a small portion of E. coli colonies were suspended in 25 µL of dimethyl sulfoxide 
(DMSO) using a sterile tooth pick and the resulting suspension was used as template DNA in 
PCR reactions using EconoTaq
®
 conducted using the primers act_left_F and act_right_R (Table 
2.2). Amplification of a 2500 bp band indicated colonies contained the desired plasmid. Colonies 
testing positive in the colony PCR assay were cultured overnight in LB broth containing 
apramycin and plasmid DNA (pDNA) was isolated and subjected to restriction analysis using 
XhoI, BamHI and BamHI/NcoI. Plasmids showing the expected banding pattern for all digests 
were used to transform E. coli ET12567(pUZ8002) cells. Transformants were plated on LB agar 
containing chloramphenicol (25 µg/mL), kanamycin (50 µg/mL) and apramycin (50 µg/ml). 
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Table 2.4. Polymerase chain reaction conditions used throughout this study, times are reported in min:s. 
Amplicon name 
Initial 
denaturation 
Amplification 
Final 
elongation 
  
Cycles  
 
Denaturation Annealing Polymerization  
act_left 
95˚C for 
02:00 
25 95˚C for 00:20 
60-70˚C for 
00:30 
70˚C for 00:30 N/A 
act_right 
95˚C for 
02:00 
25 95˚C for 00:20 
60-70˚C for 
00:30 
70˚C for 00:30 N/A 
red_left 
95˚C for 
02:00 
35 95˚C for 00:20 74.2˚C for 00:10 70˚C for 00:30 
70˚C for 
05:00 
red_right 
95˚C for 
02:00 
35 95˚C for 00:20 75.6˚C for 00:10 70˚C for 00:30 
70˚C for 
05:00 
screen_act 
95˚C for 
02:00 
35 95˚C for 00:20 
60-65˚C for 
00:30 
70˚C for 00:45 N/A 
screen_red 
95˚C for 
02:00 
30 95˚C for 00:20 74.2˚C for 00:10 70˚C for 01:00 N/A 
confirm_act_KO 
95˚C for 
02:00 
30 95˚C for 00:20 59.6˚C for 00:10 70˚C for 02:30 N/A 
confirm_red_KO 
95˚C for 
02:00 
30 95˚C for 00:20 74.2˚C for 00:10 70˚C for 01:00 N/A 
segment 1 
95˚C for 
02:00 
30 95˚C for 00:20 62˚C for 00:10 70˚C for 02:11 N/A 
segment 2 
95˚C for 
02:00 
30 95˚C for 00:20 62˚C for 00:10 70˚C for 01:00 N/A 
segment 3 
95˚C for 
02:00 
30 95˚C for 00:20 60.8˚C for 00:10 70˚C for 02:03 
70°C for 
05:00 
promoter-frag_B 
95˚C for 
02:00 
30 95˚C for 00:20 75.8˚C for 00:10 70˚C for 0:10 N/A 
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Table 2.3 (continued). Polymerase chain reaction conditions used throughout this study, times are reported in min:s. 
vec-pSET 95˚C for 
02:00 
25 95˚C for 00:20 60.2˚C for 00:10 70˚C for 01:40 N/A 
confirm_seg_2-3 98˚C for 2:00 25 98˚C for 00:20 62.3˚C for 00:15 72˚C for 4:00 72˚C for 
05:00 
confirm_pro-seg_1 98˚C for 2:00 25 98˚C for 00:20 69.8˚C for 00:15 72˚C for 1:00 72˚C for 
05:00 
RT_ORF9 94˚C for 2:00 30 94˚C for 00:15 60.5˚C for 00:15 72˚C for 0:30 72˚C for 
5:00 
RT_cyclase 94˚C for 2:00 30 94˚C for 00:15 62.9˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
RT_GGPPS 94˚C for 2:00 30 94˚C for 00:15 64.5˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
RT_HMG-CoA_R 94˚C for 2:00 30 94˚C for 00:15 64.5˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
RT_hrdB 94˚C for 2:00 30 94˚C for 00:15 62.4˚C for 00:15 72˚C for 0:30 
72˚C for 
5:00 
bafKO_left 94˚C for 2:00 30 94˚C for 00:15 71.7˚C for 00:15 72˚C for 1:20 
72˚C for 
5:00 
bafKO_right  94˚C for 2:00 30 94˚C for 00:15 73.1˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
terpKO_left  94˚C for 2:00 30 94˚C for 00:15 71.1˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
terpKO_right 94˚C for 2:00 30 94˚C for 00:15 71.1˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
aprR 94˚C for 2:00 30 94˚C for 00:15 71.3˚C for 00:15 72˚C for 1:00 
72˚C for 
5:00 
screen_bafKO 94˚C for 2:00 30 94˚C for 00:15 73.6˚C for 0:15 72˚C for 3:00 
72˚C for 
5:00 
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Table 2.3 (continued). Polymerase chain reaction conditions used throughout this study, times are reported in min:s. 
conf_bafKO_1 94˚C for 2:00 30 94˚C for 00:15 73.6˚C for 0:15 72˚C for 3:00 
72˚C for 
5:00 
conf_bafKO_2 94˚C for 2:00 30 94˚C for 00:15 73.1˚C for 00:15 72˚C for 1:20 
72˚C for 
5:00 
conf_terpKO 94˚C for 2:00 30 94˚C for 00:15 61.1˚C for 00:15 72˚C for 4:00 
72˚C for 
5:00 
 
 
 
 
 
 30 
 
Deletion of actinorhodin genes in S. lividans TK24 
The deletion plasmid, pKC1139_act_KO, was delivered into S. lividans TK24 via 
intergeneric conjugation between S. lividans TK24 spores and E. coli ET12567/pUZ8002 
harbouring pKC1139_act_KO according to published protocols
71
. Mixtures of E. 
coli::ET12567/pUZ8002/pKC1139_act_KO and S. lividans TK24 spores were plated on 
mannitol-soy agar containing 10 mM MgCl2. Following overnight incubation at 30°C, S. 
lividans TK24 exconjugants containing pKC1139_act_KO were selected for by overlaying 
plates with 1 mL of water containing 0.5 mg nalidixic acid (to inhibit the growth of E. coli) and 
1 mg apramycin and plates were incubated for an additional 16 h. Apramycin resistant 
exconjugants were subcultured twice on mannitol-soy and maltose-yeast extract-malt extract 
(MYM) containing apramycin and nalidixic acid and incubated at 30°C. Due to the temperature 
sensitive replication function of the plasmid, colonies growing at temperatures above 34˚C will 
only be resistant to apramycin if a single crossover event has occurred resulting in genomic 
integration of the plasmid; organisms were thus cultured at 37˚C on mannitol-soy containing 
apramycin. To select for a second crossover and removal of the plasmid from the host, colonies 
from the aforementioned plate were inoculated in 10 mL MYM broth containing no antibiotic 
and incubated at 30°C and 200 revolutions per minute (rpm). One hundred microliters of each 
culture was plated on mannitol-soy containing no antibiotic and grown at 30°C until colonies 
sporulated. It is expected that 50% of the resulting spores would undergo gene deletion via a 
double crossover, while the other half would revert to the original genotype. Spores were 
harvested and plated for single colonies on mannitol-soy. The sensitivity of individual colonies 
to apramycin was evaluated by sequentially plating each colony on mannitol-soy with and 
without apramycin. Apramycin sensitive colonies were kept and their genotype and phenotype 
were confirmed as described below, giving rise to S. lividans TK24 Δact.  
The gene deletion procedure was repeated, using S. lividans TK24 Δact, where a deletion 
plasmid was constructed from two 1.5 kb PCR amplified homologous regions at the extremities 
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of the 35 kb undecylprodigiosin biosynthetic gene cluster (Figure 2.3). The homologous arms 
were cloned into the HindIII and BamHI restriction sites of pKC1139 and a XhoI restriction site 
was engineered in order to ligate the left and right homologous arms. The steps were as 
described above for the ∆act strain, using primers red_left_F and red_left_R to amplify the left 
homologous arm (2045009-2046531 = 1522 bp), red_right_F and red_right_R to amplify the 
right homologous arm (2078660-2080181 = 1521 bp) and finally using red_left_F and 
red_right_R primers in order to screen via PCR for E. coli transformants containing the deletion 
plasmid. EcoRV, XhoI, KpnI and PstI were used to confirm correct assembly of 
pKC1139_red_KO. Conjugation with S. lividans TK24 ∆act was performed using E. coli 
ET12567 (pUZ8002) as the plasmid donor strain and double crossover apramycin-sensitive 
exconjugants were kept, giving rise to the genetically simplified strain S. lividans TK24 
ΔactΔred. 
Confirming the genotype and phenotype of knock-out strains 
To confirm the loss of the 5.33 kb region of the act cluster, two primers were designed 
(Table 2.2): act_nested_F which annealed 25 bp upstream of the end of the act_left arm, and 
act_nested_R which annealed 20 bp downstream of the start of the act_right arm. These primers 
amplified a 5472 bp fragment in wild-type colonies and a 145 bp amplicon in mutant colonies. 
Amplicons using the above primers were obtained using the PCR conditions listed in Table 2.4.  
Similarly, red_left_F and red_right_R primers (Table 2.2) were used to amplify the 
confirm_red_KO amplicon according to the conditions in Table 2.4 in order to confirm the loss 
of the 32.13 kb portion of the undecylprodigiosin biosynthetic gene cluster; an amplicon from 
revertant colonies could not be observed due to the large distance (35 kb) between the primers’ 
annealing location but a 3042 bp amplicon resulted from colonies having undergone gene 
deletion.  
In addition to the genetic characterization of the knock-out strains, the phenotype was also 
investigated. Firstly, pigmentation was visually assessed following a 14-day fermentation in 
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MYM broth. Secondly, taking advantage of the colour changes of act and red in response to 
different pH, 10 drops of 5 M hydrochloric acid (HCl) and 10 drops of 5 M sodium hydroxide 
(NaOH) were added to 3 mL of cultures of S. lividans TK24 and S. lividans TK24 ∆act strain 
6.1. Thirdly, quantification of each compound was achieved spectrophotometry by modifying 
the methods of Borodina et al.
74
 Actinorhodin was measured from six ∆act strains, the revertant 
strain 18.24 and wild-type strain as a positive control. Similarly, red was quantified from six 
∆act∆red strains using ∆act 6.1 and TK24 as positive controls. Organisms were grown in MYM 
at 30°C and 200 rpm for 14 d. Briefly, 5 mL of culture was treated with 10 mL of 2 M NaOH 
and 10 mL acidified methanol (MeOH) (to pH 1.5 with HCl) for act and red, respectively and 
shaken at 150 rpm overnight. The samples were centrifuged at 4000 X g for 10 min, 1 mL of the 
supernatant removed, centrifuged again at 10000 X g for 2 min and the absorbance (A) of the 
supernatants measured using a NanoDrop spectrophotometer (Fisher Scientific, Ottawa, ON) at 
640 nm and 530 nm for act and red, respectively. Concentrations of act and red were calculated 
using the rearranged Beer-Lambert equation, c=A/(ε·Ɩ), using 0.1 cm for path length (Ɩ) and 
25320 M
-1
cm
-1
 and 100500 M
-1
cm
-1
 as extinction coefficients (ε) for act and red, respectively. 
MYM medium was treated the same and used to blank the spectrophotometer. 
An analysis of variance (ANOVA) was performed to determine if there was a significant 
difference in the concentration of each compound between groups (different strains used); an α 
level of significance of 0.05 and sample sizes of 5 and 3 were used for act and red, respectively. 
Residuals were tested for normality and homoscedasticity.  
2.2.2 Construction of pTERP_1: The terpentecin biosynthetic gene cluster construct  
Amplification of the terpentecin biosynthetic genes in three individual segments 
The terpentecin biosynthetic gene cluster published by Dairi et al. in 2001
64
 (Figure 2.4) 
was amplified in three segments via PCR using KOD Hot Start DNA Polymerase according to 
the manufacturer’s instructions using K. griseola MF730-N6 genomic DNA as a template and 
the conditions listed below. Restriction sites were incorporated into the primers of each segment  
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Open reading 
frame 
Predicted protein from gene annotation  Location
a
 
ORF 1 Geranylgeranyl diphosphate synthase 17849-18895 
ORF 2 Mevalonate kinase 18976-19979 
ORF 3 Probable mevalonate diphosphate decarboxylase 20112-21014 
ORF 4 Probable phosphomevalonate kinase 21012-22100 
ORF 5 Type II IPP isomerase 22097-23191 
ORF 6 HMG-CoA reductase 23188-24249 
ORF 7 Probable HMG-CoA synthase 24380-25422 
ORF 8 Probable transmembrane efflux protein 9525-10963 
ORF 9 Unknown protein  11018-11530
*
 
ORF 10 Putative P450 11771-13021 
ORF 11 Diterpene cyclase 13044-14543 
ORF 12 Diterpene cyclase 14543-15478 
ORF 13 Putative P450 15542-16990 
ORF 14 Probable ferrodoxin  16998-17195 
Figure 2.4. Graphical representation and annotation of the terpentecin biosynthetic gene cluster. 
Modified from Dairi et al.
64
; 
a
location of genes in the sequence of the plasmid pTERP_1, 
*
complementary strand translation. 
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in order to facilitate downstream steps and primers were ordered with a 5’ phosphate in order to 
perform blunt-end ligations of the amplicons with dephosphorylated linearized vector DNA.  
The 5′ segment (segment 1), which contained the first 6770 bp of the cluster, was 
amplified using TERP-SEG 1-F and TERP-SEG 1-R primers (Table 2.2), segment 2, which 
contained base pairs 6650 to 9633 of the cluster was amplified using TERP-SEG 2-F and TERP-
SEG 2-R primers (Table 2.2) and segment 3, which contained base pairs 9575 to 16133 of the 
cluster was obtained using TERP-SEG 3-F and TERP-SEG 3-R primers (Table 2.2) according to 
the conditions listed in Table 2.4. 
Each amplicon was gel-purified using the Zymoclean gel DNA recovery kit (Zymo 
Research) and was cloned into pSET152
69
 that had previously been restricted with EcoRV and 
dephosphorylated with Antarctic Phosphatase in order to avoid vector recircularization. Blunt 
ligations were performed using T4 DNA ligase and chemically competent E. coli 10β was 
transformed with 5 µL of the ligation mixtures and plated on LB medium containing 50 µg/mL 
apramycin. 
Plasmid DNA was extracted from five colonies from each transformation using the 
QIAprep Spin Miniprep Kit (Qiagen, Toronto, ON) and pDNA was subjected to restriction 
analysis using XbaI/NheI and NcoI to confirm proper assembly and direction of each amplicon 
in pSET152. Plasmid DNA from a clone showing the expected restriction pattern was sent for 
sequencing to ensure the cloned biosynthetic gene cluster segments contained no errors. This 
was done using the M13F and M13R primers as well as primers designed to anneal at ~600 bp 
intervals in order to sequence the entire length of the segments; primer sequences are listed as 
SEQTERP in Table 2.2. The resulting sequences were assembled and compared to the published 
sequences (accession numbers AB037907.1 and AB048795.1)
64, 75
 using the software 
ContigExpress
®
 (Life Technologies, Burlington, ON). Any DNA regions containing 
discrepancies were resequenced using fresh pDNA preparations and amplicons from genomic 
DNA using EconoTaq
®
 and the following conditions: 95°C for 2 min, 30 cycles of 95°C for 20 
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s, X°C for 10 s, 70°C for Y s and a final extension of 70°C for 5 min, where the variables are 
listed Table 2.5 along with the various primers used to cover all inconsistencies; giving rise to 
pSEGMENT1, pSEGMENT2 and pSEGMENT3.  
To obtain the segments required for the assembly of the desired terpentecin biosynthetic 
gene cluster construct, segment one was obtained by restricting pSEGMENT1 with NdeI and 
NsiI, segment two by restricting pSEGMENT2 with AclI and NsiI, and segment three by 
restricting pSEGMENT3 with AclI and EcoRI. Restricted fragments were subsequently 
subjected to gel electrophoresis and bands of sizes 6.7 kb, 3 kb and 6.5 kb, respectively, were 
purified from the agarose.  
Construction of the constitutive promoter ErmE*_actII-ORF4_JC.  
The previously described constitutive promoter ErmE* in conjunction with actII-ORF4 
(Figure 2.5) was used to ensure transcription of the heterologous genes
76
. Multiple restriction 
sites were incorporated at both ends of the promoter in order to increase its versatility and since 
possible GTG start codons were present within the promoter sequence (Figure 2.6), an 
engineered stop codon was included to cease transcription of the complementary strand, 
rendering transcription of the heterologous genes more efficient. The complete sequence of the 
promoter constructed in this study is illustrated in Figure 2.6. The promoter was constructed 
from two fragments (A and B).  
Fragment A was synthesized by Bio Basic Inc. (Markham, ON) and contained the first 
1060 bp of the promoter. It was provided in the SmaI site of pUC57. In order to clone fragment 
B into pUC57 containing fragment A, plasmid DNA was digested with AgeI and SalI. The 2.7 
kb fragment was then gel-purified and dephosphorylated using Antarctic Phosphatase. Fragment 
B was obtained by PCR using Streptomyces lividans TK24 gDNA as a template and KOD 
Hotstart DNA Polymerase to amplify the 130 bp actIII to actI intergenic region with an AgeI 
restriction site engineered in the PROMOT-B-F primer (Table 2.2) according to the conditions in 
Table 2.4. The product was column purified, restricted with AgeI and SalI and column purified.  
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Table 2.5. Components and conditions used to generate 10 amplicons from gDNA of K. griseola 
MF730-N6 in order to resequence all 13 regions of discrepancy between the cloned segments 
and the published terpentecin gene cluster sequences.  
Amplicon Primer pair  
Annealing 
temperature 
 X (°C) 
Polymerization 
Y (s) 
gDNA seg1-1 
SEQTERP-1-d5-F 
SEQTERP-1-d5-R 
58.5 12 
gDNA seg1-2 
SEQTERP-1-d6-F 
SEQTERP-1-d3-R 
62.9 30 
gDNA seg2-1 
SEQTERP-2-d2-F 
SEQTERP-2-d2-R 
58.5 12 
gDNA seg3-1 
SEQTERP-3-d1-F 
SEQTERP-3-d8-R 
59.7 27 
gDNA seg3-2 
SEQTERP-3-d2-F 
SEQTERP-3-d7-R 
59.7 27 
gDNA seg3-3 
SEQTERP-3-d4-F 
SEQTERP-3-d5-R 
59.7 27 
gDNA seg3-4 
SEQTERP-3-d5-F 
SEQTERP-3-d5-R 
60.9 11 
gDNA seg3-5 
SEQTERP-3-d8-F 
SEQTERP-3-d2-R 
57.8 11 
gDNA seg3-6 
SEQTERP-3-d9-F 
SEQTERP-3-d1-R 
57.8 11 
gDNA seg3-7 
SEQTERP-3-d10-F 
TERP-SEG 3-R 
57.8 11 
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Figure 2.5. Design of the efficient promoter used to drive the transcription of the heterologous 
biosynthetic genes; adapted from Wilkinson et al.
76
 
 
 
 
 
Figure 2.6. Sequence of PErmE*_actII-ORF4_JC; start codons are boxed, the vertical line 
represents the 3 nucleotide deletion to give rise to PermE*, underligned regions are -10 and -35 
ribosomal binding sites and arrows indicate promoter initiation points. 
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Fragments A and B were ligated using T4 DNA ligase (4:1 insert:vector ratio) and used to 
transform E. coli 10 competent cells, which were plated on LB plates containing 100 µg/mL 
ampicillin. Five transformants were screened by restricting pDNA with EcoRI, EcoRV, NdeI 
and BamHI. A plasmid exhibiting the expected banding pattern was named 
pUC57_PErmE*_actII- ORF4_JC and completely sequenced to confirm no mutations had been 
introduced into the sequence. The promoter (1.2 kb) was removed from the vector by restriction 
with NdeI and EcoRI and gel-purified as described previously.  
Construction of a new Streptomyces integrating cosmid vector: pJC003  
An integrating plasmid-cosmid hybrid was designed in order to accommodate our large 
DNA fragment. This was composed of a 4 kb amplicon from pSET152 to allow antibiotic 
selection in Streptomyces (aac(3)IV; apramycin resistance), transfer of the plasmid during 
intergeneric conjugation (oriT, origin of transfer) and integration into the genome of 
Streptomyces (C31 integrase and attP) and a 4 kb fragment from pWEB (Epicentre® via 
Mandel Scientific Company Inc., Guelph, ON ) to provide stability of a large fragment and 
antibiotic selection (bla; ampicillin resistance) in E. coli (colE1 ori); the portions used from each 
plasmid are highlighted in Figure 2.7 (A). Region 1657-5711 of pSET152 (according to 
GenBank AJ414670.1) was amplified using primers VEC-pSET-F/VEC-pSET-R (Table 2.2) 
using KOD Hot Start DNA Polymerase and the conditions listed in Table 2.4 and amplicons 
were column purified.  
Linear pWEB from the Epicentre
®
 Cosmid cloning kit was phosphorylated using T4 
polynucleotide kinase (NEB) and recircularized using T4 DNA ligase. Circularized pWEB was 
used to transform and E. coli 10β and pDNA was purified and digested with HpaI, leaving blunt 
ends. The HpaI fragment was column purified and dephosphorylated using Antarctic 
Phosphatase. Gel-purification of the 4 kb band was not necessary because only plasmids formed 
from the correct fragment would result in resistance to ampicillin and apramycin.  
The 4 kb fragment from pSET152 and 4 kb fragment from pWEB were ligated using a 4:1 
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Figure 2.7. Vector maps for pSET152 and pWEB used to construct the new Streptomyces 
integrating vector pJC003; the portion amplified by PCR (pSET152) and obtained through HpaI 
digest (pWEB) are highlighted in grey (A) and vector map for pJC003 with originating 
fragments and genes in grey and black, respectively (B). 
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insert to vector (pSET:pWEB) ratio using T4 DNA ligase and E. coli 10β was transformed with 
5 µL of the ligation reaction. Transformants were selected on LB agar containing 50 µg/mL 
apramycin and 100 µg/mL ampicillin. Plasmid DNA from transformants was screened with 
EcoRV, NheI, HindIII and AclI (individually). The correctly constructed plasmid was named 
pJC003 (Figure 2.7 (B)). 
To generate the vector for the heterologous expression of terpentecin genes, pJC003 was 
restricted with EcoRI-HF. Following gel-purification of the 8 kb band, the DNA was 
dephosphorylated and the Antarctic Phosphatase enzyme was inactivated by incubating the 
reaction at 70˚C for 5 min.  
Assembly of the entire terpentecin biosynthetic gene cluster in pJC003, resulting in E. 
coli::pTERP_1 
The three segments of the terpentecin gene cluster and PErmE*_actII-ORF4_JC were 
cloned into pJC003 using the Invitrogen quick ligation kit (Life Technologies). The ligation was 
performed using a 6:1 insert to vector ratio using the quantities of DNA shown in Table 2.6. 
DNA used for the ligation reactions was concentrated from 45 µL to 15 µL using a Millipore 
centrifugal filter (nominal molecular weight limit: 30,000, Fisher Scientific) following the 
manufacturer’s protocol. Five microliters of the ligation reaction was then used to transform 
chemically competent E. coli 10β, which was plated on LB containing 50 µg/mL apramycin and 
100 µg/mL ampicillin.  
Transformants were screened by colony PCR, as mentioned previously, in order to 
identify colonies containing all 5 components. Initially, 171 colonies were screened using 
SEQTERP-2-d3-F and SEQTERP-3-d7-R primers (Table 2.2), amplifying DNA at the junction 
of segments 2 and 3 (amplicon confirm_seg_2-3) using the conditions listed in Table 2.4. 
Colonies containing the expected 3.9 kb band were then screened by amplifying DNA at the 
junction of segments 1 and 2 (confirm_seg_1-2 amplicon) using the conditions listed in Table 
2.4 and primers SEQTERP-1-d10-F and SEQTERP-2-d5-R (Table 2.2). Colonies showing the 
expected 856 bp band were grown overnight at 37˚C and 200 rpm in 10 mL LB containing  
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Table 2.6. Steps involved in the formation of each piece required for the formation of the 
terpentecin biosynthetic gene cluster construct. 
 Segment 1 Segment 2 Segment 3 Promoter Vector 
Step 1 
Extract 
plasmid 
DNA 
Extract 
plasmid 
DNA 
Extract 
plasmid 
DNA 
Extract 
plasmid 
DNA 
Extract plasmid 
DNA 
      
Step 2 
Cut NdeI + 
NsiI + 
XhoI 
Cut AclI 
Cut AclI + 
EcoRI-HF 
+ XhoI 
Cut  
EcoRI-HF 
+ NdeI 
Cut  
EcoRI-HF 
      
Step 3 
Gel-purify 
6.77 kb 
 band 
Column 
purify 
Gel-purify 
6.56 kb  
band 
Gel-purify 
1.2 kb  
band 
Gel-purify  
8.1 kb  
band 
      
Step 4  Cut NsiI   Dephosphorylate  
      
Step 5 
 
 
Gel-purify 
3 kb band 
  Heat inactivate 
      
Amount of 
DNA used 
208 ng 92 ng 202 ng 37 ng 50 ng 
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apramycin and pDNA was purified for further analysis.  
Purified pDNA from plasmids was sequenced using primers SEQTERP-1-d11-F,  
SEQTERP-1-d11-R, SEQTERP-2-d5-F, SEQTERP-2-d5-R, SEQTERP-3-d11-F, SEQTERP-3-
d11-R, PROMOT-1-R, PROMOT-B-F (Table 2.2) which annealed at locations near junctions 
between segments in order to further confirm the proper location and orientation of each 
segment. The same pDNA was also subjected to a restriction digest analysis using the following 
enzymes: NcoI, AclI, SacI, HindIII, BsrGI, NdeI/NheI, NsiI, NsiI/NdeI, and finally NotI/NdeI 
and fragments compared to in silico digests, resulting in pTERP_1. 
2.2.3 Heterologous expression of terpentecin in S. lividans TK24 ΔactΔred 
Introduction of pTERP_1 into S. lividans TK24 ΔactΔred 
E. coli ET12567::pUZ8002 was transformed with pTERP_1 and plated on LB containing 
50 µg/mL apramycin, 50 µg/mL kanamycin and 25 µg/mL chloramphenicol. pTERP_1 was 
transferred from E. coli ET12567::pUZ8002 to S. lividans TK24 ΔactΔred via intergeneric 
conjugation according to published protocols
71
. Briefly, a mixture of E. coli 
ET12567::pUZ8002::pTERP_1 and S. lividans TK24 ΔactΔred spores were plated on mannitol-
soy agar containing 10 mM MgCl2 and incubated overnight at 30°C. Plates were then overlaid 
with 1 mL of water containing 0.5 mg nalidixic acid and 1 mg apramycin and the plates 
incubated for another 16 h. To select for colonies that contained pTERP_1, potential 
exconjugants were subcultured twice on mannitol-soy containing apramycin and nalidixic acid at 
30°C. Colonies were then cultured, preserved in 25% glycerol and stored at -80˚C. This process 
was repeated using pJC003 in order to provide a control where S. lividans TK24 ΔactΔred 
contained solely the vector portion of the construct and no promoter or terpentecin related genes 
to give rise to S. lividans TK24 ΔactΔred::pJC003. 
Colony PCR was performed on apramycin resistant exconjugants using PROMOT-B-F-
Con and SEQTERP-1-d10-R primers (Table 2.2) and the cycling conditions listed in Table 2.4 
to amplify the confirm_pro-seg1 and confirm_seg_2-3 amplicons described above, ensuring that 
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all three terpentecin and the promoter segments were present in the construct. Exconjugants 
showing expected amplicons for both reactions were used in the next step and were considered 
to have all pieces of the terpentecin biosynthetic gene cluster construct, giving rise to S. lividans 
TK24 ΔactΔred::pTERP_1.  
Assessing transcription of terpentecin genes in S. lividans TK24 ΔactΔred::pTERP_1 
To confirm the heterologous genes were being expressed, reverse transcription PCR (RT-
PCR) was performed using S. lividans TK24 ΔactΔred::pTERP_1 clone 1 and S. lividansTK24 
ΔactΔred::pJC003 clone 1 as a negative control. 1.2 mL of culture was taken from a 50 mL 
culture in lean medium (in a 250 mL Erlenmeyer flask) at 21.4, 48 and 96 h of growth and 
preserved in RNAlater
®
 (Life Technologies). Ribonucleic acid (RNA) was extracted using the 
RiboPure™RNA Purification Kit (Life Technologies) and ProtoScript® M-MuLV Taq RT-PCR 
Kit (NEB) was used to synthesize complementary DNA (cDNA) according to manufacturers’ 
instructions. A negative control with no reverse transcriptase was included. PCR was then 
performed on the cDNA using EconoTaq
®
 and four sets of primers (Table 2.2): Terp_ORF9_F 
and 1d8R to amplify cDNA from ORF9 transcripts, 1d7F and 1d3R to target the terpentecin 
cyclase gene (ORF 11) cDNA, TERP_GGPPS_F and TERP_GGPPS_R to amplify GGPP 
synthase cDNA, TERP_HMG_coA_Red_F and TERP_HMG_coA_Red_R were used to amplify 
cDNA from the 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase gene transcripts. The 
hrdB gene, which is constitutively transcribed and encodes a vegetative sigma factor, was used 
as a positive control using HrdB_F and HrdB_R primers 
71
 (Table 2.2). PCR cycling conditions 
are listed in Table 2.4.  
Assessing terpentecin production in S. lividans TK24 ∆act∆red::pTERP_1 
To confirm the production of terpentecin in S. lividans TK24 ΔactΔred::pTERP_1, seven 
recombinant colonies (1, 2, 9, 11, 40, 46 and 49) were cultured and the crude extracts were 
compared to that from three colonies (1, 2 and 4) of the control strain S. lividans TK24 
ΔactΔred::pJC003 and the native terpentecin producer, K. griseola MF730-N6; media blanks 
were incubated simultaneously. Two sequential 10 mL seed cultures in seed medium were 
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grown at 30°C for 48 h in 25 X 150 mm glass culture tubes at 200 rpm. Using a 5% inoculum of 
seed #2, the S. lividans TK24 ΔactΔred::pTERP_1 recombinant strains and control strains were 
grown in 10 mL of both lean and ISP2 media for 7 d at 30°C and 200 rpm. The cultures were 
extracted twice with 10 mL and 7 mL ethyl acetate (EtOAc) and shaking for one hour for each 
extraction. The organic layers were combined and evaporated under air and the crude extracts 
were submitted to LC-HRMS at a concentration of 0.5 mg/mL. 
Samples were initially analysed by visually comparing ELSD and MS chromatograms of 
the recombinant strain and the control strains to see if there were any obvious differences in 
peaks present. Next, mass chromatograms were monitored for ions with a mass to charge ratio 
(m/z) of 365.1959 (±5 ppm), consistent with the predicted [M+H]
+
 pseudomolecular ion of 
terpentecin. Finally, a metabolomic analysis, as described in Forner et al.
24
 and also in Chapter 6, 
was performed to highlight ions which differentiated the crude extracts of S. lividans TK24 
ΔactΔred::pTERP_1 strains from that of the control strains. Intensity threshold was set to 1E3 
and data were converted to a binary format. 
2.2.4 Generation of two knock-out strains: K. griseola Δbaf and K. griseola Δterp 
In order to better understand the metabolome of K. griseola MF730-N6 and to remove any 
confounding factors in the antibacterial assay against B. subtilis (described below), two strains 
were developed: one deficient in the production of the polyketide bafilomycin (K. griseola Δbaf) 
and the other deficient in the production of the diterpene terpentecin (K. griseola Δterp). The 
arrangement of the bafilomycin gene cluster (Figure 2.8) spans over 70 kb in both S. lohii and K. 
setae. To this end, most of the bafilomycin genes and a small but essential portion of the 
terpentecin biosynthetic gene cluster was removed and the apramycin resistance gene inserted 
via double crossover of homologous arms.  
Construction of pBAFKO and pTERPKO 
Two regions flanking the regions to be deleted were PCR amplified from gDNA using 
primers pairs bafKO_left_F/bafKO_left_R, bafKO_right_F/bafKO_right_R, 
terpKO_left_F/terpKO_left_R and finally terpKO_right_F/terpKO_right_R (Table 2.2) 
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Figure 2.8. Arrangement of the bafilomycin (A) and terpentecin (B) biosynthetic gene clusters 
modified from Zhang et al.
77
 and Dairi et al.
64
; the regions removed from the genome are shown 
in black boxes. 
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according to the conditions listed in Table 2.4 to give rise to amplicons bafKO_left (8,335,5343 
bp-8,336,661 bp = 1118 bp), bafKO_right (8,407,725 bp-8,408,740 bp = 1015 bp), terpKO_left 
(12,000 bp-13,025 bp = 1025 bp) and terpKO_right (14,601 bp-15,584 bp = 983 bp), 
respectively. Following column or gel-purification of all arms, the left arms (bafKO_left and  
terpKO_left) were restricted with EcoRI-HF and SphI-HI, while right arms were restricted with 
HindIII-HF and SphI-HF to generate the proper sticky ends required for the assembly of the 
deletion plasmids. In doing so, the terpentecin left homologous arm was reduced to region 
12,877-13,025 = 148 bp while the right arm covered region 15,397-15,584 = 187 bp. 
The apramycin resistance gene (aac(3)IV) was used as a selective marker in the final 
knock-out plasmid constructs and was amplified from pJV177 (unpublished, L.C. Vining) using 
the primers pJV177_aprR_F/pJV177_aprR_R (Table 2.2) according to the conditions listed in 
Table 2.4. The 977 bp aac(3)IV amplicon was gel-purified and restricted with SphI-HF. Finally, 
the vector pSET151
69
 was restricted with HindIII-HF and EcoRI-HF and the 6 kb band was gel-
purified.  
All components of the deletion plasmids (left arm, right arm, aac(3)IV and the plasmid 
pSET151) were ligated using T4 DNA ligase. Five microliters of each ligation reaction was used 
to transform chemically competent E. coli 10and plated on LB containing 50 µg/mL 
apramycin. Colony PCR was performed on transformants harbouring pBAFKO using primers 
bafKO_left_F/bafKO_right_R (Table 2.2) using the conditions listed in Table 2.4 to generate a 
3109 bp amplicon. Plasmid DNA was extracted from clones and restricted using SacI/PstI and 
AatII for the bafilomycin knock-out plasmid and HindIII and SacI /AatII for the terpentecin 
knock-out plasmid.  
In vivo deletion of the bafilomycin and terpentecin gene clusters 
The knock-out constructs, pBAFKO and pTERPKO, were used to transform chemically 
competent E. coli ET12567::pUZ8002 and plated on LB containing 50 µg/mL apramycin. The 
plasmids (pTERPKO and pBAFKO) were then introduced into K. griseola MF730-N6 via 
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conjugation with the aforementioned E. coli strains using the method of Choi et al.
78
, which 
differs from the Streptomyces method of Keiser et al.
71
 by omitting the heat-shock treatment for 
the spores and using ISP4 containing 30 mM MgCl2 as the plating medium. After 16 h of growth 
at 30 °C, plates were overlaid with 10 µg/mL nalidixic acid and 25 µg/mL apramycin. 
The apramycin resistant colonies were patched onto mannitol-soy medium containing 50 
µg/mL thiostrepton and colonies that were resistant to apramycin but sensitive to thiostrepton, 
indicative of a double crossover and therefore gene deletion, were screened by colony PCR as 
described previously. PCR reactions to confirm the genotype of K. griseola Δbaf were 
performed as listed in Table 2.4 with primers bafKO_left_F, bafKO_right_R, and baf_Z_F and 
baf_Z_R (Table 2.2).  
To confirm the genotype of K. griseola Δterp, PCR was performed on extracted gDNA 
using primers SEQTERP-1-d5-F and SEQTERP-2-d5-R (Table 2.2) and the cycling conditions 
listed in Table 2.4. Amplicons from terpentecin knock-out strains were also sequenced with 
primers SEQTERP-1-d5-F, SEQTERP-2-d5-R, TERP_602_F and TERP_1660_R to further 
confirm the genotype. 
Assessing bafilomycin and terpentecin production in knock-out strains 
Putative knock-out strains with confirmed genotypes were cultured in duplicate in 10 mL 
of lean medium along with the wild-type K. griseola MF730-N6 in order to characterize the 
phenotype of each strain. Cultures were grown for 48 h at 30°C and 200 rpm. The fermentations 
were extracted with EtOAc as described previously and analysed by LC-HRMS. When 
necessary, a metabolomic analysis was conducted in order to reveal differences between 
metabolomes by adapting the methods of Forner et al.
24
 using a threshold value of 1E3. Once 
exported to Microsoft
®
 Excel
®
 (Redmond, USA), ions present in wild-type strains and absent 
from all replicates of the knock-out strains were selected. A principal component analysis 
(PCA), with no binary transformation of the data, was also used to determine which ions differed 
most between K. griseola MF730-N6 (WT) and K. griseola Δterp (KO) extracts.  
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Fermentation broths and crude extracts were also tested for inhibitory activity against 
Bacillus subtilis NRRL-B558 in an agar plate disk diffusion assay where B. subtilis from an 
overnight LB liquid culture was plated on LB agar using sterile cotton swabs. Disks (6 mm) 
containing the solution to be tested, either 20 µL fermentation broth or 20 µL of a 0.5 mg/mL 
crude extract in MeOH, was first dried and placed on the inoculated agar plate. 20 µL MeOH 
and 20 µL from media blank fermentations were used as negative controls. Plates were 
incubated overnight at 30 °C and inhibition of growth was evidenced by zones of inhibition. 
2.2.5 Reassessing terpentecin production in S. lividans TK24 ΔactΔred::pTERP_1.  
Three recombinant S. lividans TK24 ΔactΔred::pTERP_1 (colonies 1, 2 and 3) and three 
negative controls strains S. lividans TK24 ΔactΔred::pJC003 (colonies 1, 2, and 3) were cultured 
twice in 10 mL seed medium using 5% innocula in 150 x 25 mm culture tubes for 48 h and then 
in 10 mL medium at 30°C and 200 rpm for 3 d. The fermentation media used were MYM, 
tryptic soy broth (TSB), yeast extract-malt extract (YEME) +34% sucrose+0.5% glycine, lean 
medium, International Streptomyces Project medium 3 (ISP3) and mannitol-soy; their 
components are listed in Table 2.3. The fermentations were extracted, analysed by LC-HRMS 
and subjected to metabolomic and statistical analyses using binary transformed data as described 
previously for the knock-out experiments.  
2.3 RESULTS AND DISCUSSION 
2.3.1 Construction of S. lividans TK24 ΔactΔred 
To eliminate actinorhodin biosynthesis in S. lividans TK24 ΔactΔred, it was not necessary 
to delete the entire gene cluster as the compound is synthesized by a type II PKS which uses the 
core polyketide enzymes (acyltransferase, ketosynthase and acyl carrier protein) iteratively in 
order to assemble the polyketide backbone; the removal of any of the core enzymes terminates 
actinorhodin production. Five essential genes for the production of actinorhodin were thus 
removed from the genome of S. lividans TK24, act I ORF1-3, actVII and actIV; these genes 
encoded for the actinorhodin β-ketoacyl synthase subunits α and β, acyl carrier protein, 
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bifunctional cyclase/dehydratase and cyclase, respectively. By amplifying 1 kb flanking regions 
and cloning into the HindIII and BamHI site of pKC1139, pKC1139_act_KO was generated and 
its proper assembly was confirmed by restriction analysis. This plasmid contained the apramycin 
resistance gene for selection, an E. coli replication function derived from pUC, an origin of 
transfer that allowed transfer of the plasmid from E. coli to streptomycetes and finally a 
Streptomyces ghanaensis derived replication function which is functional in Streptomyces only 
at temperatures below 34°C
69
.  
Figure 2.9 illustrates the banding pattern of pDNA from four colonies that had shown an 
amplicon of the correct size during the colony PCR screen. Only clone 16 showed the expected 
DNA fragments when digested with BamHI (8500 bp), BamHI/NcoI (7500 bp and 1000 bp) and 
NcoI/XhoI (5500 bp and 2500 bp); pDNA from clone 16 was, thus, used to transform competent 
E. coli ET12567(pUZ8002). The E. coli strain was chosen due to its inability to methylate DNA 
and thus it permitted the transfer of the DNA into Streptomyces that have a strong methylation 
specific restriction system while the non-transmissible shuttle plasmid pUZ8002 provided the 
transfer function required for the plasmid to be donated during conjugation
70
.  
Similarly, the proper assembly of pKC1139_red_KO was confirmed by subjecting pDNA from 
four colonies showing the 2500 bp band from colony PCR to restriction digest analysis using 
EcoRV, XhoI, KpnI and PstI. All four colonies showed the same correct banding pattern (Figure 
2.10) and pDNA from clone 12 was used to transform competent E. coli ET12567(pUZ8002). 
Since a silent gene deletion method was employed, where no antibiotic resistance gene remained 
in the genome of the knock-out strains, selecting for a single crossover event was made possible 
due to the inability of the plasmid to replicate at temperatures above 34°C. Colonies that were 
grown at 37°C and were resistant to apramycin must have had undergone a single crossover 
where the plasmid had integrated to the genome at the attB site. Selecting for double crossover 
colonies was possible by sub-culturing single crossover colonies in medium without any 
antibiotic.  
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Figure 2.9. Restriction map of pKC1139_act_KO (A), the expected band sizes for each reaction 
(B) and composite agarose gel electrophoresis of restricted pDNA from pKC1139_act_KO clone 
sixteen showing the expected sized bands, M: 2-log ladder(C).  
 
 
Figure 2.10. Restriction map of pKC1139_red_KO (A), the expected band sizes for each 
enzymatic reaction (B) agarose gel electrophoresis of restricted pDNA from pKC1139_red_KO 
clone 12 showing the expected sized bands, M: 2-log ladder (C). 
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Genetic characterization 
Exconjugants were subjected to genetic analysis to determine whether or not the desired 
act
-
 genotype was achieved and to discriminate between double crossover and revertant colonies. 
Six of the investigated colonies had undergone gene deletion of the targeted 
actinorhodin genes as evidenced in Figure 2.11 by an amplicon of approximately 150 bp in 
colonies 18.40, 18.49, 18.74, 18.75, 18.76 and 6.1 when using primers annealing just outside the 
deleted region, confirming that the five genes were no longer present within the genome of these 
strains. In contrast, five colonies 18.14, 18.23, 18.52, 5.8 and 12.58 had an amplicon size around 
5500 bp when using the same primer pair, consistent with a genotype where all five act genes 
were still present; these were colonies that had reverted back to the original genotype. The same 
5.5 kb band was observed in the positive control using DNA of the wild-type organism S. 
lividans TK24.  
Genetic analysis was also performed on exconjugants that arose from conjugation between 
S. lividans TK24 ∆act clone 6.1 and E. coli::pKC1139_red_KO. From the 9 apramycin-sensitive 
red knock-out exconjugants tested, 5 colonies showed the expected 3042 bp band consistent with 
a red
-
 genotype where 29 kb of the red biosynthetic gene cluster was removed (colonies14.31, 
14.35, 4.9, 4.13 and 4.14). It was not possible to obtain amplicons from revertant colonies using 
the same primer pair since an amplicon length of 29 kb exceeded the length achievable by PCR. 
However, since a temperature sensitive origin of replication was used, only a double crossover 
event would have resulted in apramycin sensitive colonies with a 3 kb amplicon and thus no 
single crossover colonies remained.  
Phenotypic characterization 
The phenotype of various colonies was assessed based firstly on the presence of 
pigmented compounds in the fermentation medium (Figure 2.12). The culture of the wild-type 
strain TK24 was dark purple in colour, while the act knock-out strain 6.1 was red. The culture of 
strain 4.9, despite the act
-
red
-
 genotype, was light pink and finally the cultures of the remaining 
strains were beige, which was the colour of the MYM medium. Since only one PCR reaction 
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Figure 2.11. Gel image following colony PCR and electrophoresis to identify knock-out strains 
for actinorhodin (A) and undecylprodigiosin (B); amplicons consistent with knock-out strains 
are circled in white and those consistent with wild-type stains are crossed-out, M: 2-log ladder. 
 
Figure 2.12. Assessment of pigmentation in various act and red knock-out strain of S. lividans 
TK24 according to the genotype assessed previously (A) and colour changes caused by the 
presence of actinorhodin and undecylprodigiosin in S. lividans TK24 and the S. lividans TK24 
∆act, respectively, under acidic and basic conditions (B). 
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was used to determine the genotype of the red knock-out strain in combination with apramycin 
sensitivity, it is possible that the strain 4.9 had not undergone double crossover. It is possible that 
the single crossover strain had lost resistance to the antibiotic via another recombination event or 
via a sudden deleterious mutation in the origin of replication or that the colony was 
contaminated with wild-type cells. Consequently, this strain was not used in future experiments. 
A more appropriate genotyping experiment would have involved another set of primers that 
would have amplified a region nested within the deleted genes. Phenotypic characterization of 
the strains was able to discriminate between the two undesirable compounds since actinorhodin 
was known to be red under acidic conditions and blue in basic conditions, while 
undecylprodigiosin was known to be red under acidic conditions and yellow under basic 
conditions
79, 80
. As illustrated in Figure 2.12 (B), the wild-type strain (S. lividans TK24) 
contained mostly actinorhodin, evidenced by the red and blue colouration of the fermentation 
when HCl and NaOH were added, respectively. However, when no actinorhodin was produced 
in S. lividans TK24 ∆act (6.1), the presence of the compound undecylprodigiosin could be 
detected, evidenced by the appropriate colour change from red to yellow in response to NaOH 
addition. No colour change was observed in the double knock-out strain S. lividans TK24 
ΔactΔred (clone 14.35).  
The amount of act measured spectrophotometrically in the cultures is shown in Figure 
2.13 (A). Act concentrations of strains 6.1, 18.4, 18.74, 18.75 and 18.78 varied between 0.4 and 
5.5 µM and were significantly lower than the wild-type and the revertant strain 18.23 which 
showed average act concentrations of 37.7 and 32.1 µM, respectively; F=1356.646, p<0.0001. 
Previously reported act concentrations using this technique were approximately 20 µM in 
Streptomyces coelicolor A3(2)
74
. 
The amount of undecylprodigiosin measured in cultures of strains 4.13, 4.14, 14.31 and 
14.35 (Figure 2.13 (B)) varied between 0.6 and 1.2 µM and were significantly lower than that 
from the wild-type and strains 6.1 and 4.9 which showed average red concentrations of 2.7, 6.4  
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Figure 2.13. Amounts of compound quantified spectrophotometrically for various strains of the 
act knock-out (A) and red knock-out (B) procedures and shown as mean+1 standard deviation, 
letters represent groups that are significantly different from one another in the ANOVA using 
α=0.05, n=5 and n=3, respectively.  
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and 2.9 µM, respectively; F=31.8519 p<0.0001. The analysis also revealed that the act knock-
out strain 6.1 contained significantly higher amounts of red than the wild-type strain, perhaps 
due to the lack of competition for acetate units necessary for the biosynthesis of both act and 
red
72, 73
. Previously reported red concentrations using this technique were of approximately 2 µM 
in Streptomyces coelicolor A3(2)
74
.  
Since this technique was based on spectrophotometric measurements and thus the 
transmission of light, it is likely that the readings observed in the knock-out strain were caused 
by background absorbance caused by other bacterial metabolites rather than by the presence of 
act and red. An alternative negative control could have been a closely related strain of 
Streptomyces incapable of producing act and red.  
The residuals were tested for normality (Shapiro-Wilk W=0.927382; p=0.0234 and 
W=0.849277; p=0.0021 for act and red, respectively) and homoscedasticity (Bartlett’s 
F=1.3204; p=0.2438 and F=3.1909; p=0.0022 for act and red, respectively). Although the 
assumption of normality and homoscedasticity were violated, the analyses were continued for 
two reasons: ANOVA analyses are robust
81
 and slight changes in the p-value obtained due to a 
lack of normality would not have changed the conclusions drawn. 
Due to consistency between the genotype and phenotype of strain 6.1, it was renamed S. 
lividans TK24 Δact and was used to generate the red knock-out strain. Similarly, strain 14.35 
was renamed S. lividans TK24 ΔactΔred. 
Such a host has been developed previously by Martinez et al. at Aventis Pharmaceuticals 
(now Sanofi) and its usefulness as a heterologous host was demonstrated by the production of 
granaticin, via the appearance of a purple compound and new peaks in the high performance 
liquid chromatography (HPLC) profile of the recombinant strain
82
. This was however not a 
commercially available strain and the development of such a strain would be beneficial for 
future uses in our laboratory. Although there are slight differences in the genotypes of the strain 
developed in this study and that which was previously published, where a smaller portion of the 
 56 
 
act cluster was remove in this study, the phenotypes of both strains are the same: neither are 
capable of producing the endogenous natural products act and red. The strain S. lividans TK24 
ΔactΔred developed in this study was thus used for the heterologous expression of the 
terpentecin biosynthetic gene cluster described below. 
2.3.2 Construction of pTERP_1: The terpentecin biosynthetic gene cluster construct  
Amplification of the terpentecin biosynthetic genes in three individual segments 
To clone the terpentecin biosynthetic genes from K. griseola MF730-N6, PCR was used to 
amplify the gene cluster in three fragments: 6770, 2983 and 6558 bp. Each segment was 
successfully PCR amplified (Figure 2.14) and following gel-purification and restriction with the 
appropriate enzymes, each segment was successfully blunt-end cloned into pSET152.  
Five transformants putatively containing cloned segment 1 (pSEGMENT1) were 
subjected to restriction analysis with the enzymes XbaI/NheI and NcoI (Figure 2.15). Clones 
number 1 and 5 contained plasmids consistent with a forward insertion of segment 1 at the 
EcoRV site of pSET152, while clones 2 and 4 showed a banding pattern consistent with the 
reverse incorporation of the insert. Clone 5 had extra bands when restricted with NcoI, this most 
likely due to partial digestion of the pDNA and clone 3 had a banding pattern inconsistent with 
the two acceptable options and therefore was not used.  
When cloning blunt-ended DNA into a plasmid from which the genes will be expressed 
(expression plasmids), the direction of insertion is an important factor to consider ensuring 
correct transcription and translation of the inserted DNA. However, for the purposed of this 
research, the constructed plasmids’ role were simply to provide sufficient quantities of each 
fragment for sequencing and to construct pTERP_1 and therefore the direction of insertion of the 
clone chosen was unimportant. 
Similarly, Figure 2.16 illustrates that the pDNA from clones 1 and 2 of pSEGMENT2 
showed restriction patterns consistent with inserts in the reverse direction while clone 5 was 
consistent with an insert in the forward direction in relation to the ΦC31 integrase gene of  
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Figure 2.14. PCR amplicons of each terpentecin segment following gel electrophoresis; DNA 
that was gel-purified and cloned into pSET152 is shown in boxes, M: 2-log ladder.  
 
Figure 2.15. Predicted fragment sizes of pSEGMENT1 plasmid DNA digests according to the 
direction of insertion in relation to the plasmid backbone (A) and picture of the gel following 
electrophoresis for each digest for various clones. Five clones were initially screened (1-5) with 
XbaI/NheI and NcoI and clones showing the expected banding pattern were replated and five 
colonies were subjected to restriction by XhoI and BamHI to assess population homogeneity 
(X.1-X.5) (B); samples with a banding pattern consistent with a forward and reverse insert are 
circled and boxed, respectively, and those inconsistent are crossed-out; when insertional 
direction cannot be determined, a correct banding pattern is circled by default, M: 2-log ladder. 
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Figure 2.16. Predicted fragment sizes of pSEGMENT2 plasmid DNA digests according to the 
direction of insertion in relation to the plasmid backbone (A) and picture of the gel following 
electrophoresis for each digest. Five clones were initially screened (1-5) with XbaI/NheI and 
NcoI and clones showing the expected banding pattern were replated and five colonies were 
subjected to restriction by XhoI and BamHI to assess population homogeneity (X.1-X.5) (B); 
samples with a banding pattern consistent with a forward and reverse insert are circled and 
boxed, respectively and those inconsistent are crossed-out; when insert direction cannot be 
determined, a correct banding pattern is circled by default, M: 2-log ladder.  
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pSET152. Clones 3 and 4 were discarded as their restriction patterns were not consistent with 
either direction and the sum of the fragment sizes were much smaller than expected (8718 bp).  
Finally, restriction analysis of pSEGMENT3 (Figure 2.17) revealed that clones 1, 2, 4 and 
5 had plasmids with inserts in the forward direction, while clone 3 had incorporated the insert in 
the opposite direction in pSET152. Although restriction analysis with XhoI and BamHI was 
performed on clones, 1, 2, 4 and 5, only one example is shown as they all showed the same 
pattern. Plasmid DNA from clone 2 was used for sequencing.  
Plasmid DNA from pSEGMENT1-#5, pSEGMENT2-#5 and pSEGMENT3-#2 were 
sequenced and the assembly of the sequences with the reference sequences (AB048795.1 and 
AB037907.1) (Figure 2.18) revealed a total of 13 regions with inconsistencies between the 
segments and reference sequences, with segment 3 having the majority of inconsistencies. Fresh 
pDNA was resequenced and showed the same inconsistencies and thus ruled out sequencing 
errors. Ten PCR amplicons from K. griseola gDNA (Table 2.4) were sequenced at both strands 
for all regions with errors and the same discrepancies with the published terpentecin biosynthetic 
gene cluster were present in the genome, suggesting that these were not due to PCR generated 
errors in the cloned segments, but rather were probably sequencing errors present in the 
published sequence of the terpentecin biosynthetic gene clusters. With DNA sequencing 
technologies becoming faster, less expensive and more accurate through the discovery of better 
DNA polymerases, it is not surprising that this many errors were found in the published 
sequence. Furthermore, 10 of the 13 errors were present in the late part of the cluster, the 
mevalonate pathway genes, which were submitted to GenBank in 1998 (accession AB015626.1) 
while the terpentecin specific genes were submitted to GenBank in 2001 (accession 
AB048795.1). The terpentecin segments were thus proven to be error free and were ready to be 
assembled.  
Construction of the constitutive promoter ErmE*_actII-ORF4_JC.  
To remove the reliance on native promoters to drive the transcription of the terpentecin gene  
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Figure 2.17. Predicted fragment sizes of pSEGMENT3 plasmid DNA digests according to the 
direction of insertion in relation to the plasmid backbone (A) and picture of the gel following 
electrophoresis for each digest. Five clones were initially screened (1-5) with XbaI/NheI and 
NcoI and clones showing the expected banding pattern were replated and five colonies were 
subjected to restriction by XhoI and BamHI to assess population homogeneity (X.1-X.5) (B); 
samples with a banding pattern consistent with a forward and reverse insert are circled and 
boxed, respectively, M: 2-log ladder.  
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Figure 2.18. Assembly of reference sequence (top) with sequencing results of pSEGMENT1-#5 (A), pSEGMENT2-#5 (B) and pSEGMENT3-#2 
(C) illustrating the location of all 13 inconsistencies between the cloned and reference gene cluster sequences; boxed numbers represent start and 
end of each segment, while dashed lines represent the locations of inconsistencies. 
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cluster, the actinorhodin activator-promoter system described in Wilkinson et al.
76
 was used in 
this construct. The constitutive ErmE* promoter drives the transcription of actII-ORF4, whose  
protein then activates the actI promoter, which in turns ensures the transcription of the 
biosynthetic genes downstream of pactI. To this end, two fragments needed to be assembled. 
The promoter fragment A was provided by Bio Basic Inc. within the SmaI site of pUC57 
and showed the expected banding pattern (Figure 2.19 (A)). The analysis confirmed the presence 
of unique SalI and AgeI restriction sites and thus allowed the unidirectional insertion of 
fragment B at those sites. Fragment B was successfully amplified from S. lividans TK24 gDNA 
(Figure 2.19 (B)) and cloned into the aforementioned sites. Following transformation of 
competent E. coli with the newly ligated reaction, the resulting fragments from digested pDNA 
of clone 4 (Figure 2.19 (D)) were consistent with the predicted fragment sizes. The promoter 
was sequenced using multiple primers and there were no discrepancies between the sequenced 
plasmid DNA and the promoter reference sequence; pUC57::PErmE*_actII-ORF4_JC pDNA 
was isolated in high yield and prepared accordingly for pTERP_1 construction.  
Construction of a new Streptomyces integrating cosmid vector: pJC003  
Since Streptomyces integrating plasmid vectors such as pSET152 would not remain stable 
with a 14 kb insert, it was necessary to construct a cosmid vector that would allow integration of 
the DNA at the attB site of the Streptomyces genome. To this end a 4 kb fragment from 
pSET152 containing the apramycin resistance gene, the origin of transfer and the ΦC31 
integrase and attachment site (attP)
69
 was PCR amplified (Figure 2.20) and ligated to a 4 kb 
HpaI fragment from pWEB containing the ampicillin resistance gene, the ColE1 E. coli origin of 
replication and a bacteriophage cos site for λ packaging. Plasmid DNA from 5 transformants 
was digested with restriction enzymes (Figure 2.20); clones 1 and 4 showed a restriction pattern 
consistent with a forward insertion of the pWEB fragment, where the translational direction of 
all genes in both fragments was in the same direction. In contrast,  
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Figure 2.19. Restriction analysis of pUC57::fragment_A (A), PCR amplification of fragment B 
from S. lividans TK24 gDNA (B), banding pattern of plasmid DNA from 
pUC57::PErmE*_actII-ORF4_JC expected (C) and observed from clone 4 (D) and overview of 
the assembly of sequencing results (light grey) with the promoter reference sequence (dark grey) 
confirming the proper assembly and accuracy of the constructed promoter sequence (E), M: 2-
log ladder. 
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Figure 2.20. Predicted and observed DNA fragments following digestion and gel electrophoresis 
of pJC003 clones 4 and 5 illustrating a “forward” and “reverse insertion of the 4 kb pSET152 
fragments, respectively, when comparing the translational direction of the genes from both 
fragments, M: 2-log ladder.  
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clones 2, 3 and 5 showed restriction patterns consistent with opposite translational directions. 
Conjugation efficiencies of the resulting shuttle vector constructs were tested to ensure their 
suitability for heterologous expression studies. Conjugation efficiencies observed for colonies 4 
and 5 in S. lividans TK24 Δact∆red were similar, where each construct resulted in a lawn of 
exconjugants, thus clone 4 was used as the vector in the construction of pTERP_1. 
Assembly of the entire terpentecin biosynthetic gene cluster in pJC003 -pTERP_1 
To construct pTERP_1, segments 1-3 of the terpentecin gene cluster were combined with 
the ErmE*_actII-ORF4_JC promoter and pJC003 in a 5-way ligation which was used to 
transform competent E. coli. Transformants (171) were screened by colony PCR for the presence 
of segments 2 and 3 of the terpentecin gene cluster. A single clone (#7) supported the 
amplification of the expected 3.9 kb fragment (Figure 2.21 (A)). Clone 7 was further screened 
for the presence of segment 1 and 2 and the expected 856 bp amplicon was obtained (Figure 2.21 
(B)), giving rise to pTERP_1 (Figure 2.22). 
The correct assembly of pTERP was further confirmed by sequencing the cloning 
junctions using a variety of primers and is summarized in Figure 2.23; the sequences matched 
the expected sequences exactly and indicated a reverse insertion into the vector when comparing 
the translational directions. To confirm the overall length of the construct, nine restriction 
digests of pTERP_1 were performed (Figure 2.24); all were consistent and confirmed the reverse 
insertion of the genes within the vector backbone. Due to the low transformation efficiency of 
the constructed plasmid, it was not possible to obtain the other conformation of the plasmid. The 
genetic evidence presented here supported the proper construction of pTERP_1 containing the 
terpentecin biosynthetic gene cluster under the control of a constitutive promoter. 
2.3.3 Heterologous expression of terpentecin in S. lividans TK24 ΔactΔred  
To heterologously express the terpentecin biosynthetic genes in S. lividans TK24 
∆act∆red, it was first necessary to transform E. coli ET12567::pUZ8002 with pTERP_1 and the  
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Figure 2.21. Colony PCR to screen transformants that contained terpentecin segments 2 and 3 
(A) and colony PCR on clone 7 for DNA of terpentecin segments 1 and 2 (B); K. griseola 
MF730-N6 was used as positive control (+C) and no DNA was added in PCR reaction for 
negative control (-C); clone #7 is circled, M: 2-log ladder. 
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Figure 2.22. Map of pTERP_1 containing the terpentecin biosynthetic gene cluster under the 
control of the constitutive promoter ErmE*_actII-ORF4_JC. DNA fragments are shown in grey, 
amplicons used to screen transformants and exconjugants via colony PCR are shown in 
crosshatch and vector features are shown in black. 
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Figure 2.23. Overview of the assembly between the reference sequence for pTERP_1 (top, dark grey) and the sequencing results of the junctions 
from the resulting pDNA (light grey); the black arrows indicate the approximate location of the junctions and the cos and ampicillin resistance 
vector genes used to determine the direction of insertion are boxed. 
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Figure 2.24. Predicted (A) and observed DNA fragments (B-D) from nine restriction digests of 
pTERP_1 clone 7; diagnostic bands are circled in white along with the expected sized fragment 
in bold, lanes are numbered according to the digest in A; gel C was taken in two separate 
pictures using different exposure times to allow the detection of smaller bands without 
oversaturation of the larger ones, M: 2-log ladder. 
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empty vector as a negative control strain. This ensured the foreign DNA would evade the native 
restriction system of S. lividans due to the mutations in dam, dcm and hsdM methyltransferases
83
 
of the E. coli strain, resulting in non-methylated DNA. The non-transmissible plasmid pUZ8002 
also provided the transfer functions required during conjugation
70
. The non-methylating E. coli 
was then used as the donor strain during conjugation with S. lividans TK24 ∆act∆red.  
Five pJC003 and 49 pTERP_1 apramycin-resistant exconjugants were preserved and 
chromosomal integration was confirmed by colony PCR of two regions within the terpentecin 
biosynthetic gene cluster (Figure 2.25): one amplicon covered the promoter to segment1 junction 
region (confirm_pro-seg1), while the other amplified the junction between segments 2 and 3 
(confirm_seg2-seg3); both amplicons were present in recombinant strains whereas they were 
absent in control strains containing pJC003. All 49 clones showed the correct 1 kb amplicon 
spanning the promoter and the terpentecin segment 1, though some were faint. Colony PCR also 
determined that all clones other than 6, 7, 26 and 27 contained the 3.7 kb amplicon spanning 
terpentecin segments 2 and 3. PCR experiments could have been repeated using genomic DNA 
if necessary; numerous colonies were however shown to contain all fragments of the promoter 
and gene cluster.  
Since the presence of the terpentecin biosynthetic genes was confirmed in 43 exconjugant 
colonies, reverse transcription RT-PCR was used to assess expression of key terpentecin 
biosynthetic genes. To this end, RNA was extracted from the recombinant strain, S. lividans 
TK24 ∆act∆red::pTERP_1 clone 1, and control strain, S. lividans TK24 ∆act∆red::pJC003 clone 
1, following 21.5, 48 and 96 h of incubation in a 250 mL flask containing 50 mL of lean 
medium. The RNA was then converted to cDNA and used as a template to amplify various 
regions within the terpentecin biosynthetic gene cluster.  
The results confirmed that various terpentecin biosynthetic genes throughout the cluster 
were successfully being expressed (Figure 2.26) as amplicons were obtained at all three time 
points for the recombinant strain, while being absent in the control host containing  
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Figure 2.25. PCR screen for the presence of terpentecin genes by amplification of the region 
spanning the promoter to segment 1 (A) and segment 2 to segment 3 (B) regions in 49 clones of 
S. lividans TK24 ΔactΔred::pTERP_1; for simplicity, only the results from clones 37 to 42 as 
well as from the 5 control clones are shown along with a negative control (-C) where no DNA 
was added to the PCR reaction; M: 2-log ladder. 
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Figure 2.26. Monitoring the expression of terpentecin biosynthetic genes throughout the cluster; 
genes targeted in the RT-PCR experiment are circled (A). Reverse transcription PCR experiment 
illustrating that heterologous terpentecin genes were being expressed in S. lividans TK24 
ΔactΔred::pTERP_1 clone 1, while no expression was detected in S. lividans TK24 
ΔactΔred::pJC00; agarose gel showing amplicons from cDNA of four terpentecin and one 
reference (hrdB) gene transcripts (B); negative controls for each time point and strain were 
included to ensure amplicons were not a result of contaminating DNA (no reverse transcriptase 
enzyme was used during the protocol).   
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only the vector pJC003. It was also clear that amplicons originated from mRNA transcripts and 
not from residual genomic DNA as per the absence of amplicons in negative control reactions 
where no reverse transcriptase enzyme was used in the process. The positive control used here 
were mRNA transcripts from the hrdB gene, the major and essential sigma factor gene in 
Streptomyces, responsible for the transcription of housekeeping genes
84, 85
; this transcript was 
found in both recombinant and control strains at all sampling times (Figure 2.26).  
The transcripts were detected early during the fermentation, as was expected due to the 
presence of the constitutive promoter ErmE*_actII-ORF4_JC directly upstream of the cluster. 
The terpentecin and mevalonate genes had previously been shown to be polycistronically 
transcribed, where ORF 10 to 14 provided a 6.5 kb transcript and ORF 1-7 provided a 8.5 kb 
transcript
64, 75
. PCR amplicons for ORF 11 transcripts were thus necessary to prove that the first 
transcript was present, while monitoring of ORF 1 and 6 proved that the latter transcript was 
present in the recombinant strain. Since ORF 9 is transcribed from the complementary DNA 
strand, presence of the transcript was also monitored.  
The evidence of transcription from ORFs 9, 11, 1 and 6 shown here was thus sufficient to 
assess that the terpentecin biosynthetic genes were expressed in the recombinant strain. Due to 
the saturated bands resulting from the amplified cDNA following electrophoresis (Figure 2.26), 
it was not possible to quantitate the relative amounts of transcripts at different sampling times; 
earlier sampling times, reducing the amount of cDNA template or reducing the number of cycles 
during PCR may provide such information. However, the objective of the experiment was to 
assess whether or not the heterologous genes were expressed; the presence of such transcripts 
was sufficient to conclude that the terpentecin biosynthetic genes were being transcribed in the 
recombinant strain S. lividans TK24 ∆act∆red::pTERP_1 clone 1.  
Assessing terpentecin production in S. lividans TK24 ∆act∆red::pTERP_1 
Since the terpentecin biosynthetic genes were proven to be not only present, but to also be 
transcribed in the recombinant strain, the fermentation and extraction of seven recombinant and 
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three control clones was undertaken to detect the presence of the diterpene terpentecin using 
three analytical approaches: a visual inspection of HPLC traces with MS detection, single ion 
monitoring for mass to charge ratio consistent with that of terpentecin, and finally a 
metabolomic analysis of the mass spectral data. The native terpentecin producer, K. griseola 
MF730-N6, was also included.  
Following a 7-day culture in both ISP2 and lean medium at 30°C and 200 rpm, the 
fermentations were extracted with EtOAc and the crude extracts were analysed by LC-HRMS. A 
comparison of the ELSD chromatograms between seven recombinant strains carrying the 
terpentecin gene cluster and three control strains fermented in the same medium was performed 
to determine if major differences could be detected visually. Most ELSD traces of crude extracts 
from cultures grown in ISP2 showed an initial peak at 0.5 min, indicating the presence of salts in 
the extracts, followed by a single peak at 2.58 min, indicating that these extracts contained 
mostly one major compound.  
Most ELSD traces of the lean medium looked very similar to one another; an initial salt 
peak at 0.5 min, followed by a chromatogram devoid of any significant peaks, indicating that 
most extracts did not contain any compounds in high abundance. An exception to these 
observations was the ELSD chromatograms of the extracts from recombinant strain 9 grown in 
the lean medium (Figure 2.27). These extracts contained two major compounds which did not 
appear in the extract of the control strains grown in the same medium. Unfortunately, the mass 
spectra for both recombinant and control strains were very similar at 2.60 and 2.88 min (Figure 
2.28), and thus it was unclear which ions were contributing to the differences in ELSD 
intensities. It is possible that the compounds detected at those times did not ionize well and thus 
did not provide good mass spectral data. The same ELSD peaks were however present in one 
replicate of the control strain 1 grown in ISP2 medium (data not shown); it is possible that these 
compounds were not a product of the heterologous terpentecin genes, but rather they may be 
compounds that were variably produced by S. lividans TK24 ∆act∆red. 
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Figure 2.27. Evaporative light scattering detector (ELSD) chromatograms showing the most 
obvious differences between crude extracts from recombinant strain (clone 9) and crude extracts 
from control strain (clone 1) grown in lean medium.  
  
 
7
6
 
 
Figure 2.28. Selected portion of mass spectra for recombinant strain clone 9 and control stain clone 1 at 2.60 and 2.88 min illustrating that 
although the recombinant strain contained large evaporative light scattering detector peaks at these retention times, the mass spectra did not appear 
to contain any differing ions, suggesting that perhaps the compounds present in the recombinant strain did not ionize well, tR: retention time, m/z: 
mass to charge ratio. 
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The second approach involved the monitoring of single ions consistent with that of the 
pseudomolecular [M+H]
+
 of terpentecin (m/z of 365.1959 ±5 ppm) within the mass spectra to 
assess whether the recombinant strain could produce terpentecin. This analysis revealed that this 
mass to charge ratio was not helpful to predict the production of terpentecin since it was also 
found in the control strains containing the empty vector (Figure 2.29). In comparison to extracts 
from the native terpentecin producer, K. griseola MF730-N6, ions with m/z 365.1959 had 
slightly different retention times (tR) ; the ions were detected at 2.85 min in K. griseola, while 
being detected around 2.61 min in the recombinant and control strains, respectively. The 
presence of this ion in recombinant and control strains most likely represents a compound with 
either the same molecular formula as terpentecin or a compound with a different molecular 
formula that gave rise to a molecular ion within 5 ppm of that from terpentecin. If another peak 
was observed in chromatograms of the recombinant strains at 2.85 min, a better chromatographic 
separation method could have been developed and in combination with tandem mass 
spectrometry experiments (MS
n
) could have allowed the differentiation between the two 
compounds, but no such peak was observed. There was no evidence to suggest that this ion 
indicated the presence of terpentecin.  
The third strategy to detect terpentecin in recombinant strains involved a metabolomic 
analysis to list all ions present in the extracts above the peak intensity threshold of 1E3. 
Although the analysis was performed on all seven recombinant clones grown in both media, only 
clone 9 grown in lean medium had mass spectral ions that were absent from the control strains. 
Seventeen ions, listed in Table 2.7, were present in triplicate extracts of the recombinant strain 
clone 9 grown in the lean medium that were also absent from all control strains of the same 
medium. The average retention time of these ions was 2.52 min and the m/z ranged between 
203.1796 and 412.7023. Since a standard of terpentecin could not be obtained, the ions resulting 
from the fragmentation of the desired compound and their retention times are unknown and thus 
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Figure 2.29. Chromatograms from single ion monitoring for ions 365.1959±5 ppm in extracts 
from the native terpentecin producer (K. griseola), recombinant strain (S. lividans TK24 
∆act∆red::pTERP_1), vector control strains (S. lividans TK24 ∆act∆red::pJC003) and the 
heterologous strain (S. lividans TK24 ∆act∆red); the terpentecin [M+H]+ pseudomolecular ion 
mass to charge ratio was not an appropriate predictor of terpentecin production since it was 
found in the control strains.  
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Table 2.7. Ions present in extracts from S. lividans TK24 ∆act∆red::pTERP_1 clone 9 grown in 
lean medium that were absent from the control strains (S. lividans TK24 ∆act∆red::pJC003) 
grown in the same medium as determined by metabolomic analysis; m/z: mass to charge ratio, 
tR: retention time. 
m/z tR (min) 
203.1796 3.08 
251.1504 0.65 
257.1286 2.75 
263.1155 2.95 
279.1104 2.74 
279.1340 1.50 
284.1969 1.76 
311.1692 2.91 
314.1448 2.98 
325.1069 1.67 
334.659 2.89 
335.1605 2.86 
335.2216 2.59 
391.2093 2.85 
405.1915 2.88 
412.2007 2.88 
412.7023 2.89 
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it was difficult to determine whether the ions listed here were fragments/derivatives of 
terpentecin. Knock-out experiments were thus undertaken in order to determine which ions in 
the native producer’s extracts could be correlated with the production of the compound 
terpentecin. 
2.3.4 Generation of two knock-out strains: K. griseola Δbaf and K. griseola Δterp 
To abolish the production of bafilomycins and terpentecin in K. griseola MF730-N6, the 
removal of most of the bafilomycin biosynthetic genes and two essential terpentecin biosynthetic 
genes were carried out using the constructed deletion plasmids pBAFKO and pTERPKO. The 
bafilomycin knock-out strain was developed in order to assess the involvement of this known 
antibiotic in agar-based disk diffusion assay of K. griseola extracts against Bacillus subtilis and 
to identify which ELSD peaks and mass chromatogram ions belonged to the bafilomycins. 
Plasmids were constructed using the suicide plasmid pSET151 as the vector backbone along 
with the apramycin resistance gene flanked by left and right homologous arms. The suicide 
plasmid pSET151 was used as the backbone of the deletion plasmids due to its inability to 
replicate in a Streptomyces host and a thiostrepton resistance marker, making it suitable for rapid 
detection of single crossover mutants by resistance to thiostrepton in Kitasatospora
69, 78
.  
E. coli harbouring pBAFKO were first subjected to colony PCR and17 of the 20 clones 
screened contained a 3 kb amplicon (Figure 2.30). Plasmid DNA from clone number 12 was 
then subjected to restriction analysis with PstI/SacI and AatII. At the time of this  
experiment, the DNA sequence of the bafilomycin gene cluster in K. griseola M730-N6 was not 
known; preliminary K. griseola sequence data along with sequence data from K. setae had 
allowed the design of primers to amplify the left and right homologous arms but the exact 
location of restriction sites were unknown. The restriction analysis was thus ineffective at 
confirming proper assembly. However, a diagnostic 750 bp fragment resulting from SacI 
digestion (Figure 2.30), confirmed that the apramycin resistance gene was present  
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Figure 2.30. Restriction map of pBAFKO (A), PCR screening of 20 E. coli pBAFKO 
transformants (clone 12 is circled) (B), the expected fragment sizes for each restriction digest 
(C) agarose gel of pBAFKO clone 12 restriction digests (D); M: 2-log ladder.  
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in pBAFKO clone 12. Subsequently, the bafilomycin biosynthetic gene cluster sequence was 
determined in K. griseola and it was confirmed that the fragment sizes obtained during the  
restriction digest were accurate. This clone was thus used in subsequent steps to generate the 
bafilomycin knock-out strain.  
Similarly, pTERPKO was properly formed in clone 1 (Figure 2.31) as a fragment of 
approximately 8 kb was observed when linearized with HindIII, fragments of 3-4 kb and 700-
800 bp when restricted with SacI and finally fragments of approximately 3 kb, 1500 bp, 600 bp, 
550 bp and 500 bp following restriction by AatII. Since the observed bands were consistent with 
the predicted fragment sizes, this clone was used in subsequent steps to generate the terpentecin 
knock-out strain.  
To identify baf and terp mutants, gDNA from putative mutant colonies were screened by 
PCR. Since a very large region was removed from the genome in K. griseola Δbaf, two different 
PCR reactions were necessary to confidently assign the knock-out genotype. The first PCR 
reaction used primers baf_Z_F and baf_Z_R which annealed within the cluster; a 759 bp 
amplicon was expected in wild-type strains and no amplicon was expected for knock-out strains 
since this region was absent. The gel picture (Figure 2.32 (A)), confirmed that the bafilomycin 
genes were still present in clone 6 as well as in the wild-type and suggested that they were absent 
from K. griseola::pBAFKO clones 1, 2, 3, 4, 5 and 7. The second PCR reaction used primers 
bafKO_left_F and bafKO_right_R which annealed at the outwards boundaries of the 
homologous arms; no amplicon was expected from the wild-type strain due to the large distance 
(73 kb) between the two primer annealing sites and a 3112 bp amplicon was expected in knock-
out strains. The 3 kb amplicon (Figure 2.32 (A)) confirmed gene deletion in K. 
griseola::pBAFKO clones 3, 4, 5 and 7. K. griseola::pBAFKO clone 7 was renamed K. griseola 
∆baf. 
Similarly, PCR was used to determine the genotype of putative K. griseola::pTERPKO 
clones using primers SEQTERP-1-d5-F and SEQTERP-2-d5-R; a 3856 bp amplicon was  
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Figure 2.31. Restriction map of pTERPKO (A), the expected fragment sizes for restriction 
digests (B) agarose gel of pTERPKO clone 1 restriction digests(C); M: 2-log ladder.  
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Figure 2.32. PCR identification of bafilomycin (A) and terpentecin (B) mutants; bands that 
correspond to a gene deletion are circled in white while those indicative of the wild-type 
genotype are marked with an X; the numbers refer to the clone number during the gene deletion 
process, while WT refers to the wild-type organism K. griseola MF730-N6 containing intact 
genes, M: 2-log ladder.  
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expected in the wild-type strain while a 2498 bp amplicon was expected in the knock-out strains. 
The genotype of K. griseola::pTERPKO colonies 1 and 2 (Figure 2.32 (B)) was consistent with 
the removal of ORF11 and ORF12 (partial) from the terpentecin biosynthetic gene cluster due to 
a 2.5 kb amplicon whereas amplification from wild-type genomic DNA resulted in a 4 kb 
amplicon. K. griseola::pTERPKO clone 1 was thus renamed K. griseola ∆terp.  
Sequencing of the 2500 bp amplicons from K. griseola::pTERPKO colonies 1 and 2 
confirmed the replacement of ORF11 and ORF12 with the apramycin resistance gene. The 
sequenced amplicon from clone 1 matched the regions flanking the left and right homologous 
arms with an apramycin resistance gene at its centre; the sequence revealed that the apramycin 
resistance gene had been incorporated into pTERPKO in the forward direction. The same results 
were obtained for amplicons generated from K. griseola::pTERPKO clone 2. Although it is 
preferable to have two constructs of the deletion plasmid, one for each direction of transcription 
of the resistance gene, only the forward direction was obtained here and thus we cannot dismiss 
polar effects caused by this directionality on downstream genes. However, since the purpose of 
this experiment was not to confirm the role of ORF11 and ORF12 gene products in terpentecin 
biosynthesis but rather to cease the production of terpentecin in the organism, a polar effect here 
would not interfere with this goal. The same was true for the construct of the bafilomycin knock-
out strain where the directionality of transcription of the apramycin resistance gene was not 
studied.  
Assessing bafilomycin and terpentecin production in wild-type and knock-out strains  
From the literature, K. griseola MF730-N6 was only known to produce two secondary 
metabolites: bafilomycin B1 (setamycin) and terpentecin
67, 86
. It is however clear from the ELSD 
of the HPLC trace (Figure 2.33 (A)) that there are far more than two secondary metabolites 
produced by this strain. In order to conclusively assign known compounds to ELSD peaks, two 
knock-out experiments were undertaken.  
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Figure 2.33. Evaporative light scattering detector (ELSD) chromatograms (A) and single ion 
monitoring of m/z of 838.4348 ± 5 ppm in HRMS chromatograms (B) for compounds produced 
in the wild-type K. griseola MF730-N6 and knock-out strain K. griseola ∆baf. The black box is 
placed on the region where metabolites disappeared in the knock-out strain, and inhibitory 
activity of 20 µL of fermentation broth from the wild-type strain (a) and knock-out strains (b,c) 
against B. subtilis (C).  
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By removing most of the bafilomycin biosynthetic genes from the genome of K. griseola 
MF730-N6, a clear phenotypic difference was seen in the metabolome of the knock-out strain 
(Figure 2.33 (A)), where the ELSD peak present at 5.50 min in the wild-type is no longer present 
in fermentation extracts of the knock-out strain. Since HRMS data was also collected 
simultaneously, confirmation that the compounds detected at this time were in fact bafilomycin 
was obtained by scanning the mass spectra for a mass to charge ratio (m/z) of 838.4348 ± 5 ppm 
which represented the sodium adduct pseudomolecular ion [M+Na]
+
 of bafilomycin B1 (Figure 
2.33 (B)) where these ions were present in the wild-type strain and absent from the knock-out 
strain.  
The inhibitory activity present in fermentations of K. griseola MF730-N6 was not caused 
solely by the presence of bafilomycins since growth inhibition in B. subtilis was still observed in 
the knock-out strains (Figure 2.33 (C)). The reduction in inhibition zone size may be caused by 
the slight inhibitory properties of bafilomycins against B. subtilis or by variations in yields of 
bioactive metabolites produced per 10 mL culture. This experiment confirmed the identity of the 
metabolites detected at 5.5 min in crude extracts of K. griseola as the bafilomycins and that they 
were only partly or not at all responsible for the inhibitory activity observed in crude extracts 
against B. subtilis. 
When the essential terpentecin genes ORF 11 and ORF 12, encoding for diterpene 
cyclases, were removed from the genome of K. griseola MF730-N6, it was unclear from the 
HPLC-ELSD chromatograms (Figure 2.34 (A)) which metabolites were no longer produced in 
the knock-out strain. A metabolomic analysis using a threshold value of 1E3 was thus 
undertaken. Rather than transforming the data to a binary data set as described in Forner et al.
24
, 
the peak areas were kept for this study. This permitted a simpler visualization of which 
compounds were most affected by the knock-out of terpentecin genes. 
From the Excel
®
 data sheet generated from the metabolomic analysis, 53 ions (Table 2.8.) 
were determined to be present in all wild-type fermentation extracts and absent from all  
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Figure 2.34. Evaporative light scattering detector (ELSD) chromatogram (A) and mass 
chromatogram selecting for ions of m/z of 365.1959 ± 5 ppm (B) for compounds produced in the 
wild-type K. griseola MF730-N6 and knock-out strain K. griseola ∆terp and inhibitory activity 
of 20 µL of fermentation broth from the wild-type strain (a,b) and knock-out strains (c-f) against 
B. subtilis (C).  
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Table 2.8. Ions absent from fermentations of K. griseola ∆terp as determined by metabolomic 
analysis. WT: wild-type, m/z: mass to charge ratio, tR: retention time, the [M+H]
+
 
pseudomolecular ions predicted for terpentecin
a
, UCT-4B
b
 and the O-methyl derivative of 
terpentecin
c
 are noted.  
Ions present in all 4 WT fermentations 
 Ions present in 3 
WT fermentations 
m/z tR (min)  
m/z tR (min)  m/z tR (min) 
201.1278 3.08 
 
419.2041 3.07  259.1147 3.08 
205.1588 2.80 
 
430.2436 2.52  263.1642 2.86 
313.1797 3.08 
 
432.2593 2.76  286.2126 2.86 
329.1748 2.80 
 
435.1992 2.55  289.1775 3.04 
331.1904 2.64 
 
437.2148 2.74  311.1641 2.76 
333.2060 2.61 
 
442.2803 3.08  315.1952 2.68 
343.1902 3.07 
 
457.2617 2.56  352.2481 3.43 
345.1698 2.45 
 
459.2777 2.39  381.227 2.58 
347.1856 2.80 
 
473.2568 2.40  384.2377 2.95 
349.2010 2.63 
 
475.2727 2.33  386.2524 2.67 
351.2164 2.70 
 
484.2906 3.07  389.1933 2.92 
361.2010 3.08 
 
485.2203 2.51  391.2094 2.67 
363.1802 2.48 
 
487.2362 2.38  407.2042 2.60 
365.1957
a
 2.80 
 
489.2521 2.35  411.2374 2.73 
368.2429 2.81 
 
491.2679 2.28  413.2172 2.28 
373.1987 2.83 
 
501.2515 2.48  421.1834 2.35 
377.1958 2.53 
 
503.2312 2.04  448.2542 2.25 
379.2114 2.58 
 
505.2472 2.35  477.2891 2.27 
379.2482 3.10 
 
513.2321 2.62  483.2409 2.91 
381.1908
b
 2.34 
 
517.2462 2.48  500.2863 2.60 
383.2064 2.82 
 
519.2623 2.41  502.3015 2.75 
395.2063 2.52 
 
521.2419 2.00  527.2484 2.57 
397.2219
c
 2.77 
 
531.2429 2.37  536.2891 2.92 
400.2329 2.81 
 
535.2572 2.08  541.2444 2.93 
405.1885 2.81 
 
545.2592 2.57  544.2637 2.60 
414.2496 3.08 
 
557.2382 2.54  552.2841 2.45 
416.2279 2.37 
   
 559.2747 2.62 
      561.2535 2.14 
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those of terpentecin knock-out strains; all were detected between 2.00 and 3.43 min. From the 
ELSD chromatogram (Figure 2.34 (A)), there was a very complex mixture of compounds 
detected between 2 and 3.5 min. This complex mixture may be a consequence of the dimer and 
hemiacetal tautomers formed when terpentecin was analysed previously
87, 88
. This may also 
explain why previous attempts to isolate terpentecin from the native hosts were unsuccessful 
using our chromatographic separation and detection methods (data not shown). 
Clerocidin, a clerodane diterpene very similar to terpentecin, differing only in the 
substituents on the decalin ring, was previously reported to be easily transformed from its 
dimeric form into the O-methyl derivative in methanol
87
. Given its structural similarity to 
terpentecin and since the crude extracts were also dissolved in methanol for LC-HRMS analysis, 
it is possible that terpentecin had been transformed into its O-methyl derivative (Figure 2.35). In 
fact, ions consistent with both the pseudomolecular ion [M+H]
+
 and the sodium adduct 
[M+Na]
+
of the O-methyl derivative were highlighted (Table 2.8) as ions present in wild-type 
extracts and absent from all knock-out extracts (calculated m/z: 397.2202 and 419.2040, 
respectively) during the metabolomic analysis.  
A further 28 ions were added to the list by using ions which were found in three of the 
four wild-type fermentations while still being absent from all eight knock-out fermentations. 
Present in these lists were ions with m/z consistent with the pseudomolecular ion [M+H]
+
 of 
terpentecin (365.1957) and m/z 381.1908, which was consistent with that of UCT-4B, a 
compound almost identical to terpentecin, differing only in the presence of an extra hydroxyl 
group (Figure 2.35). Since HRMS data rarely provide structural information past the molecular 
formula, it remains unclear whether K. griseola is capable of producing both terpentecin and 
UCT-4B or whether it is producing another hydroxylated derivative of terpentecin; NMR 
experiments on the purified compound would provide this information. To date only 
Streptomyces sp. s464 has been reported to produce both terpentecin and UCT-4B
89
. Only two 
more suggestions regarding the listed ions’ possible molecular compositions could be  
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Figure 2.35. Structures of terpentecin and related structures UCT4B and clerocidin as well as its 
possible O-methyl derivative when dissolved in methanol.  
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made: ions with m/z 379.2114 and 395.2063 may be analogues of terpentecin and UCT-4B 
where an extra methyl group would be present somewhere on the molecules (calculated [M+H]
+
 
375.2115 and 395.2064, respectively). 
A principal component analysis of the HRMS ions present within each sample was used to 
rapidly identify which ions contributed most to the variability between wild-type and knock-out 
crude extracts. The analysis revealed that the chemical composition of the terpentecin knock-out 
strains was clearly different from that of the wild-type K. griseola strain as seen in the scores 
plot of principal components 1 and 2 (Figure 2.36 (A)). The ions responsible for this 
differentiation are shown in the loadings plots of the same principal components (Figure 2.36 
(B)) and included the following m/z: 487.2362, 519.2623, 505.2472, 503.2312, 535.2572, 
489.2521, 379.2144, 365.1957, 414.2496 and 419.2041, all of which had been previously 
highlighted from the Excel
®
 data sheet analysis.  
From the Excel
®
 and principal component analyses, it was now possible to restrict the 
range of m/z in the mass chromatograms (Figure 2.34 (B)) where ions consistent with the 
[M+H]
+
 pseudomolecular ion of terpentecin were detected in the wild-type and were absent in 
the knock-out strains.  
The lack of production of terpentecin in the knock-out strains was further supported by the 
lack of growth inhibition of Bacillus subtilis by 20 µL of broth and crude extract (0.5 mg/mL) of 
knock-out strains. Although it was known that K. griseola produced another antibacterial 
compound, bafilomycin B1, it was clear that the majority of the B. subtilis inhibitory activity in 
the broth and crude extracts of K. griseola MF730-N6 was due to the presence of terpentecin 
since the knock-out of essential terpentecin genes completely abolished any inhibitory activity 
against B. subtilis (Figure 2.34 (C)).  
This observation was consistent with the reported minimal inhibitory concentrations 
(MIC) of <0.05 µg/mL and 25 µg/mL for terpentecin and bafilomycin B1 respectively, against 
B. subtilis PCI 219
67, 90
 and by previous experiments where the same lack of growth inhibition  
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Figure 2.36. Scores plot (A) and loadings plot (B) of the principal component analysis 
highlighting the differences in ions present in the wild-type (WT) and terpentecin knock-out 
(KO) strains. 
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towards B. subtilis was observed when the same genes were inactivated in K. griseola MF730-
N6
64
. The reduced bioactivity in the bafilomycin knock-out strain may be a reflection of the 
yields of terpentecin in the fermentation broths since the latter is at least 500 times more potent 
than bafilomycins. It is however also possible that there were other bioactive compounds that 
were not consistently being produced and were thus confounding the results or that there is 
synergism between terpentecin and bafilomycins. This can only be confirmed by fully 
characterizing the metabolome and the genome of this strain. 
Although a complementation study was not performed here, there is evidence to suggest 
that the knock-out phenotype was not a result of polar effects causing failed transcription in 
genes at other loci on the genome. Firstly, there were no apparent differences in growth rates or 
sporulation between knock-out and wild-type strains and secondly, the knock-out strain was still 
capable of producing other secondary metabolites as evidenced by the peaks at 5.49 min which 
were proven to be bafilomycins in the K. griseola ∆baf strain. 
Now that we were able to correlate the presence of ion m/z 391.2094 (tR 2.67 min) with 
the ability of a strain to produce terpentecin, it may be suggested that the ion m/z 391.2093 (tR 
2.85 min) detected in recombinant fermentations (clone 9, lean medium) indicated heterologous 
terpentecin production. However, discrepancies between the retention times suggested that these 
two ions represented different compounds. The evidence was thus not sufficient to conclude that 
terpentecin was produced heterologously as only one terpentecin-relation ion was detected in 
only one replicate of one recombinant clone and the retention times did not match. Another 
fermentation study was thus carried out.  
2.2.5 Reassessing terpentecin production in S. lividans TK24 ΔactΔred::pTERP_1.  
Now that the presence of various ions could be correlated with the ability of the organism 
to produce the diterpene terpentecin, another fermentation study was undertaken in order to find 
any terpentecin related ions in three recombinant strains S. lividans TK24 ∆act∆red::pTERP_1 
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using a greater variety of media: MYM, TSB, YEME+34% sucrose+0.5% glycine, lean medium, 
ISP3 and mannitol-soy. 
The results were analysed individually by medium since the principal component analysis 
(Figure 2.37) revealed that samples (recombinant strain and control) were separating based on 
the fermentation medium used rather than by the genotype of the strain.  
The Excel
®
 data sheet was used to highlight which ions were present in extracts of the 
recombinant (S. lividans TK24 ΔactΔred::pTERP_1) and absent from that of the control strain 
(S. lividans TK24 ΔactΔred::pJC003) and media blank. Firstly, there were only 5 ions that were 
present in all three recombinant strain fermentations and absent from all control and media 
fermentation extracts: ions with m/z 257.1287 and 418.2799 from the lean medium and 
577.5195, 586.5408 and 617.5120 from the fermentation medium mannitol-soy. An example of 
the mass chromatograms for the ion with m/z 257.1287 (Figure 2.38), where the presence of a 
new compound is detected in extracts from the recombinant strain while being absent from that 
of control extracts. Although none of the five new ions had been highlighted as being related to 
terpentecin in the previously mentioned knock-out experiment, ion with m/z 257.1287 had been 
previously highlighted during the first fermentation as a heterologous metabolite as it was 
present in all replicates of recombinant strain clone 9 extracts while being absent from the 
control strains (see Section 2.3.3). 
It is possible that the compounds obtained from the recombinant strain are not identical to 
those produced by the native host. This has been observed previously in this strain when the 
diterpene cyclase genes of the terpentecin biosynthetic gene cluster were heterologously 
expressed in S. lividans along with GGPP synthase and the production of a new compound, 
terpentetriene, was observed
64
. It is thus possible that some of the highlighted ions may be 
analogues of terpentecin, intermediate compounds that were not biosynthesized by the entire 
terpentecin biosynthetic gene cluster or perhaps shunt metabolites, where biosynthetic 
intermediates were further modified into new compounds. It is also possible that the terpentecin  
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Figure 2.37. Scores plot of the principal component analysis using the entire data set to illustrate 
that the metabolites present in the crude extracts of the recombinant and wild-type strains 
differed mostly by fermentation medium used rather than by genotype. 
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Figure 2.38. Screening for presence of heterologously expressed metabolites by single ion 
monitoring of m/z of 257.1286 ± 5 ppm in fermentation extracts of three colonies of the 
recombinant strain (S. lividans TK24 ΔactΔred::pTERP_1), three colonies of the control strain 
(S. lividans TK24 ΔactΔred::pJC003) and one media blank.  
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biosynthetic gene cluster was incomplete and that there were genes missing from the 
recombinant strain’s genome that are resulting in partial biosynthesis. Although there are only  
two cytochrome P450 genes in the reported gene cluster, 6 oxygenation reactions are predicted; 
it is not possible to predict whether other P450 enzymes are necessary or whether the same 
enzyme can catalyze multiple oxygenations as is the case for PikC which carries out 
hydroxylations at two different sites of the pikromycin macrolactone core
91
. Since regions 
flanking the biosynthetic gene cluster did not seem to be involved in terpentecin biosynthesis 
(data not shown), it is also possible that other P450 enzymes in K. griseola were acting in trans 
to perform the additional oxygenation reactions. Knock-out experiments of each individual P450 
gene within the terpentecin biosynthetic gene cluster would indicate the biosynthetic step(s) 
accomplished by each enzyme and until terpentecin is produced in a recombinant strain, the 
minimal biosynthetic gene cluster remains unknown. 
The new compounds whose ions were detected in the extracts of recombinant strain 
fermentations would need to be purified and their structure elucidated in order to confirm 
structural similarity to terpentecin. Priority should be given to the compounds originating from 
the lean medium extract since those ions were not detected in any other medium, whereas those 
from mannitol-soy medium were also detected in control fermentations in ISP3 medium, making 
them less likely to represent compounds produced via the heterologously expressed genes; they 
were perhaps present below the detection level in the control strains cultured in mannitol-soy 
medium.  
2.4 CONCLUSION 
In attempting to develop a general host for the heterologous production of bioactive 
terpenes in high yield, numerous molecular tools were generated including the new integrating 
cloning vector pJC003 capable of cloning large biosynthetic gene clusters into Streptomyces, a 
new version of a known constitutive promoter to drive the transcription of downstream genes 
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and finally another version of S. lividans with a simplified metabolic profile for easy detection of 
heterologously expressed metabolites. Given that these tools were not commercially available, 
their development during this study has made them available to other members in our laboratory 
and collaborators for future genetic studies involving microorganisms of the genera 
Streptomyces and Kitasatospora.  
In attempting to heterologously produce the diterpene terpentecin, great effort was 
dedicated to confidently detect terpentecin in fermentation extracts. Following the knock-out of 
essential genes in the native producer K. griseola, we were able to confirm that terpentecin was 
produced in this strain under our laboratory conditions and that LC-HRMS could be used to 
detect terpentecin, though in very low yields, via the monitoring of 106 ions, some with m/z 
consistent with the pseudomolecular ions [M+H]
+ 
for terpentecin, UCT-4B and the O-methyl 
derivative of terpentecin: 365.1959, 381.1908 and 397.2220, respectively.  
Although the terpentecin biosynthetic gene cluster was successfully integrated in the 
genome of S. lividans TK24 ∆act∆red, there was insufficient evidence to confidently support 
heterologous production of terpentecin. In the first fermentation study, numerous colonies were 
cultured in two media and only clone 9 grown in the lean medium produced any metabolite 
absent from control fermentations. The second fermentation thus investigated fewer recombinant 
strains and instead increased the number of media used to six; two media showed metabolites 
not produced in control strains, lean medium and mannitol-soy. Lean medium thus seemed to be 
promising for the heterologous production of terpentecin as it is inexpensive, easy to prepare and 
provides a clean HRMS background; it was also the medium reported to culture K. griseola 
MF730-N6 for terpentecin production
67
. This medium could thus be used in future heterologous 
studies using S. lividans TK24 ∆act∆red for the heterologous expression of terpentecin or other 
target compounds.  
Although the evidence presented here did not confirm the production of terpentecin in the 
recombinant strain, the in-depth analysis of numerous fermentations conducted during this study 
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has lead to the discovery of new natural products from members of the genus Kitasatospora; this 
will be the subject of the following chapters of this thesis.  
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CHAPTER 3 - ISOLATION AND STRUCTURE 
ELUCIDATION OF SATOSPORIN A AND B: 
NEW POLYKETIDES FROM THE 
ACTINOMYCETE KITASATOSPORA 
GRISEOLA 
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This chapter is a modification of the material published as  
 
Arens, J.C., F. Berrue, J.K. Pearson, and R.G. Kerr, Isolation and structure elucidation of 
satosporin A and B: new polyketides from Kitasatospora griseola. Org. Lett., 2013. 15(15): 
3864-7. 
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3.1 INTRODUCTION 
Actinomycetes are filamentous, spore-forming, Gram-positive bacteria of high G+C 
content associated with sediments of both terrestrial and marine sources
71
. They are the most 
prolific source of antibiotics and are responsible for the production of 45% of all reported 
bioactive metabolites of microbial origin
20, 92, 93
. Due to this prolific secondary metabolite 
production, there is much precedence for searching unexplored habitats for the discovery of 
novel actinomycetes
28
.  
Although this method has experienced success, there is also genetic evidence to support 
the observation that previously studied organisms have the potential to produce far more 
secondary metabolites than what has been reported. Streptomyces coelicolor, for example, has 
been well studied since the 1960s and had been reported to produce 4 antibiotics: actinorhodin, 
prodiginines, calcium-dependant antibiotic and methylenomycin
71
. It was not until its genome 
was sequenced by Bentley et al. in 2002 that its true metabolite production potential was 
revealed, indicating a total of 20 biosynthetic genes clusters
30
. Since then, the new peptide 
natural product coelichelin was successfully isolated from the organism using an iron-deficient 
culture medium
32
. 
The genus Kitasatospora, formely Kitasatosporia, contains 20 accepted species isolated 
mostly from soil samples from Japan, Korea, China, India and Brazil. The main characteristics 
separating members of this genus to other Actinomycetales are: the presence of both LL- and 
meso-diaminopimelic acid (DAP) in the peptidoglycan layer of the cell wall at certain stages of 
differentiation, the presence of galactose in cell hydrolysates and their ability to form submerged 
spores in liquid cultures
86
. The genus was, however, so closely related to Streptomyces that a 
decade after its first description by Omura et al. in 1982
94
, the two genera were unified based on 
partial 16S rRNA sequences being incapable of discriminating between the two
95
. This 
unification was short-lived as the genus Kitasatospora was re-established by Zhang et al. in 
1997 when full length 16S rRNA and 16S-23S rRNA gene spacer sequences were used to 
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resolve the two genera
96
. Since then, evidence continues to support the differentiation of the two 
genera; for example, drastic differences can be observed in the amino acid sequences of SsgB, a 
protein involved in sporulation and cell division, between Streptomyces and Kitasatospora 
organisms
97
.  
The first compound isolated from Kitasatospora was setamycin in the early 1980s
94
. Since 
then, numerous other compounds have been isolated from both accepted and proposed species 
including a bafilomycin-like compound, phosalacine, propioxatins, terpentecin, compound FR-
900494, cystargin, tyrostatin, compound SUAM-20007-20012, phospholipase D, compound F-
0368, kimorexins, fuzanins E-I and most recently endophenazine derivatives from Kitasatospora 
sp. HKI 714 in 2014
98-100
. The numerous compounds produced by this genus favour the 
possibility of discovering new natural products from fermentations of these bacteria.  
In our efforts to identify new natural products, members of the genus Kitasatospora were 
cultured and this has led to the isolation of the novel polyketides, satosporin A (1) and B (2) 
(Figure 3.1). The aim of this research was to fully elucidate the structure of these compounds as 
well as the corresponding aglycone, satosporin C (3), and to briefly investigate their biological 
activity.  
3.2 MATERIALS AND METHODS 
3.2.1 Fermentation of Kitasatospora griseola MF730-N6 
Seed cultures of K. griseola MF730-N6 were obtained first in 25 X 150 mm glass culture 
tubes and second in 250 mL Erlenmeyer flasks containing glass beads and 10 mL and 50 mL of 
sterile seed media containing 10 g of glucose and 10 g of yeast extract per liter. The first seed 
was inoculated with a scraping from an agar plate containing the sporulating organism, while the 
second seed was inoculated with 2.5 mL of seed 1. Seed cultures were allowed to grow for 24 h 
at 30°C in an orbital shaker at 200 rpm. A total of 24 fermentations were carried out in Fernbach 
flasks containing 500 mL of the lean production medium
67
 containing 0.4 g glucose, 0.8 g 
galactose, 0.8 g maltose, 1.6 g dextrin, 0.8 g Bacto™-Soytone and 0.3 g (NH4)2SO4 per liter  
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Figure 3.1. Structures of satosporins A-C. 
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inoculated with 5 mL from the second seed and were grown for 48 h, 200 rpm and at 27°C to 
give a total volume of 12 L. A sample was taken from each fermentation and plated on agar to 
ensure a single bacterial colony type and thus no contamination of the cultures. 
3.2.2 Isolation of satosporins from K. griseola fermentation  
Isolation of satosporin A and B  
Fermentations were extracted by shaking each 500 mL Fernbach for 1 h with 100 g 
activated Diaion
®
 HP-20 resin which was then rinsed with 250 mL diH2O and extracted using 
250 mL 50% aqueous MeOH and finally 250 mL 100% MeOH. Extracts were then combined 
and solvents were removed using a rotary evaporator. The 100% MeOH extract was then 
sequentially partitioned using water and EtOAc followed by hexane and ACN. The ACN extract 
was then subjected to two consecutive orthogonal silica based fractionations. Firstly, the sample 
was loaded onto a 500 mg capacity Diol HyperSep™ SPE cartridge (Thermo Scientific) and 
fractions were obtained by eluting with 15 mL 80:20 hexane:tert-butyl methyl ether (TBME), 
100% TBME, EtOAc and finally MeOH. Fraction 4 (MeOH) was then loaded onto a 500 mg 
capacity C18 HyperSep™ cartridge and fractions were obtained by eluting with 15 mL 95:5 H2O: 
ACN, 70:30 H2O: ACN, 50:50 H2O: ACN, 100% ACN, isopropyl alcohol (IPA), acetone and 
finally 1:1 dichloromethane (DCM):MeOH. HPLC was then used to obtain pure compounds 
using a Gemini
®
 5 µm C18 column and a 30:70 H2O:MeOH isocratic solvent system for 20 min 
followed by washing the column with 100% MeOH for 6 min and equilibrating the column back 
to the starting conditions for 9 min using 100 µL injections of a 10 mg/mL solution. Samples 
were subjected to LC-HRMS analysis at various steps along the purification process using 
Thermo Scientific™ LTQ Exactive equipment with a Core Shell Kinetex 1.7 µm C18, 50 X 2.1 
mm, 100 Å column, photodiode array detector, SEDEX 80 Sedere LT-ELSD evaporative light 
scattering detector and a Finnigan LXQ ion trap mass spectrometer in positive mode equipped 
with a electrospray ionization source detecting m/z between 190 and 2000. Chromatographic 
separation was achieved with a 4.8 min gradient of 95:5 water:ACN to 100% ACN, 3.2 min of 
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100% ACN and finally a return to starting conditions over 3 min; solvents contained 0.1% 
formic acid and a flow rate of 500 µL/min was used.  
Satosporin A (1): colourless oil; [α]25D: -5.2 (c 0.1, MeOH); IR νmax 3363, 2952, 2919, 
2875, 1736, 1704, 1592. HRESIMS m/z 711.3558 [M+Na]
+
,(calculated for C34H56O14Na 
711.3562, Δ = -0.6 ppm). MSn: m/z 667.3663, 549.3041, 505.3146, 387.2524, 369.2419, 
365.1072, 347.0968. NMR data are shown in Table 3.2.  
Satosporin B (2): colourless oil; [α]25D: -16.9 (c 0.04, MeOH); IR νmax 3367, 2927, 1736. 
HRESIMS m/z 549.3021 [M+Na]
+
, (calculated for C28H46O9Na 549.3040, Δ = -2.3 ppm). NMR 
data are shown in Table 3.3.  
Obtaining the aglycone satosporin C by enzymatic deglucosylation 
An enzymatic deglucosylation was attempted following the method of Shafiee et al.
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using first endo-1,3(4)-β-glucanase (Sigma-Aldrich, G4423-100g) and then β-glucosidase from 
almond (Sigma-Aldrich, 49290-250mg). 10 µL of a 50 mg/mL solution of satosporin A in 
DMSO was incubated at 37°C in 990 µL 0.1 M sodium acetate buffer (pH 6.0) along with 10 mg 
enzyme in a microcentrifuge tube. 25 µL aliquots were taken at times 0, 0.5, 1, 2, 4, 8, 14, 24, 
48, 96 and 192 h, added to 225 µL MeOH and kept at 4°C until the experiment was terminated. 
A sample was also taken prior to the addition of the enzyme in order to serve as a negative 
control.  
The samples were analysed by LC-HRMS and the relative amounts of each analogue was 
assessed by creating a processing method in the Xcalibur™ software (Thermo Scientific™) to 
measure the area under the peak for the ions with m/z values of 711.3562, 549.3040 and 
387.2511 (± 5 ppm) representing the [M+Na]
+
 adducts for each analogue and using the sum of 
all three areas to represent each analogue as a percentage of total satosporins. Satosporin C was 
recovered from the enzymatic reaction by EtOAc extraction and HPLC purification as 
mentioned previously but with a 20 min 80% MeOH isocratic method. The structure of the 
compound was confirmed by NMR analysis. 
 107 
 
Satosporin C (3): colourless oil; [α]25D: +23.2 (c 0.02, MeOH); IR νmax 2954, 2926, 1735, 
1704, 1599. HRESIMS m/z 387.2506 [M+Na]
+
, (calculated for C22H36O4Na 387.2511, Δ = -0.5 
ppm). NMR data are shown in Table 3.4. 
3.2.3 Structure elucidation of satosporins 
NMR experiments were performed on a Bruker (Milton, ON) 600 MHz spectrometer; 
samples were dissolved in deuterated methanol (CD3OD) in a 1.7 mm NMR tube. Spectra were 
standardized using the proton solvent residual peak signal at 3.31 ppm and carbon signal at 
49.00 ppm as a reference
102
 and interpreted using the program MestReNova (Mestrelab research, 
Santiago de Compostela, Spain). The program Xcalibur™ was used to analyse the LC-HRMS 
data. Infrared spectra were obtained on a Bruker Alpha FT-IR spectrometer. Optical rotation 
measurements were performed on a Rudolph (Flanders, USA) Autopol III polarimeter in a 50 
mm cell containing 1 mL of sample dissolved in methanol at 0.1982%, at 589 nm and 24.7°C. 
The instrument was verified for its accuracy by using the quartz cell. Average optical rotation 
was taken from 5 readings. 
3.2.4 Determining the relative and absolute stereochemistry by computational modeling 
Computational calculations of in silico interatomic distances were performed using the 
PM3 semi-empirical model as implemented in the Spartan 08
 
package (Wavefunction, Irvine, 
USA). The nuclear overhauser effect spectroscopy (NOESY) experimental parameters used a 
mixing time of 500 ms and a relaxation time of 5 ms and the distance of 1.807 angstrom (Å) 
between the vicinal protons H7a and H7b was used as a reference to calculate the predicted 
interatomic distances.  
In order to predict the theoretical electronic circular dichroism (ECD) spectra of both 
possible enantiomers of satosporin C, an extensive conformer search over the potential energy 
surfaces was performed using the PM3 semi-empirical method
103
 in conjunction with the 
automated conformer distribution algorithm implemented in the Spartan 08 package. The 
theoretical ECD and UV spectra were determined using the time-dependent B3LYP/6-31G* 
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density functional method
104, 105
 incorporating a polarizable continuum solvent model (PCM) 
representing methanol
106, 107
. Satosporin C (0.5 mg) was sent to Dr Allison Thompson at 
Dalhousie University and the experimental ECD spectra was obtained on a JASCO
 
(Halifax, NS) 
J-810 spectropolarimeter in 0.3 mL of HPLC-grade MeOH with a measurement range of 180-
700 nm. 
3.2.5 Determining the absolute configuration at C16 by the modified Mosher’s reaction 
Following the method of Latypov et al., the synthesis of the (S)-methoxyphenylacetic acid 
(MPA) ester of satosporin C was achieved by adding a solution of 4-dimethylaminopyridine 
(DMAP) (10 µg, 0.1 eq) to a 1 mL colourless solution containing satosporin C (0.25 mg, 0.6 
µmol), N,N'-diisopropylcarbodiimide (2.0 µl, 25 eq), (S)-MPA (0.5 mg, 5 eq) and 3 Å molecular 
sieves under an N2 atmosphere
108
. The reaction mixture was concentrated under a stream of N2 
and eluted through a plug of C18 using MeOH. The filtrate was evaporated in vacuo and further 
purified by semi-preparative reversed-phase HPLC to tens of micrograms of the desired product 
which was then analysed by NMR at 25°C and -20°C. 
3.2.6 Determining the stereochemistry of the carbohydrate moiety of satosporin A by the 
modified Tanaka’s derivatization 
Satosporin A (400 µg) was dissolved in 200 µl of ACN and hydrolysis was performed 
overnight by adding 200 µl of a trifluoroacetic acid (TFA) solution at a 4 M concentration in 
order to hydrolyze the sugars. After evaporation, the sample was redissolved in pyridine (1 mL), 
2 mg of L-cysteine methyl ester was added and the reaction mixture was heated at 60ºC for 1 h. 
2 µL of o-tolylisothiocyanate was added and heating was continued for an additional hour and 
then the product was concentrated in vacuo. The residue was suspended in 5% MeOH in H2O 
and fractionated over a C18 SPE cartridge (500 mg). Five fractions were generated by successive 
elution with 5% (F1), 25% (F2), 50% (F3), 75% (F4) and 100% MeOH (F5). Samples were 
dried in vacuo and resuspended in MeOH at 0.5 mg/mL and analysed by LC-HRMS using a 
Thermo Gold C18 column and the following solvent system: 20 min isocratic conditions of 87:13 
water:ACN followed by a 8 min gradient to 70:30 water:ACN and holding the conditions for 2 
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min, then a gradient to 100% ACN over 2 min and holding these conditions for 3 min, and 
finally a return to starting conditions over 2 min for the remainder of the 45-minute run; solvents 
contained 0.1% formic acid and a flow rate of 300 µL/min was used.  
3.2.7 Searching for satosporins in other Kitasatospora strains  
Eleven cultures from the agriculture research service culture collection (ARS/NRRL) 
which were labelled as Kitasatospora spp. were ordered and cultured as previously mentioned 
but in 10 mL of production media along with the satosporin producer K. griseola MF730-N6 and 
media blanks; the organisms used in the study are listed in Table 3.1. A simplified extraction 
procedure was used which consisted of extracting the fermentation with 10 mL EtOAc, allowing 
1 h for the fermentations to extract with the solvent at 200 rpm, removal of the organic layer and 
repeating the process a second time. The EtOAc layers were then combined and dried under air 
and analysed by LC-HRMS (0.5 mg/mL in MeOH). Retention time and m/z of satosporins were 
used to screen our collection of Kitasatospora spp. for the production of compounds 1 and 2. 
3.2.8 Biological activity of satosporins 
Satosporin A (1) was tested following the clinical laboratory standards institute testing 
standards in a microplate broth assay at concentrations up to 64 µg/mL against the following 
microorganisms: methicillin-resistant Staphylococcus aureus ATCC 33591, vancomycin-
resistant Enterococcus faecalis EF 379, Candida albicans ATCC 14035, Pseudomonas 
aeruginosa ATCC 14210, Proteus vulgaris ATCC 12454, Staphylococcu warneri ATCC 17917, 
Malassezia furfur ATCC 38593 and Propionibacterium acnes ATCC 6919. Satosporin A was 
also sent to the National Cancer Institute (Bethesda, USA) and tested against 58 cancer cell lines 
at 10 µM. Finally satosporin A was tested against healthy human keratinocyte (HEKA) and 
fibroblast (BJ) cell lines at 128 µg/mL and the aglycone (3) was tested against methicillin-
resistant S. aureus, vancomycin-resistant E. faecalis and C. albicans at 64 µg/mL; these assays 
were performed by Martin Lanteigne (UPEI) following the clinical laboratory standards institute 
testing standards (2003) in a microplate broth assay.  
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Table 3.1. Species of Kitasatospora used in the study to assess the potential for satosporin 
production by members of the same genus.  
Species Culture collection n° 
Kitasatospora griseola MF730-N6 FERM BP-1045 
Kitasatospora griseola NRRL B-16229 
Kitasatospora cystarginea NRRL B-16505 
Kitasatospora grisea NRRL B-16503 
Kitasatospora kifuensis NRRL B-24284 
Kitasatospora mediocidica NRRL B-16109 
Kitasatospora melanogena NRRL B-16502 
Kitasatospora papulosa NRRL B-16504 
Kitasatospora phosalacinea NRRL B-16230 
Kitasatospora streptosporus NRRL B-16228 
Kitasatospora setae NRRL B-16185 
Kitasatospora sp. NRRL F-6133 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Fermentation of Kitasatospora griseola MF730-N6 
Following the 24 h incubation of K. griseola in the seed medium, growth was evidenced 
by a cloudy fermentation. After the 48 h shaken incubation in 24 Fernbach flasks containing 500 
mL of lean medium, the broths were slightly red in colour and long filamentous mycelia were 
produced as previously reported in the literature
67, 86
. When all samples were plated to ensure 
one colony type and thus no contamination of the cultures, small white colonies formed after a 
24 h incubation of the lean medium agar plate at 30°C. After 2 to 3 d, the plates still contained a 
single filamentous colony type where the aerial hyphae had differentiated into spores with a 
powdery grey surface as expected for this organism
86
.  
3.3.2 Isolation and structure elucidation of satosporins from K. griseola fermentation 
From the 12 L of K. griseola MF730-N6 fermented in this study, 456.38 mg of crude 
extract was obtained from eluting the HP20 resin with 100% methanol. The first liquid-liquid 
partition (H2O:EtOAC) of this crude extract provided 362.22 mg of product in the EtOAc layer 
which was then taken through another liquid-liquid partitioning step (hexanes:ACN) to provide 
145.77 mg of product in the ACN fraction. Satosporins were obtained from various fractions of 
the mixture of compounds from the ACN fraction.  
Satosporin A  
Satosporin A was present in both the ethyl acetate and methanol fractions of the normal-
phase flash chromatography performed using a Diol HyperSep™ cartridge. From the 20.17 mg 
that eluted from the diol column using ethyl acetate, 2.4 mg of satosporin A was obtained (tR= 
20 min) from reverse-phase HPLC using 30:70 water:methanol isocratic conditions for 20 min. 
Unpure satosporin A was also obtained from the 30% and 50% aqueous ACN fractions of the 
MeOH fraction mentioned above during reversed-phase flash chromatography using C18 
HyperSep™. HPLC purification of satosporin A from these fractions was performed as 
previously mentioned to result in 1.63 mg and 1.29 mg from the 30% and 50% aqueous ACN 
 112 
 
fractions, respectively. Fractions from which satosporin A were obtained are illustrated in Figure 
3.2.  
HRESIMS supported a molecular formula of C34H56O14 as the base peak at m/z 711.3558 
was consistent with the sodium adduct pseudomolecular ion [M+Na]
+
 (Δ = -0.6 ppm). This also 
indicated seven degrees of unsaturation in the structure of satosporin A. The 
1
H and 
13
C NMR 
data, shown in Table 3.2, indicated the presence of carbonyls at δC 181.4 (C1) and δC 218.1 (C9) 
respectively in addition to two sugar residues with the characteristic anomeric carbon chemical 
shifts at δC 101.8 (C1’) and δC 105.1 (C1”). Since the satosporin aglycone was devoid of sp
3
 
quaternary carbons, the structure of satosporin A was mostly elucidated by the interpretation of 
the key correlation spectroscopy (COSY) correlations highlighted in Figure 3.3, where cross 
peaks between hydrogen atoms of adjacent carbons (J
3
-coupling) allowed the connectivity of the 
backbone between carbons 17, 16, 15, 14, 13, 12, 11, 2, 3, 4, 5, 6, 7, 8 and finally back to carbon 
3. Furthermore, COSY cross peaks also connected C22 to C16, C21 to C12, C20 to C10 to C11, 
C18 to C4 and C19 to C6. The remainder of the molecule was elucidated by analyzing the 
spectrum obtained from a heteronuclear multiple bond correlation (HMBC) experiment which 
also confirmed the previously assigned connectivities. The partially overlapping signals at δH 
2.37 (m, H8) and δH 2.39 (m, H12) required the HMBC correlations H8/C3, H8/C7, H12/C10 
and H12/C14 to unambiguously located the two methines H8 and H12 on the carbon skeleton. 
Finally, the ketone moiety (δC 218.1) was located at C9 due to key HMBC correlations H20/C9, 
H10/C9, H3/C9, H11/C9, and H8/C9 and the ring closure to form the 8-membered lactone was 
evident from the key HMBC correlations H2/C1 and H15/C1 (Figure 3.3).  
The two sugar residues were identified by interpretation of 
1
H-
1
H COSY correlations and 
coupling constant (J) analysis; they revealed the two glycosidic spin systems H1’ to H6’ and 
H1’’ to H6’’. The large coupling constant values for the methine at δH 4.39 (d, J = 8.0 Hz, H1’) 
and the methine at δH 3.47 (t, J = 9.0 Hz, H4’) placed H1’, H2’, H3’, H4’ and H5’ in axial 
positions and suggested that this unit was a β-glucopyranosyl residue. This conclusion was in 
  
 
1
1
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Figure 3.2. Purification scheme leading to the isolation of satosporin A and B from various fractions from the fermentation of 12 liters of K. 
griseola; HPLC, HPLC_1 & HPLC_2: Isocratic water (0.1% formic acid):methanol (0.1% formic acid) 30:70 for 20 min.
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Table 3.2. NMR table for satosporin A (1); s: singlet, d: doublet, t: triplet, q: quartet, m: 
multiplet, b: broad, J; coupling constat. 
Position δC, Type δH (J in Hz) COSY HMBC ROESY 
1 181.2, C   -  
2 49.7, CH 2.80 t (9.5) H3, H11 C1, C3/C4, C10,C11 H4, H20, H21, H18 
3 42.0, CH 
1.74 ddd (13.1, 9.7, 
9.7) 
H2, H4, H8 
C1, C2, C4, C7, C8, C9, 
C18 
H20, H18, H5b, H7b 
4 42.1, CH 1.35 m H3, H5a,b, H18 - H2, H11, H8 
5 44.9, CH2 
1.60 bd (12.6) 
0.71 q (12.5) 
H4, H5b, H6, H7a 
H4, H5a, H6 
C3/C4 
C3/C4, C6, C7, C18, C19 
H18 
H3 
6 32.0, CH 1.47 m H5a,b, H7a,b, H19 - H8,  
7 36.0, CH2 
2.12 bd (13.2) 
0.77 q (12.4) 
H5a, H6, H7b, H8 
H6, H7a, H8 
C3 
C6, C8, C19 
H19 
H3 
8 48.0, CH 2.37 m H3, H7a,b  C3, C7, C9 H4, H6 
9 218.1, C   -  
10 43.6, CH 2.55 dq (4.3, 7.7) H11, H20 C2, C9, C11, C20 H20, H21 
11 44.6, CH 2.65 m H2, H10, H12 
C1, C2, C9, C10, C12, 
C13,C20, C21 
H3, H4, H7a, H18, H20, 
H21 
12 37.6, CH 2.39 m H11, H21 C10, C14 - 
13 40.1, CH2 
1.89 q (15.6, 10.5, 
3.1) 
0.95 m 
 H14, H12, H13a 
C11, C12, C14, C15, C21 
C12, C14, C15, C21, C22 
H15, H20  
- 
14 39.3, CH 2.34 m H13a,b, H15, H22 C15, C16, C22 - 
15 87.1, CH 4.58 d (10.1) H14, H16 C1, C14, C22 H13a, H21, H22 
16 72.5, CH 4.23 bq (6.3) H15, H17 C17, C1’ H14, H22, H1’ 
17 16.5, CH3 1.24 d (6.8) H16 C15, C16 H15, H1’ 
18 19.9, CH3 0.86 d (6.5) H4 C3, C4, C5 H2, H3, H4a,b, H11 
19 22.6, CH3 0.93 d (6.6) H6 C5, C6, C7 H5a,b, H7a,b 
20 15.6, CH3 1.21 d (6.7) H10 C9, C10, C11 H2,H3, H11, H13a 
21 24.5, CH3 1.04 d (7.3) H12 C11, C12, C13 H2, H10,H11 
22 18.7, CH3 0.92 d (6.7) H14 C13, C14, C15 H13a, H15, H16 
*-Glucose (C16)    
1’ 101.8, CH 4.39 d (8.0) H2’ C16, C2’,C3’, C5’ H16, H17, H3’, H5’ 
2’ 74.0, CH 3.44 t (8.5) H1’, H3’ C1’, C3’ - 
3’ 87.8, CH 3.59 t (8.8) H2’, H4’ C2’, C4’, C1’’ H1’, H5’ or H5’’, H1’’ 
4’ 69.9, CH 3.47 t (9.0) H3’,H5’ C3’, C5’, C6’ H1’’,  
5’ 77.2, CH 3.33 m H4’, H6’a,b - - 
6’ 62.6, CH2 
3.87 m 
3.72 dd (11.7, 5.5) 
H5’ 
H5’ 
C4’, C5’ 
C5’ 
- 
H4’ 
*-Glucose    
1’’ 105.1, CH 4.58 d (8.1) H2’’ C3’, C2’’ H3’,H4’, H3’’, H5’’ or H5’ 
2’’ 75.3, CH 3.29 t (9.0) H1’’, H3’’ - - 
3’’ 77.6, CH 3.40 t (9.0) H2’’, H4’’ C1’’, C2’’, C4’’ H1’’ 
4’’ 71.4, CH 3.29 t (8.9) H3’’, H5’’ - - 
5’’ 77.7, CH 3.33 m H4’’, H6’’a,b - - 
6’’ 62.5, CH2 
3.89 m 
3.64 dd (11.8, 6.3) 
H5’’ 
H5’’ 
C4’’ 
C4’’, C5’’ 
- 
H4’’ 
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Figure 3.3 Key COSY and HMBC (H→C) of satosporin A. 
 116 
 
agreement with the rotating frame overhauser effect spectroscopy (ROESY) data (Figure A.9). 
The HMBC cross peak between H1’ and the resonance at δC 72.5 (C16) unambiguously located 
this sugar on the aglycone. In a similar manner, the second sugar was also identified as a β-
glucose and was found to be attached to first sugar by a 1,3-β-glycosidic linkage according to the 
key HMBC correlations H1’’/C3’and H3’/C1’’. The structure of the new polyketide satosporin 
A (1) was thus established (Figure 3.1).  
Satosporin B 
Satosporin B was purified from a single fraction; the 22.14 mg that eluted with MeOH 
during normal-phase flash chromatography of the ACN partition was further separated by C18 
flash chromatography, where satosporin B was purified from the 30% aqueous ACN fraction 
(5.79 mg) using reverse-phase HPLC and a 70:30 water:MeOH isocratic conditions for 20 min 
to yield 0.34 mg of satosporin B (tR=21 min). Due to the strong resemblance of the 1D and 2D 
NMR data shown in Table 3.3 with those of satosporin A, the structure of satosporin B was 
rapidly identified as the monosaccharide analogue. Slight changes in chemical shifts were 
observed in the 
1
H and 
13
C spectra at locations 1’, 3’ and 4’ and all signals associated with C1’’ 
to C6’’ were absent from spectra of satosporin B, consistent with the only structural difference 
being the loss of the glucose moiety from C3’. HRESIMS supported a molecular formula of 
C28H46O9 since the observed base peak at m/z 549.3021 was consistent with the sodium adduct 
pseudomolecular ion [M+Na]
+
 (Δ = -2.3 ppm). This was also consistent with the loss of a 
glucose molecule (C6H10O5) when compared to satosporin A. 
Satosporin C 
Satosporin C is the aglycone analogue of the new polyketides and although it was never 
isolated from the producing strain, it was necessary in order to assign the absolute 
stereochemistry at the C16 stereogenic centre and could not be obtained by acid hydrolysis due 
to the possible opening of the lactone ring. The aglycone satosporin C was thus obtained by 
enzymatic deglucosylation of pure satosporin A. Endo-1,3(4)-β-glucanase failed to cleave any  
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Table 3.3. NMR table for satosporin B (2); s: singlet, d: doublet, t: triplet, q: quartet, m: 
multiplet, b: broad, J; coupling constat. 
Position δC, Type* δH (J in Hz) COSY HMBC ROESY 
1 181.4, C    - 
2 49.7, CH 2.78 t (9.5) H3, H11 C1, C11 H4, H20, H21, H18, H12Y 
3 42.0, CH 1.74 ddd (13.1, 9.7, 9.7) H2, H4, H8  - 
4 42.0, CH 1.35 m H3, H5a,b, H18  - 
5 44.8, CH2 
1.60 bd (12.8) 
0.71 q (12.2) 
H4, H5b, H6, 
H7a 
H4, H5a, H6 
 
 
H18,  
H3 
6 31.9, CH 1.47 m H5a,b, H7a,b, 
H19 
 H8,  
7 35.9, CH2 
2.12 bd (13.9) 
0.77 q (12.2) 
H5a, H6, H7b, 
H8 
H6, H7a, H8 
 
 
H19 
H3 
8 47.9, CH 2.37 m H3, H7a,b   H4, H6 
9 218.6, C     
10 43.6, CH 2.54 dq (4.4, 7.8) H11, H20 C9 H20, H21 
11 44.5, CH 2.65 m H2, H10, H12 C1,C12, H3, H4, H7a, H18, H20, H21 
12 37.7, CH 2.39 m H11, H21,H13b  - 
13 40.1, CH2 
1.89 ddd (15.6, 10.6, 3.4) 
0.95 m 
H13b,H14,  
 H14, H12, H13a 
C12, C14, 
 
H20  
- 
14 39.3, CH 2.34 m H13a,b, H15, 
H22 
 - 
15 87.1, CH 4.58 d (10.4) H14, H16  H13a, H21, H22 
16 72.2, CH 4.23 bq (6.4) H15, H17 C1’ H14, H22, H1’ 
17 16.3, CH3 1.24 d (5.6) H16 C15, C16 H15, H1’ 
18 19.9, CH3 0.86 d (6.6) H4 C3, C4, C5 H2, H3, H4a,b, H11 
19 22.5, CH3 0.93 d (6.4) H6 C5, C6, C7 H5a,b, H7a,b 
20 15.6, CH3 1.21 d (7.3) H10 C9, C10, C11 H2,H3, H11, H13a 
21 24.5, CH3 1.04 d (7.4) H12 C11, C12, C13 H2, H10,H11 
22 18.7, CH3 0.92 d (6.8) H14 C13, C14, C15 H13a, H15, H16 
*-Glucose (C16)    
1’ 102.1, CH 4.33 d (7.9) H2’ C16,  H16, H17, H3’, H5’ 
2’ 74.6, CH 3.23 t (8.2) H1’, H3’  - 
3’ 78.0, CH 3.38 t (8.8) H2’, H4’  H1’, H5’  
4’ 71.4, CH 3.32 t (9.2) H3’,H5’   
5’ 77.7, CH 3.28 m H4’, H6’a,b  - 
6’ 62.6, CH2 
3.87 dd (11.7, 2.0) 
3.69 dd (11.7, 5.7) 
H5’, H6’b 
H5’, H6’a 
C4’, C5’ 
C5’ 
- 
H4’ 
* Chemical shift were indirectly obtained by interpretation of the heteronuclear single quantum 
coherence (HSQC) and HMBC data. 
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glucose molecules from satosporin A, but as seen in Figure 3.4, β-glucosidase from almond was 
successful , where the rapid disappearance of satosporin A within the first hour of incubation is 
followed by complete conversion into the aglycone in 8 d. The slow removal of the second 
glucose moiety may be explained by a greater steric hindrance or a competitive inhibition at the 
β-glucosidase active site by cleaved glucose molecules109. These results also suggested that both 
sugar moieties might be β-D-glucoses since the enzyme belongs to the enzyme group E.C. 
3.2.1.21 which is also known as β-D-glucopyranoside glucohydrolase.  
Satosporin A eluted from the column during LC-HRMS analysis and was detected by the 
mass spectrometer at 3.09 min and the resulting base peak at m/z 711.3573 corresponded to the 
sodium adduct [M+Na]+ of the disaccharide polyketide (Figure 3.5). Similarly, satosporin B was 
detected at 3.24 min and the mass spectrum base peak at m/z 549.3033 corresponded to the 
sodium adduct [M+Na]+ of the monosaccharide polyketide. Finally, the aglycone was detected 
at 4.12 min and the mass spectrum base peak at m/z 387.2506 corresponded to the sodium 
adduct [M+Na]+ of the aglycone polyketide. Pure satosporin C was obtained by extracting the 
incubated reaction with EtOAc and purifying by HPLC; the aglycone eluted at 14.5 min of the 
80% MeOH isocratic method.  
The structure elucidation of satosporin C was rapidly assessed by comparing the 
1
H and 
13
C NMR spectra shown in Table 3.4 to that of satosporin B (2). Most signals were similar to 
those of satosporin B, except that all signals associated with glucose, C1’ to C6’, were absent 
from satosporin C spectra and slight changes in chemical shifts at positions 16 and 17 were 
observed, both of which are consistent with the lack of the carbohydrate moiety at C16.  
HRESIMS supported a molecular formula of C22H36O4 since the observed base peak at m/z 
387.2506 was consistent with the sodium adduct pseudomolecular ion [M+Na]
+
 (Δ = -0.5 ppm). 
This was also consistent with the loss of a glucose molecule (loss of C6H10O5) when compared to 
satosporin B. 
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Figure 3.4. Enzymatic deglucosylation of satosporin A into the corresponding monosaccharide 
and aglycone following an 8 day incubation period with β-glucosidase from almond at 37°C. 
 
 
Figure 3.5. Mass chromatogram and corresponding mass spectrum for satosporin A (A), 
satosporin B (B) and satosporin C (C). 
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Table 3.4. NMR table for satosporin C (3); s: singlet, d: doublet, t: triplet, q: quartet, m: 
multiplet, b: broad, J; coupling constat. 
Position δC, Type δH (J in Hz) COSY HMBC 
1 181.4, C   - 
2 49.6, CH 2.87 t (9.5) H3, H11 C1, C3/C4, C10 
3 42.0, CH 1.71 ddd (13.2, 9.7, 9.7) H2, H4, H8  
4 42.0, CH 1.36 m H5b, H18  
5 44.8, CH2 
1.59 bd (13.0) 
0.69 q (12.5) 
H4, H5b, H6, H7a 
H4, H5a, H6 
 
C3/C4 
6 32.2, CH 1.47 m H5b, H19  
7 36.1, CH2 
2.12 m 
0.75 q (12.2) 
H5a, H7b, H8 
H6, H7a, H8 
 
 
8 48.1, CH 2.36 m H3, H7a,b   
9 218.8, C    
10 43.7, CH 2.54 dq (4.4, 7.9) H11, H20  
11 44.4, CH 2.65 m H2, H10, H12 C2, C9, C10, C12, C21 
12 37.6, CH 2.41 m H21  
13 40.1, CH2 
1.90 ddd (15.6, 10.8,3.8) 
0.97 m 
H13b,H14,H12,  
H14, H13a 
C11, C14, C15  
 
14 39.7, CH 2.19 m H13a,b, H15, H22  
15 87.6, CH 4.48 d (10.5) H14, H16 C1 
16 65.8, CH 4.01 bq (6.4) H15, H17  
17 20.3, CH3 1.18 d (6.5) H16 C15, C16 
18 19.9, CH3 0.85 d (6.5) H4 C3/C4, C5 
19 22.6, CH3 0.93 d (6.5) H6 C5, C6, C7 
20 15.6, CH3 1.21 d (7.8) H10 C9, C11 
21 24.5, CH3 1.04 d (7.5) H12 C11, C12, C13 
22 18.7, CH3 0.89 d (6.8) H14 C14, C15 
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Satosporins possess an unprecedented tricyclic ring system comprising an oxo-decalin 
unit fused to an 8-membered lactone with 11 stereogenic centres present on the aglycone moiety. 
This eight membered lactone ring was unusual since most macrolide natural products contain a 
14- or 16-membered ring such as in compounds such as erythromycin, bafilomycin and 
oleandomycin
110-112
. The unique lactone was found in only two other natural products: 
octalactins, which were isolated from a marine bacterium of the genus Streptomyces which 
showed cytotoxic activity against murine carcinoma (half maximal inhibitory concentration 
(IC50) =7.2 ng/mL) and human colon cancer (IC50=0.5 µg/mL) cell lines, and gonioheptolides, 
which were isolated from the bark of the plant Goniothalamus giganteus and showed moderate 
cytotoxicity against various human tumor cell lines with the best median effective dose (ED50) 
reported as 4.25 µg/mL
113
. The sugar moieties of satosporins were also unusual as most bacterial 
glycosylated natural products contain 6-deoxyhexoses that may also be further modified
114
. 
Other glucose containing natural products include vancomycin, chloroeremomycin, 
rebeccamycin, pyralomycin and glucosylated-oleandromycin 
111, 115-117
. 
3.3.3 Determining the relative and absolute stereochemistry of satosporins 
Since the three-dimensional structure of cyclohexane rings has been studied extensively, 
coupling constants and NOESY correlations were used to determine the relative stereochemistry 
of the oxo-decalin moiety of satosporins
118
. The apparent doublet of triplets at δH 1.71 (H3, J = 
13.2, 9.7 Hz) and the two apparent quartets at δH 0.69 (H5b, J = 12.5 Hz) and δH 0.75 (H7b, J = 
12.2 Hz) with large coupling constants placed H3, H4, H5b, H6, H7b and H8 in axial positions 
on the cyclohexane ring system. These conclusions were further confirmed by the observed 
nuclear overhauser effect (NOE) correlations between H4/H6/H8 and H3/H5b/H7b (Figure 3.6). 
The key NOE correlations H8/H11, H2/H4 located H2 and H11on the same face of the carbon 
skeleton, whereas the methyl group H3-20 was placed on the opposite side, consistent with the 
NOE correlation H3/H3-20. 
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Figure 3.6. Key NOESY correlations of satosporin C. 
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Since the conformation of the 8-membered lactone was not easily predicted, 
computational techniques were used to predict in silico interatomic distances for each conformer 
generated by varying the absolute stereochemistry at positions 12, 14, and 15 of satosporin C; 
this provided the eight conformers listed in Figure 3.7 along with their relative stereochemistry.  
In order to simplify the complexity and the amount of computational calculations required 
to predict the relative and absolute stereochemistries, the aglycone moiety of satosporins was 
used. This was made possible by the successful purification of the aglycone molecule (3) by 
enzymatic deglucosylation of satosporin A as mentioned previously. Since the presence of the 
sugars would not affect the three-dimensional structure of the eight-membered lactone, it was 
possible to extrapolate the results from this experiment to the structures of satosporin A and B. 
Furthermore, given the stereoselective nature of the domains of modular PKSs, it is not expected 
that satosporin analogues would have different stereochemistries than satosporin C given that the 
backbone of the molecule would be made from the same synthases and would only differ in how 
much post-PKS modifications they underwent by the glycosyltransferase
119
. Analysis of the 
satosporin biosynthetic gene cluster would confirm whether the origin of satosporin A and B 
were indeed from the same PKS. 
The equilibrium conformer of each isomer was located by scanning the potential energy 
surface and allowed the prediction of interatomic proton distances. The NOESY experiment 
allowed the calculation of relative distances between proton atoms by remaining in the linear 
prediction limit and absolute distances were derived from the known 1.807 Å distance between 
protons H7a and H7b. This allowed a quantitative comparison between the theoretical structural 
parameters and the experimental NOE spectrum of satosporin C. 
Firstly, three diagnostic distances were used to assess which of the eight stereoisomers 
matched the experimental results. As illustrated in Figure 3.7 (A), the interatomic distance 
between H2 and H12 eliminated isomers BAA, BAB, BBA and BBB, while that of H12 to H14 
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Figure 3.7. Experimental and calculated diagnostic proton distances (Å) for each stereoisomer of satosporin C when varying the relative 
stereochemistry at carbons 12, 14 and 15 (A) and three-dimensional representation of the AAA stereoisomer of satosporin C (B),* refers to the 
relative stereochemsitry at each stereocentre.
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further eliminated isomers ABA and ABB, and finally the H15 to H14 interatomic distance of 
3.030 Å further eliminated isomer AAB, leaving AAA (Figure 3.7 (B)), to be the only possible 
isomer. Secondly, NOE for all interatomic proton distances of AAA were compared to 
experimental ones; all were consistent with the predicted values of isomer AAA, with the 
highest amount of divergence being 6.66% as shown in Table 3.5. Furthermore, the strong NOE 
correlations H2/H12 (2.5 Å) and H12/H14 (2.2 Å) located H12 and H14 on the β side of the 
molecule, whereas the large coupling constant of the apparent doublet at δH 4.48 (H15, J = 10.5 
Hz) placed H15 on the α side of the 8-membered lactone ring.  
The interatomic distances of H15/H16, H16/H12 and H16/H22 depended on the 
stereochemistry at C16 and at the time of the experiment this stereochemistry was unknown and 
thus the distances were not calculated.  
Determining the absolute stereochemistry by circular dichroism spectroscopy 
The absolute stereochemistry of satosporin C was then determined by comparing the 
experimental electronic circular dichroism spectrum with theoretically predicted spectra for 
compound AAA, with S, R and R configuration at carbons 12, 14 and 15 respectively and its 
enantiomer AAA’ with R, S and S configurations at carbons 12, 14 and 15 respectively. 
During the extensive conformer search over the potential energy surfaces of AAA and 
AAA’, only two additional structures were located within 3 kcal/mol of the equilibrium 
conformer and these corresponded to minor rotations of the side chain at position 15. This 
obviated the usual requirement of assembling the ECD spectra by a Boltzmann average over low 
energy molecular conformers
120
. 
The theoretical ECD and UV spectra were determined using the time-dependent 
B3LYP/6-31G* density functional method
104, 105
 incorporating a polarizable continuum solvent 
model (PCM) representing methanol
106, 107
. Such a methodology has been well-tested and shown 
to be suitable for such purposes
121-124
. Specifically, the 40 lowest energy transitions (∆Ei) were 
calculated along with the corresponding rotatory strengths (  ) in both the dipole velocity and
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Table 3.5. Comparison of proton interatomic distances between experimental NOESY data and 
predicted values for the stereoisomer AAA of satosporin C. The reference distance of 1.807 
angstrom between the vicinal protons H7a and H7b is shown in italics. 
     Distance (Å) 
Error % 
   Integral Experimental Theory (AAA)  
H15/H22 1 2942206 2.503 2.632 -4.90 
H15/H17 2 2729202 2.534 2.656 -4.58 
H15/H13a 3 1983040 2.673 2.627 1.75 
H15/H14 4 935130 3.030 3.101 -2.30 
H15/H16 5 4386154 2.342 N/A N/A 
H16/H15 6 4245438 2.355 N/A N/A 
H16/H17 8 5396434 2.262 N/A N/A 
H16/H22 9 3198782 2.468 N/A N/A 
H2/H18 10 1164252 2.921 2.911 0.35 
H2/H4 11 4643264 2.320 2.336 -0.70 
H2/H3 12 1323000 2.860 3.056 -6.43 
H2/H12 13 3296316 2.456 2.519 -2.50 
H2/H11 14 5057380 2.287 2.248 1.73 
H11/H2 15 4265480 2.353 2.248 4.66 
H11/H21 16 3274562 2.459 2.575 -4.52 
H10/H21 17 5563650 2.251 2.140 5.18 
H10/H20 18 4218908 2.357 2.368 -0.46 
H12/H2 19 3591452 2.421 2.519 -3.89 
H12/H14 20 6616316 2.187 2.248 -2.73 
H12/H21 21 3917548 2.386 2.457 -2.88 
H8/H7a 22 3636900 2.416 2.486 -2.81 
H14/H12 23 4991146 2.292 2.248 1.95 
H7a/H7b 24 20778476 1.807 1.807 0.00 
H7a/H6 26 2041296 2.660 2.494 6.66 
H13a/H13b 28 22097268 1.789 1.797 -0.47 
H13a/H20 29 7949812 2.121 2.058 3.05 
H3/H20 30 1428382 2.823 2.959 -4.59 
H5a/H5b 31 19355970 1.828 1.809 1.08 
H5a/H18 32 5145662 2.280 2.391 -4.63 
H6/H19 33 3800260 2.398 2.494 -3.83 
H4/H18 34 4005418 2.377 2.457 -3.24 
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dipole length formalisms utilizing the Gaussian 09 (Wallingford, USA) suite of programs. The 
ECD spectrum was then simulated as a sum of normalized Gaussian functions
120
. 
We used σ = 0.17 eV for all transitions but the first two, where we empirically found that 
σ1 = 0.05 eV and that σ2 = 0.08 eV produced a significantly better trace. The transition energies, 
∆Ei, and rotatory strengths, Ri, are in units of eV and 10
-40 
cgs, respectively. The spectrum may 
be given in eV but it is more common to present it in nm using the appropriate conversion factor. 
We also compared the theoretical UV spectra for AAA and AAA’ with the experimental UV 
spectrum in order to determine the so-called UV correction
125
. Due to the fact that a time-
dependent density functional theory (TDDFT) generally gives better results for the low-lying 
states than for the high-energy transitions, where Rydberg states are involved, we determined the 
UV correction using the spectrum generated from only the first 10 transitions
120
. This 
corresponded to a UV correction of 12 nm. The UV corrected spectra for AAA and AAA’ are 
shown in Figure 3.8; there was an excellent agreement between the lineshape of the 
experimental spectrum and that of AAA. In particular, the direction of all Cotton effects are 
reproduced exactly, though the peaks near 250 nm and 300 nm are not as broad as those in the 
experimental spectrum. The ECD spectrum of AAA’ is, as expected, opposite in sign to that of 
AAA and thus a clear absolute stereochemical assignment was made. The observed negative 
Cotton effect at 295 nm in the spectrum of satosporin C, corresponding to the n→π* transition of 
a carbonyl group, along with the remaining data collectively indicated that the configuration of 
satosporin C was 2R,3R,4S,6R,8R,10S,11R,12S,14R,15R. 
3.3.4 Determining the absolute configuration at C16 by the modified Mosher’s reaction 
The configuration of the C16 stereogenic centre was determined from interpretation of 
NOESY data and further confirmed by chemical derivatization of the secondary alcohol in 
satosporin C (3) using a modified Mosher methodology. Indeed, the strong NOE correlations 
H15/H16 (2.342 Å) and H15/H17 (2.534 Å) indicated that H15 and the hydroxyl group held an 
anti conformation while the NOE correlation H16/H3-22 (2.468 Å) suggested an R configuration 
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Figure 3.8. Calculated (dashed lines) electronic circular dichroism (ECD) spectra for both possible enantiomers AAA and AAA’ and experimental 
(solid line) ECD spectrum obtained from satosporin C sample. 
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for C16. This observation was further validated by the synthesis of the (S)-methoxyphenylacetic 
ester of satosporin C and analysis of 
1
H NMR spectra (Figure 3.9) recorded at two different 
temperatures: T1: 25 °C and T2:-20 °C. The difference of chemical shift Δδ
T1,T2 being negative for 
1
H signals H2, H8, H11, and H15 indicated that the cyclic portion of the aglycon was shielded 
by the phenyl ring in the ap conformer, and consequently confirmed the R configuration at C16.  
3.3.5 Determining the stereochemistry of the carbohydrate moiety of satosporin A by the 
modified Tanaka’s derivatization 
In order to determine which glucose enantiomers were present in satosporin A, a modified 
Tanaka derivatization was performed on the hydrolyzed sugars using pyridine, L-cysteine 
methyl ester and o-tolylisothiocyanate to give rise to diastereomeric sugar derivatives which 
would be distinguishable via LCMS analysis and compared to derivatized sugar standards.  
Screening for m/z of 447.1252±5 ppm, which corresponded to the [M+H]
+
 adduct of the 
isothiocyanate derivatives (Figure 3.10), revealed that the standard and polyketide glycoside 
derivatives were in fraction F3 during reverse-phase chromatographic separation. The L-glucose 
derivative standard was detected at 14.53 min, while its enantiomer’s, D-glucose, derivative was 
detected at 16.40 min. The derivatized sugars hydrolyzed from satosporin A were detected by 
the mass spectrometer at 16.48 min (Figure 3.11); since the retention time was the same as that 
of the derivatized D-glucose standard, sugars of satosporin A were determined to both be D-
glucose.  
Although the experiment was not performed on the sugar moiety of satosporin B, it is 
unlikely that it would contain L-glucose given that the glycosyltransferase enzyme presumably 
used the monosaccharide as a substrate to attach the second sugar. The examination of the 
biosynthetic gene cluster for satosporins in K. griseola would provide further evidence as to 
whether a single enzyme or two different enzymes are involved in the glycosylation steps 
leading to the biosynthesis of satosporins.  
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Figure 3.9. Overlay of 
1
H NMR spectra of the (S)-methoxyphenylacetic ester of satosporin C, obtained at 25°C and -20°C, to determine the 
absolute stereochemistry at C16. 
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Figure 3.10. Sugar derivatization reaction using first L-cysteine methyl ester in pyridine and o-
tolylisothiocyanate to give rise to the diastereomeric derivatives.  
 
 
Figure 3.11. HRMS chromatograms for m/z of 447.1252±5 ppm showing the retention times 
associated with both glucose enantiomer derivative standards (black) compared with the 
retention times of the sugars from the polyketide disaccharide, satosporin A (grey).  
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3.3.6 Searching for satosporins in other Kitasatospora strains  
Apart from the current producer K. griseola MF730-N6, no other Kitasatospora strain 
investigated here was capable of producing satosporins, including a different strain of the same 
species, K. griseola NRRL B-16229. Until the same or a very similar gene cluster is found in 
another organism, it is difficult to comment on the evolutionary history of this gene cluster, but it 
is clear that it was acquired from K. griseola MF730-N6 late in the diversification of this genus 
given that no other Kitasatospora strain produced the compound. This is in contrast to 
bafilomycins, which can be isolated from over 2% of Streptomyces and some Kitasatospora and 
is thus thought to have been acquired earlier in the evolutionary history of actinomycetes
28
. 
Terpentecin is another compound which seems to be produced by K. griseola MF730-N6 but not 
by K. griseola NRRL B-16229. Terpentecin has, however, been isolated from Streptomyces sp. 
s464
126
, which may be another example of convergent evolution, where the production of the 
same compound has been adopted by different microbial lineage to provide an evolutionary 
advantage to the producing organism. It is also possible that Streptomyces sp. s464 may be more 
closely related to K. griseola as anticipated since members of the two genera are difficult to 
differentiate and could thus have been mislabelled as Streptomyces
97
. A more comprehensive 
genetic analysis of the secondary metabolite gene clusters present in the genomes of 
Kitasatospora and Streptomyces species would be necessary in order to gain knowledge on the 
evolutionary origins of the satosporin biosynthetic gene cluster.  
3.3.7 Biological activity of satosporins 
Satosporin A showed no inhibitory activity against methicillin-resistant Staphylococcus 
aureus, vancomycin-resistant Enterococcus faecalis, Candida albicans, Pseudomonas 
aeruginosa, Proteus vulgaris, Staphylococcus warneri, Malassezia furfur and 
Propionibacterium acnes at 64 µg/mL or against the National Cancer Institute’s 58 cancer cell 
lines at 10 µM. It was however also non-toxic to the healthy human keratinocyte (HEKA) and 
fibroblast (BJ) cell lines at 128 µg/mL, providing a promising perspective for future applications 
of this natural product. Since the production of complex compounds such as satosporins is 
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energetically costly to the producing bacterium, it is strongly believed that all natural products 
serve a biological function that benefits the host
1
. The pharmaceutical and cosmetic industries 
have taken advantage of these biological activities and can develop the natural product into 
drugs such as antibiotics, antifungal agents, anticancer drugs etc. Since no activity has been 
described for satosporins, we are unable to make predictions as to the possible human and 
animal health applications these compounds may have. We can however conclude that whatever 
biological activities satosporins may have, there is a good chance that the activity will be 
specific towards the target and, most importantly, it appears to be non-toxic to healthy human 
cells.  
 
3.4 CONCLUSION 
This research described the isolation and structure elucidation of two new polyketides, 
satosporin A and B, isolated from fermentations of K. griseola. Along with the uncommon 
glucosylation of the polyketide aglycone, the eight-membered lactone ring seen in satosporins is 
rare amongst natural products; the compounds octalactin and gonioheptolides are the only other 
natural products with this saturated octalactone. Fermentations of K. griseola MF730-N6 is thus 
an efficient means to obtain these rare chemical entities.  
As of 2012, twelve species were described as belonging to the genus Kitasatospora and 
almost half of them were also reported to produce a natural product
86
. Efforts to selectively 
isolate members of this genus have been fruitful in describing new species as well as new 
compounds with interesting chemistry and bioactivity
98, 127
. This research supports previous 
findings that members of the genus Kitasatospora are prolific producers of secondary 
metabolites and that further investigations of their metabolome may provide additional novel 
natural products. The biosynthetic scheme leading to the production of satosporins will be 
discussed in the following chapter.  
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SATOSPORIN BIOSYNTHETIC GENE 
CLUSTER IN KITASATOSPORA GRISEOLA 
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4.1 INTRODUCTION 
Polyketides are an important class of natural products with major roles in human 
therapeutics as antimicrobials, antifungals, immunosuppressants, cholesterol-lowering and 
anticancer agents
128
. Although the majority of polyketides are biosynthesized from very few 
starter and extender building blocks (i.e. acetate, propionate, malonyl-CoA and methymalonyl-
CoA), the tremendous structural diversity within this class is a result of the vast combinations of 
reducing domains within each module of the PKS. For every extender unit, the β-ketone may be 
sequentially reduced to an alcohol, an alkene or an alkane via a ketoreductase, dehydratase and 
enoylreductase domains, respectively
9
. Since analysis of the protein sequence of PKSs reveals 
which domains are present within each module, the ketide product of Type I PKSs can easily be 
predicted from genetic information.  
Satosporins A (1) and B (2) (Figure 4.1) are two polyketides recently isolated from the 
terpentecin-producing actinomycete Kitasatospora griseola (see Chapter 3) with unique 
structures featuring a tricyclic ring system comprising an oxo-decalin ring fused to an 
octalactone to which either one or two glucose units are attached
129
. Their biosynthesis (Figure 
4.2) was predicted to occur via multimodular type I PKSs containing one loading and seven 
extender modules incorporating a rare lactate starter unit along with five methylmalonate and 
two malonate extender units, resulting in a 17-carbon ACP-bound ketide. Following 
macrocyclization and release from the synthase via the thioesterase domain, the macrolide was 
predicted to then undergo intramolecular cyclization via the removal of the α-proton followed by 
the nucleophilic attack to the β-carbon forming a new σ-bond from π electrons resulting in a 
hydroxyl leaving group and yielding the aglycone. The addition of a glucose molecule via a 
glycosyltransferase would result in satosporin B (2), while the transfer of two glucose molecules 
would yield satosporin A (1).  
Although the biological activity of these compounds remains undetermined, insight into 
the genes that govern its biosynthesis can lead to the generation of bioactive analogues while  
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Figure 4.1. Structure of the polyketides satosporins A and B from K. griseola MF730-N6. 
 
 
Figure 4.2. The initially proposed structure-based satosporin biosynthesis involved a rare, but 
documented, lactate starter unit, a ketone originating from the lack of β-keto processing enzymes 
at module 4, an intramolecular cyclization of the macrolactone to yield the aglycone and finally 
one or two glycosyltransferases to glucosylate the aglycone; circles indicate the resulting 
functional group from the domains present within the module. AT: acyltransferase, KS: 
ketosynthase, ACP: acyl carrier protein, KR: ketoreductase, DH: dehydratase, ER: 
enoylreductase, TE: thioesterase.
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simultaneously increasing the knowledge about polyketide biosynthetic genes to improve 
functional annotation predictions. The objective of this study was thus to locate and annotate the 
gene cluster from Kitasatospora griseola MF730-N6 responsible for the biosynthesis of 
satosporins.  
4.2 MATERIALS AND METHODS 
4.2.1 Fermentation of Kitasatospora griseola and chemical extraction  
Two seed cultures of K. griseola MF730-N6 were grown, first from a scraping from the 
sporulating organism on an agar plate and then using a 5 % inoculum of the first seed, in 
disposable culture tubes containing 10 mL seed medium (10 g/L yeast extract and 10 g/L 
glucose) for 48 h each at 30°C and 200 rpm. 10 mL of lean medium
67
 containing 0.4 g glucose, 
0.8 g galactose, 0.8 g maltose, 1.6 g dextrin, 0.8 g Bacto™-Soytone and 0.3 g (NH4)2SO4 per 
liter was then inoculated using 500 µL from seed #2 and allowed to grow for 48 h under the 
same conditions. Purity plates were prepared following fermentations to ensure one colony type 
and thus no contamination. To assess satosporin production, the fermentations were extracted by 
shaking twice with 10 mL ethyl acetate (EtOAc) for 1 h and drying the combined organic layers 
under air. The crude extract was then analysed by liquid chromatography-high resolution mass 
spectrometry (LC-HRMS).  
4.2.2 Sequencing of the sat cluster 
Polyketide KS-AT region amplification using degenerate primers  
Amplicons were generated with EconoTaq
® 
2X plus green (Lucigen) master mix using the 
previously developed primer pair K1F and M6R and using K. griseola genomic DNA as a 
template with the following cycling conditions: an initial denaturation at 94°C for 2 min 
followed by 30 cycles of denaturation at 94°C for 30 s, annealing at 59.4, 57.7, 54.6, 52.4, 50.9 
and 50°C for 15 s and polymerization at 72°C for 1:20 min and a final extension at 72°C for 5 
min. Amplicons were then gel-purified and cloned into Escherichia coli using the instaTAclone 
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PCR cloning kit (Fermentas, Thermo Scientific™) following the manufacturer’s instructions. 
Ampicillin resistant clones were then subcultured and either subjected directly to colony PCR, as 
described in Chapter 2, or their pDNA extracted and used as template for PCR using M13F and 
M13R primers
130
 using the cycling conditions mentioned above except that the annealing 
temperature was 45°C. Amplicons were then subjected to restriction analysis by digesting 20 µL 
of the PCR reaction with XmaI and RsaI enzymes according to the manufacturer’s instructions. 
Following electrophoresis, banding patterns were compared and grouped by similarity. All 
amplicons were then sent for sequencing with M13F primer and their DNA sequence was used 
to dereplicate identical amplicons using the program ContigExpress
® (Vector NTI Advance™, 
Life Technologies) and also to query a local bafilomycin sequence databases using the 
nucleotide Basic Local Alignment Search Tool (BLAST
®
n, ) using the freeware BioEdit 
(Carlsbad, USA) sequence alignment editor program
131
. Primers and strains used throughout this 
study are listed in Table 4.1.  
Illumina
®
 sequencing 
Genomic DNA was isolated from cultures of K. griseola MF730-N6 grown for 48 h in 
tryptic soy broth (17 g pancreatic digest of casein, 3 g Bacto™-Soytone, 5 g NaCl, 2.5 g 
K2HPO4 and 2.5 g dextrose per liter and pH adjusted to 7.3) at 30°C and 200 rpm using the 
PureLink genomic DNA mini kit (Invitrogen). The sample was sent to Dr Nathan Magarvey at 
McMaster University for Illumina
®
 sequencing using MiSeq sequencer and data was provided as 
contigs assembled from 150 bp reads and visualized in Geneious (Biomatters, San Francisco, 
USA). Nodes greater than 5 kb and contigs larger than 1 kb were submitted to antiSMASH at the 
following URL: http://antismash.secondarymetabolites.org/
38
. Sequences containing polyketide 
biosynthetic genes were then submitted to BLAST
®
p to query the National Center for 
Biotechnology Information (NCBI) database following ORF prediction using FramePlot 4.0 at 
the following URL: http://nocardia.nih.go.jp/fp4/
132
.  
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Table 4.1. Primers and plasmids used during this study. 
Primer name Sequence or relevant characteristics
a
 Reference 
M13F TGTAAAACGACGGCCAGT 
130
 
M13R CAGGAAACAGCTATGACC 
130
 
K1F TSAAGTCSAACATCGGBCA 
133
 
M6R CGCAGGTTSCSGTACCAGTA 
133
 
N2491KO_L_F GCTTCGGAATTCCGAGCAGTCCGAGGTCTTCC This study 
N2491KO_L_R GTAGCATGCGTCCACGCTGTCCTCGTCGG This study 
N2491KO_R_F GTAGCATGCGGCGAGGACCAGGTGGCGAT This study 
N2491KO_R_R GACTGCAAGCTTGAAGAACGCCGCGTCGAAGT This study 
N2491_confirm_F CGTGGTGAACGGACCCGCGG This study 
N2491_confirm_R CCTTGGCCGTGACGACGTCG This study 
pSET151 Th
R
, Apr
R
, xylE, rep
pUC
, oriT, lacZα 69 
a
Th
R
:thiostrepton resistance marker, Apr
R
: apramycin resistance marker, xylE: catechol 2,3-
dioxygenase reporter gene, rep
pUC
: E. coli replication function from pUC, oriT: origin of transfer 
from RK2 and lacZα: β-galactosidase for blue-white screening.  
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PacBio sequencing 
Genomic DNA was isolated from 10 mL K. griseola cultures grown overnight in seed 
medium containing 10 g/L glucose and 10 g/L yeast extract at 30°C and 200 rpm using the 
Qiagen genomic tip 100/G kit. The sample was kept at 4°C and 500 µL of 80 ng/µL gDNA was 
sent the following day to the McGill University and Génome Québec Innovation Centre to be 
sequenced using the Pacific Biosciences
® 
RS II platform; data was provided as contigs from a de 
novo assembly and visualized in Geneious.  
4.2.3 Insertional inactivation of module 1 
Module 1 of the putative satosporin biosynthetic gene cluster in quiver_44 was inactivated 
through the insertion of the apramycin resistance gene via double crossover of homologous 
regions
71
. Briefly, two ~1.5 kb regions of homology were PCR amplified from K. griseola 
gDNA using primers pairs N2491KO_left_F and N2491KO_left_R, N2491KO_right_F and 
N2491KO_right_R using EconoTaq
®
 2X plus green and the following cycling conditions: an 
initial denaturation at 94°C for 2 min followed by 30 cycles of denaturation at 94°C for 30 s, 
annealing at 72.3°C for 15 s and polymerization at 72°C for 1:30 min and a final extension at 
72°C for 5 min. This gave rise to amplicons N2491KO_left (bp: 12-1491) and N2491KO_right 
(bp: 1519-2889), which following column purification were restricted with EcoRI-HF/SphI-HI 
and SphI-HF/HindIII-HF, respectively, to generate the proper sticky ends required for the 
assembly of the deletion plasmid. The apramycin resistance gene was used as a selection marker 
and was obtained as described previously in Section 2.2.4. Plasmid DNA from pSET151
69
 was 
restricted with EcoRIHF/HindIII-HF and the 6 kb band was gel-purified.  
All components of the deletion plasmids (left arm, right arm, apramycin resistance gene 
and the plasmid pSET151) were added to a microcentrifuge tube along with T4 DNA ligase and 
the reaction components according to the manufacturer’s instructions. 5 µL of the ligation 
reactions were then used to transform chemically competent E. coli and plated on LB containing 
50 µg/mL apramycin. Colony PCR was first performed on E. coli harbouring pN2491KO using 
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primers N2491KO_left_F and N2491KO_right_R following the same cycling conditions as 
before except that the polymerization time was extended to 3 min to generate 3819 bp 
screen_N2491KO amplicons. Plasmid DNA was then extracted from transformed colonies and 
restriction digests were performed using SacI/PstI and AatII.  
The remainder of the knock-out procedure was as described in Section 2.2.4 and PCR was 
used to confirm the genotype of K. griseola ΔN2491 using genomic DNA as template, the new 
primer pair N2491_confirm_F/R (which annealed within the homologous arms) and similar 
cycling conditions as before except that the annealing temperature was 68.6°C and the 
polymerization time was 2:30 min. Genomic DNA was obtained by phenol chloroform 
extraction
71
. Production of satosporin in wild-type and knock-out strains was assessed by 
culturing and extracting the fermentations as described in 4.2.1 and assessing whether or not 
satosporins were present in the crude extracts by LC-HRMS.  
4.2.4 Sequence analysis of the sat cluster 
The DNA sequence of quiver_44 was submitted to the antiSMASH tool online. Open 
reading frames (ORF) and ribosome binding sites (RBS) were confirmed using FramePlot 4.0 
and annotation was confirmed by BLAST
®
 analysis against publicly available databases. The 
NRPS-PKS and Dock_Dom_Anal interfaces of the structure based sequence analysis of 
polyketide synhtases (SBSPKS) program were also used to analyse the PKSs
134
. These 
sequences have been submitted to GenBank under accession number JXZB00000000.  
4.3 RESULTS AND DISCUSSION 
4.3.1 Fermentation of Kitasatospora griseola and chemical extraction 
Following a 48-hour fermentation, growth of the organism in the lean medium was 
evidenced by a cloudy reddish medium and formation of aerial mycelia as expected for this 
organism
86
. Purity plates contained a single phenotype where white colonies appeared after 24 h 
incubation and no other colony type appeared over the next 3 d. Following extraction by EtOAc 
and LCMS analysis, satosporin was detected in crude extracts, as reported previously
129
, 
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evidenced by the presence of the pseudomolecular ion [M+H]
+
 of satosporin A (1) and its 
sodium adduct with m/z 689.3749 and 711.3564 (∆ = 0.9 ppm and 0.2 ppm), respectively, in the 
mass chromatogram (Figure 4.3).  
4.3.2 Sequencing of the sat cluster 
Degenerate primers to amplify KS clones  
The first strategy to elucidate the satosporin biosynthetic gene cluster was to use 
previously designed K1F and M6R degenerate primers designed to anneal to conserved regions 
of the ketosynthase and methylmalonyl-CoA transferase modules, respectively
133
. The PCR 
reaction using these primers and K. griseola genomic DNA generated amplicons roughly 1200 
bp long. Following gel-purification and cloning of the amplicons into E. coli, inserts were 
amplified by PCR using M13 forward and reverse primers. The amplicons were then subjected 
to a restriction digest with XmaI and RsaI to give rise to the fragmentation patterns shown in 
Figure 4.4. Fifty-eight amplicons were categorized into 11 groups based on similarity of the 
restriction pattern as listed in Table 4.2. From this analysis, two thirds of the amplicons analysed 
were grouped into categories A, B and C; amplicons in category E were not necessarily identical 
as the amplicons were not restricted by the enzyme and, thus, provided no information regarding 
the ~1200 bp ketosynthase to methylmanolyl-CoA transferase (KS-AT) region.  
Since the restriction analysis provided no information on the actual DNA sequence of the 
amplicon, each was also sent for sequencing. First, an assembly was performed to dereplicate 
identical sequences. No sequence data was obtained for four of the amplicons using M13F 
primer, 47 sequences fell into 6 contigs and 7 sequences did not form any contig. The analysis 
provided similar groupings to those obtained by restriction pattern analysis, where the majority 
of sequences fell into two groups, 1 and 4 of Table 4.3. The smaller groups were less consistent 
between the two methods, which was expected given the high resolution of the sequence 
assembly and the much lower resolution of the restriction analysis; the latter was however 
inexpensive and therefore would be an appropriate dereplication tool for large datasets where 
only a few representatives from each group would need to be sequenced.  
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Figure 4.3. Evaporative light scattering detector (ELSD) (A), mass chromatogram (B) and selected portion of the mass spectrum at 3.11 min (C) of 
the crude extract from K. griseola illustrating the production of satosporin A via the presence of the pseudomolecular ion [M+H]
+
 and its sodium 
adduct m/z 689.3749 and 711.3564, respectively.  
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Figure 4.4. Restriction patterns, following digest and electrophoresis, of 75 KS-AT insert amplicons which grouped into 11 groups labelled from A 
to K; M: 2-log DNA ladder.  
Table 4.2. Preliminary dereplication of each amplicon based on the 11 fragmentation patterns following XmaI and RsaI digest where the majority 
of amplicons have the restriction pattern of group A, B or C.  
Group Colonies Group Colonies  
A 1, 5, 6, 7, 13, 16, 18, 23, 31, 32, 35, 36, 45, 47 G 41  
B 2, 4, 9, 17, 19, 24, 27, 55 H 50  
C 3, 8, 10, 11, 12, 21, 22, 26, 29, 30, 33, 34, 44, 46, 49, 58 I 59  
D 15, 20, 28, 37 J 63, 69, 70, 72  
E 25, 43, 51, 56, 62 K 14  
F 38, 39, 40    
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Table 4.3. Contigs generated by assembling the nucleotide sequences generated from 
sequencing all 58 KS-AT clone amplicons; 50 sequences grouped into 6 contigs while 8 
sequences did not group into any contigs.  
Contig Colony 
1 
3, 8, 10, 11, 21, 26, 29, 30, 
33, 34, 46, 49, 58, 70, 72 
2A 2, 12, 50 
2B 4, 9, 37, 55 
3 
1, 6, 7, 13, 15, 16, 18, 23, 32, 
35, 36, 38, 40, 41, 45, 47, 59,  
4 43, 56 
5 17, 19, 20, 24, 27  
No contig 14, 22, 25, 28, 39, 51, 62, 69 
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To further support the sequence-based groupings and to provide information as to which 
biosynthetic gene cluster these sequences originated from, a nucleotide BLAST
®
 search was 
performed using a local database containing the bafilomycin PKS nucleotide sequences from K. 
griseola generated during this research. Of the 54 amplicons sequenced, 49 had greater than 94% 
sequence identity to a ketosynthase and/or methylmalonyl-CoA transferase region of the 
bafilomycin gene cluster, as listed in Table 4.4. The groups generated using the BLAST
®
n 
results were very similar to the contigs except that better resolution was provided for sequences 
that had not grouped into a contig. The sequence of colony 22 was now clearly part of group I as 
it shared 99% nucleotide identity to the same KS-AT region of bafilomycin module 1 and those 
of colonies 25, 51 and 62 could now be grouped in IV as they shared 99% sequence identity with 
the acyltransferase of module 7. The analysis also revealed that although colonies 69, 39, 28 and 
14 did not have duplicates, these KS-AT regions were those of modules 1, 5, 8 and 10, 
respectively of the bafilomycin gene cluster.  
In the case of KS-AT amplicons from modules 1, 4 and 5 (groups I, II and III), two 
contigs and/or groups were generated for each amplicon representing the two insertional 
directions illustrated in Figure 4.5 that are possible during cloning of the PCR products. Since 
the cloning strategy took advantage of the adenosine overhang produced by the Taq polymerase; 
the PCR products could thus be cloned into the plasmid in either direction
135
.  
According to the published bafilomycin gene cluster, the modules containing a 
methymalonyl-CoA transferase domain, and thus the sequence recognized by the degenerate 
primer M6R, were those of modules 1, 3, 4, 7, 8, 9, 10 and 11. Although the acyltransferase of 
module 5 had substrate specificity for methoxymalonyl-CoA, the M6R primer was successful in 
annealing to the DNA as evidenced by the amplicons of group III. Further inspection of the 
sequence of this domain revealed that the sequence used to design the primer was conserved in 
this module loading methoxymanolyl-CoA as its sequence differed by only one base at position 
11 of the primer. We were thus successful at obtaining amplicons for two thirds of the possible  
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Table 4.4. Groups of KS-AT clones and associated modules of the bafilomycin biosynthetic 
gene cluster of K. griseola. 
Group
a
  Colony 
Bafilomycin domains in K. griseola
b
 
 (nucleotide sequence identity>94%) 
I-F 
3, 8, 10, 11, 21, 22, 26, 29, 30, 33, 34, 
46, 49, 58, 70, 72 
KS1AT1 (BfaS1-AT2) 
I-R 69 AT1 (BfaS1-AT2) 
II-F 2, 12, 50,  KS4AT4 (BfaS2-AT1) 
II-R 4, 9, 37, 55 AT4 (BfaS2-AT1) 
III-F 39 KS5AT5 (BfaS2-AT2) 
III-R 
1, 6, 7, 13, 15, 16, 18, 23, 32, 35, 36, 
38, 40, 41, 45, 47, 59 
AT5 (BfaS2-AT2) 
IV 25, 43, 51, 56, 62 AT7 (BafS3-AT1) 
V 28 AT8 (BafS3-AT2) 
VI 14 AT10 (BafS4-AT2) 
other 17, 19, 20, 24, 27 No bafilomycin similarity 
 
a
F for a forward and R for a reverse insertion of the ketosynthase-acyltransferase (KS-AT) 
amplicon in E. coli; 
b
domain numbering was based on the overall extender module number while 
numbering in parenthesis refers to the synthase and the module within that synthase.  
 
 
 
 
 
 
Figure 4.5. Graphical representation of the possible orientations of the KS-AT amplicon during 
cloning that explains why two groups were generated for amplicons sharing high sequence 
identity to the same bafilomycin domains. 
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bafilomycin KS-AT regions; increasing the number of clones sequenced could have generated 
better coverage. However, given that the objective was to obtain KS-AT sequences that did not 
belong to the bafilomycin cluster, further cloning and sequencing was not necessary.  
The sequences of colonies in contig 5 were the only ones without high nucleotide identity 
to bafilomycin genes, suggesting that these amplicons did not originate from the bafilomycin 
cluster and, thus, could potentially represent a PKS KS-AT region from the satosporin 
biosynthetic gene cluster. It was also possibly amplified from a KS-AT region of another 
polyketide gene cluster as actinomycetes are known to have numerous secondary metabolite 
biosynthetic gene clusters in their genomes
30, 136
. When the sequences from amplicons in contig 
5 were submitted to BLAST
®
x against the NCBI protein database, most hits had only 65% 
sequence identity to PKS genes, suggesting that these proteins shared similar functions but did 
not belong to the same gene clusters
137
.  
Illumina
®
 sequencing 
 To obtain the DNA sequence of the entire satosporin biosynthetic gene cluster, 
Illumina
®
 sequencing was performed on K. griseola genomic DNA. The sequencer generated 
3,048,153 reads (150 bp), which first grouped into 3291 nodes between 26.427 kb to 61 bp long 
with a median length of 1192 bp and where half of the assembly could be generated using 
fragment lengths of 4467 bp or longer (N50). These nodes assembled into 596 contigs ranging 
between 143 and 32,727 bp in length with an N50 contig size of 8942 bp. Of the 534 contigs (>1 
kb) and 390 nodes (>5 kb) submitted to antiSMASH, 30 sequences contained secondary 
metabolite genes and are listed in Table 4.5. Thirteen were assigned to portions of the 
bafilomycin gene cluster by performing a local BLAST
®
x search against protein sequences from 
the bafilomycin gene cluster in K. setae, while one sequence, node 345, had high sequence 
identity to the late portion of the terpentecin biosynthetic gene cluster in the same strain of K. 
griseola. The remainder of the sequences encoding for polyketide biosynthetic genes were 
analysed further by submitting them to BLAST
®
x against the NCBI database.  
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Table 4.5. Secondary metabolite biosynthetic genes in nodes and contigs generated from 
sequencing of K. griseola gDNA using Illumina
®
 technology as detected by antiSMASH. 
Sequence antiSMASH hit
a
 Domains detected
b
 
Originating 
Gene cluster 
Length 
(bp) 
contig 1 Type I PKS AT-DH-ER-KR-ACP-KS 
 
6995 
contig 222 Type I PKS KS-AT-DH 
 
3651 
node 439 Type I PKS KS-AT 
 
3645 
node 697 Type II PKS KS 
 
10593 
  
 
 
 
contig 95 Type I PKS KS-AT-DH-ACP 
 
23531 
node 2086 NRPS-PKS  
 
6143 
contig 141 NRPS-PKS 
 
KS-AT-DH-KR-ACP- 
C-A-T-TE 
 
Possible 
homolog of 
frontalamide 
16424 
contig 277 NRPS-PKS  KSE_27190 18466 
contig 278 Lantibiotic  
 
17679 
node 840 Squalene/hopanoid  
 
8465 
contig 147 Squalene/hopanoid  
 
13186 
contig 144 Siderophore  
 
14561 
node 392 Siderophore  
 
10524 
contig 56 Other  
 
32727 
contig 45 Other  KSE_61120 18541 
contig 338 Other  
 
7788 
contig 4 Type I PKS  Bafilomycin 22436 
contig 98 Type I PKS  Bafilomycin 15766 
contig 60 Type I PKS  Bafilomycin 11823 
contig 369 Type I PKS  Bafilomycin 6749 
contig 78 Type I PKS  Bafilomycin 4195 
contig 553 Type I PKS  Bafilomycin 1409 
node 3541 Type I PKS  Bafilomycin 22436 
node 1072 Type I PKS  Bafilomycin 15766 
node 3611 Type I PKS  Bafilomycin 11823 
node 253 Type I PKS  Bafilomycin 6749 
node 127 Type I PKS  Bafilomycin 3330 
node 598 Type I PKS  Bafilomycin 3282 
node 3223 Type I PKS  Bafilomycin 1409 
node 345 Terpene  Terpentecin 21158 
a
PKS: polyketide synthase, NRPS: non-ribosomal peptide synthetase, 
b
AT: acyltransferase, KS: 
ketosynthase, ACP: acyl carrier protein, KR: ketoreductase, DH: dehydratase domains. 
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Sequences from contigs 141 and 277 as well as node 2086 were ruled as unlikely 
satosporin gene cluster fragments as no NRPS genes were predicted to be necessary during 
biosynthesis. This left contigs 1, 95 and 222 as well as nodes 439 and 697 as possible satosporin 
fragments as they all encoded for PKS domains that would be consistent with the predicted 
domains required for biosynthesis; contig 1 could represent the sequence of modules 2 or 6 
whereas that of contig 222 may be that of modules 2, 5, 6, or 7 of the predicted pathway shown 
in Figure 4.2. The modules predicted from nodes 439 and 697 could belong to any modules as 
they contained the minimal domains required for chain elongation during polyketide 
biosynthesis; no module could be correlated with the domains predicted from contig 95 as DNA 
coding for the ketoreductase (KR) domain seems to be lacking and thus the dehydratase 
predicted here would have no hydroxyl group to act upon.  
Since a KS-AT region had been amplified from degenerate primers (Section 4.3.2) that 
did not belong to the bafilomycin biosynthetic gene cluster, a locat BLAST
®
n was performed 
with sequences from colonies 17, 19, 20, 24 and 27 against the 3391 nodes generated from 
Illumina
®
 sequencing. All five sequences had 94-100% sequence identity to region 669-1 of the 
2962 bp region of node 2491. Although this region had not been identified by antiSMASH as 
secondary metabolite biosynthetic genes, a BLAST
®
x analysis revealed the presence of a partial 
acyltransferase, ketoreductase, acyl carrier protein and partial ketosynthase domains. This region 
would be consistent with modules 1 and 3 of the predicted satosporin biosynthetic gene cluster; 
it could however also belong to another PKS that produced a hydroxyl group during polyketide 
backbone assembly.  
PacBio sequencing 
Since Illumina
®
 sequences failed to provide a contig containing the entire satosporin 
biosynthetic gene cluster, K. griseola gDNA was sent to the McGill University and Génome 
Québec Innovation Centre to be sequenced using PacBio technology. This technology was 
chosen here for its ability to produce long raw reads (~2 kb) to enable de novo assembly due to 
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its single molecule real-time (SMRT
®
) cell technology. Similar to Illumina
®
 technology, PacBio 
sequencing provides sequencing by synthesis without the need to generate PCR amplified 
clusters of sequences. Instead, a single DNA molecule is bound to a DNA polymerase and 
immobilized in a well, called zero-mode waveguides (ZMWs), which then emits different light 
wavelengths as different bases are incorporated and their fluorophore cleaved
138
. Although the 
sequencing accuracy of a single read is poor (85-87%), resequencing allows for 99.09% 
accuracy after 7 passes
139
. The high coverage (>100X) obtained during this experiment was 
sufficient to overcome the low accuracy of single reads to generate high accuracy sequences. 
The assembly contained 15 contigs (quiver_34-48) ranging in size between 2.8 kb and 2.3 
megabase pair (Mb); more details on these data will be provided in Chapter 5 of this thesis. A 
local BLAST
®
n of non-bafilomycin KS-AT clone sequences (17, 19, 20, 24 and 27) and 
potential sequences highlighted by Illumina
®
 sequences (contigs 1, 95 and 222 and nodes 439 
and 697) against the assembled contigs generated from PacBio sequencing revealed which gene 
clusters had been previously detected in the genome of K. griseola as summarized in Table 4.6.  
Contig 222 and node 697 had high sequence identities with quiver_36 and when analysed by 
antiSMASH, revealed a NRPS-PKS gene cluster similar to that found in Streptomyces 
clavuligerus and Streptomyces griseus; the domain organization was clearly inconsistent with 
the predicted satosporin biosynthetic gene cluster. The region in quiver_42 which aligned with 
the sequence of contig 95 contained a single module with domains KS-AT-DH-ACP; the other 
necessary domains were absent from the surrounding regions and thus there was no evidence to 
suggest that this was the satosporin biosynthetic gene cluster.  
Contig 1, node 439, node 2491 and the sequences of the non-bafilomycin KS-AT 
amplicons were revealed to be sequences present within quiver_44. An antiSMASH analysis of 
this region revealed a region between 467’063 and 566’778 containing, in addition to other 
genes, two large PKS containing 5 and 3 modules which was consistent with the one loading and 
seven extender modules predicted for satosporin biosynthesis. Contig 1 and node 2491 were both  
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Table 4.6. Alignment results between the potential satosporin gene cluster fragments discovered 
using degenerate primers and Illumina
®
 sequencing with the 15 contigs (Quiver_xx) generated 
using PacBio genome sequencing technology. 
Hits Alignment hit Alignment region
a
 % identity 
Contig 222 Quiver_36 
Q: 276-3651 
S: 1’785’414-1’788’768 
100% with 
misassembly 
    
Node 697 Quiver_36 
Q: 1-10’593 
S: 1’789’159-1’799’751 
99% 
    
Contig 95 Quiver_42 
Q: 2182-22’907 
S: 1’690’212-1’669’487 
99% 
 
    
Contig 1 Quiver_44 
Q: 552-4266 
S:515’829-511’958 
and other alignments 
91-100% with 
misassembly 
    
Node 439 Quiver_44 
Q: 1-3645 
S: 493’004-489’360 
100% 
   
 
Node 2491 Quiver_44 
Q: 1-2992 
S: 542’212-539’221 
100% 
    
KS-AT clones 
(17, 19, 20, 24, 27) 
Quiver_44 
Q: 1-732 
S: 541’536-542’275 
93-100% 
 
a
Q: query, S: subject. 
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sequences from these PKSs, while node 439 was present within another gene within the cluster. 
This suggested that the two PKSs in quiver_44 between 506’676 and 546’778 bp were probably 
responsible for the biosynthesis of the polyketide backbone of satosporin.  
4.3.3 Insertional inactivation of module 1 to generate K. griseola ∆sat 
To assess the involvement of the probable gene cluster present within quiver_44, the 
apramycin resistance gene was inserted within the sequence of the PKSs’ first extender module 
(module1, Figure 4.6 (A)).  
To achieve the insertional inactivation of module 1, the deletion plasmid N2491KO was 
designed using PCR amplified 1.5 kb homologous arms and the apramycin resistance gene 
within the suicide plasmid pSET151. Once the pieces were ligated and E. coli was transformed 
with the ligation reaction, pDNA was restricted from colony 6, 7 and 10 which had shown the 
appropriate amplicon between 3 and 4 kb during colony PCR. Although the fragments generated 
from colony 7 following digestion with AatII enzyme were not consistent with the predicted 
fragment sizes, those of colonies 6 and 10 were consistent in both restriction digests and thus 
pDNA from E. coli::pN2491KO colony 6 was used for the transformation of E. coli ET12567 
harbouring pUZ8002 with the deletion plasmid, followed by conjugation with K. griseola 
MF730-N6.  
Genetic characterization 
Exconjugants were subcultured three times on media containing apramycin and nalidixic 
acid and then on media with apramycin and media with thiostrepton to screen for double cross-
over exconjugants. Genomic DNA from clones that seemed resistant to apramycin but sensitive 
to thiostrepton was used to characterize the genotype using primers that annealed within the 
homologous arms used for the deletion plasmid assembly. A 1538 bp amplicon was expected for 
wild-type and single cross-over colonies, while a single 2493 bp amplicon was expected for 
double cross-over colonies. Clones 1, 2 and 4 showed amplicons consistent with a double cross-
over of homologous arms as evidenced by a single band between 2 and 3 kb following gel  
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Figure 4.6. Probable satosporin biosynthetic genes present in quiver_44; regions of homology 
used for the insertional inactivation procedure are boxed in grey (A), amplicons generated from 
genomic DNA of apramycin resistant and thiostrepton sensitive knock-out (KO) clones as well 
as from gDNA from the wild-type (WT) as a positive control and a negative control (-C) was 
also included where no DNA was added to the PCR reaction; bands consistent with a double 
cross-over of homologous arms are circled while those consistent with the native genotype are 
crossed-out, M: 2-log DNA ladder (B) and evaporative light scattering detector (ELSD) 
chromatograms of wild-type (WT) strain and knock-out (KO) strain; satosporin A was detected 
at 3.07 min in wild-type strains and was not detected in crude extracts of the knock-out strain 
where the apramycin resistance gene replaced 38 bp of sequence in module 1 of the probable 
satosporin biosynthetic PKS gene (C).  
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electrophoresis (Figure 4.6 (B)). The wild-type strain showed an amplicon of approximately 1.5 
kb, consistent with the native genotype and, finally, clones 5 and 9 showed amplicons of both 
lengths, representing most likely a single cross-over event even though the colonies seemed 
sensitive to thiostrepton. It is possible that these clones simply grew slower than their 
counterparts plated on media containing apramycin; verifying the genotype of the strains was 
thus a crucial step to choose a correct clone for phenotypic characterization. Since exconjugant 
clone # 1 showed genotype consistent with the desired insertional mutation, it was renamed K. 
griseola ∆sat.  
Phenotypic characterization 
The phenotype of K. griseola ∆sat was then compared to that of the wild-type following 
48-hour fermentations in lean medium and EtOAc extraction. From the ELSD chromatograms 
(Figure 4.6 (C)), satosporin was detected in the crude extract of the wild-type strain, as 
evidenced by a peak at 3.07 min with m/z of 711.3575 in the mass spectrum. The crude extract 
from fermentations of the knock-out strain failed to show an ELSD peak around 3 min and no 
ions with m/z 711.3562±5 ppm could be detected in any mass spectrum. There was no evidence 
of analogues or shunt metabolites.  
Although a complementation study was not performed here, there is evidence to suggest 
that the phenotype was not a result of polar effects causing failed transcription in genes at other 
loci on the genome. Firstly, there were no apparent differences in growth rates or sporulation 
between knock-out and wild-type strains and secondly, the knock-out strain was still capable of 
producing other secondary metabolites as evidenced by the peaks at 5.26 and 5.57 min which 
had been shown to be bafilomycins.  
The evidence supports the hypothesis that the polyketide genes present between base pairs 
506’676 and 546’778 of quiver_44 encode for the two PKSs responsible for biosynthesizing the 
backbone structure of satosporins.  
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4.3.4 Sequence analysis of the sat cluster and revised proposed biosynthesis 
Sequence analysis 
AntiSMASH predicted a gene cluster of 99.7 kb containing the PKSs involved in 
satosporin biosynthesis; it spanned nucleotides 467’063 to 566’778 of quiver_44 and had a G+C 
content of 73.5%, consistent with that of Kitasatospora reported previously
136
.  
ORF10 and ORF1 were proposed as the boundaries of the sat cluster, spanning the 67.590 
kb region between bases 481’188 and 548’778 of quiver_44. Given that most genes were 
transcribed from the complimentary strand (from right to left), the DNA sequence of quiver_44 
was reverse-complemented to discuss the sat cluster as illustrated in Figure 4.7. The end of the 
cluster was predicted to be ORF10 due to the presence of genes with homology to transposases 
(ORF11-12) downstream of the cluster. Since horizontal gene transfer is considered to play an 
important role in gene cluster formation, mobile genetic elements such as transposons and DNA 
repeats commonly flank secondary metabolite biosynthetic gene clusters
140
. Since no role in 
satosporin biosynthesis could be attributed to genes upstream of ORF1, the beginning of the 
cluster was proposed to be with ORF1. Knock-out experiments would be necessary to confirm 
that the genes outside the delimited cluster were not involved in satosporin biosynthesis.  
The open reading frame prediction was confirmed using FramePlot and the resulting 
protein sequence was used to query the NCBI protein database using BLAST
®
p; hits for similar 
proteins to each ORF are listed in Table 4.7 where identity between query and database 
sequences varied between 33 and 90% whereas their similarity varied between 50 and 94%. 
Given the high sequence similarities (>40%) between ORFs and the database, it was possible to 
extrapolate and propose functions, as listed in Table 4.8, for most of the newly sequenced 
proteins within the sat cluster of K. griseola
141
.  
  
 
1
5
7
 
 
Figure 4.7. The proposed biosynthesis of satosporins based on organization of the gene cluster involves two large multimodular polyketide 
synthase genes (satB and satC, black arrows) as well as tailoring enzyme genes encoding P450 monoxygenases (satA and satD, red arrows) and a 
glycosyltransferase (satE, green arrow). Regulatory and self-resistance genes (ORF2, 8 and 9, blue arrows) were also found within the sat cluster 
in K. griseola; genes not predicted to be involved are shown in dark grey and stereochemistry is not shown to simplify visualization of the Diels-
Alder intramolecular cyclization, mmal:methylmalonyl-CoA and mal: malonyl-CoA extender units, AT: acyltransferase, KS: ketosynthase, ACP: 
acyl carrier protein, KR: ketoreductase, DH: dehydratase, ER: enoylreductase, TE: thioesterase. 
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Table 4.7. BLAST
®
p results for each open reading frame (ORF) within the satosporin biosynthethic gene cluser; aa, amino acid.  
Protein 
Size 
(# aa) 
Similar protein, origin, (%identity/similarity), accession number 
ORF1 298 Hypothetical protein, Streptomyces roseochromogenes, (66/79), WP_023545500.1 
SatA 389 Cytochrome P450, Amycolatopsis mediterranei, (50/66), WP_013227439.1 
SatB 7590 Polyketide synthase ObsC, Saccharopolyspora spinosa, (51/61), AAS00421.1 
SatC 5774 Polyketide synthase Pks12, Mycobacterium tuberculosis M1283, (52/64), KAY30031.1 
SatD 750 
Beta-ketoacyl synthase-like protein, Saccharopolyspora spinosa, (53/69), WP_010696351.1, (aa 1-323) 
Cytochrome P450, Nocardia brasiliensis, (61/74), WP_029895429.1, (aa 349-748) 
SatE 387 Antibiotic resistance macrolide glycosyltransferase, Saccharopolyspora spinosa, (52/63), WP_010692853.1 
ORF2 429 MFS transporter, Stackebrandtia nassauensis, (33/53), WP_013020978.1 
ORF3 1066 Amino acid adenylation domain protein, Microcoleus vaginatus, (33/50), WP_006635040.1 
ORF4 765 Polyketide synthase family protein, Oscillatoria acuminata, (44/61), WP_015149440.1 
ORF5 1145 Amino acid adenylation protein, Streptomyces flavogriseus, (39/50), WP_014155552.1 
ORF6 953 Polyketide synthase, Myxococcus xanthus, (45/56), WP_011553648.1 
ORF7 536 Peptide synthase (partial), Pseudomonas sp. Lz4W, (47/63), WP_003444907.1 
ORF8 679 SARP family transcriptional regulator, Catenulispora acidiphila, (38/51), WP_015793868.1 
ORF9 332 Putative regulatory protein, Streptomyces atroolivaceus, (71/80), AF484556_16 
ORF10 510 Hypothetical protein KCH_77500, Kitasatospora cheerisanenses KCTC 2395, (90/94), KDN80516.1 
ORF11 524 Transposase IS4 family, Streptomyces ipomoeae, (77/94), WP_009338417.1 
ORF12 316 Transposase, Streptomyces canus, (77/84), WP_028808298.1 
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Table 4.8. Deduced function of each open reading frame (ORF) based on sequence similarity to previously annotated genes; AT: acyltransferase, 
KS: ketosynthase, ACP: acyl carrier protein, KR: ketoreductase, DH: dehydratase, ER: enoylreductase, TE: thioesterase, C: condensation, A: 
adenylation, PCP: peptidyl carrier protein domains.  
 Protein Proposed function in satosporin biosynthesis and domains present when appropriate  
ORF1 Unknown 
SatA P450 hydroxylation 
SatB 
Polyketide backbone assembly by type I PKS 
KS
Q
, AT
L
, ACP
L
, KS
1
, AT
1
, KR
1
, ACP
1
, KS
2
, AT
2
, DH
2
, ER
2
, KR
2
, ACP
2
, KS
3
, AT
3
, DH
3
, KR
3
, ACP
3
, 
KS
4
, AT
4
, DH
4
, KR
4
, ACP
4
 
SatC 
Polyketide backbone assembly by type I PKS 
KS
5
, AT
5
, DH
5
, ER
5
, KR
5
, ACP
5
, KS
6,
 AT
6
, DH
6,
 ER
6
, KR
6
, ACP
6
,  
KS
7
, AT
7
, DH
7
, KR
7
, ACP
7
, TE
7
 
SatD P450 oxidation 
SatE Glycosylation of the aglycone 
ORF2 Secretion/resistance 
ORF3 
Unknown 
C, A, PCP 
ORF4 
Unknown 
KS 
ORF5 
Unknown 
C, A, PCP 
ORF6 
Unknown 
KS, AT, ACP 
ORF7 
Unknown 
A 
ORF8 Regulation 
ORF9 Regulation 
ORF10 Unknown 
ORF11 Horizontal gene transfer 
ORF12 Horizontal gene transfer 
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Polyketide backbone assembly by multimodular polyketide synthases SatB and SatC 
Two large multimodular PKSs were found to be encoded by satB and satC; together they 
provided the loading module as well as the seven extender modules necessary to extend the 
loading unit by 14 carbon units. 
SatB contained, at its N-terminus, a loading module with domains KS
Q
, AT
L
 and ACP
L
. 
Both the KS and AT domains had protein characteristics supporting an acylation and 
decarboxylation mechanism for polyketide chain initiation observed in many modular PKSs 
including those involved in pikromycin, oleandromycin and tylosin biosynthesis
9
. Firstly, the 
ketosynthase was structurally similar to other KSs; however, the cysteine (C) residue within the 
active site VDTACSSS was replaced by glutamate (Q)
142
, a characteristic feature in all KS
Q
, 
allowing the enzyme to decarboxylate the malonyl or methylmalonyl unit bound to ACP
9
. 
Secondly, the AT domain contained the conserved arginine
117
 residue, which is present in 
loading and extender AT domains that interact with CoA esters of dicarboxylic acids such as 
malonyl- and methylmalonyl-CoA. This is in contrast to the loading AT domains that 
incorporate monocarboxylic acid-CoA such as acetyl- and propionyl-CoA, such as in the 
eryththromycin AT
L 
for example, where the arginine residue is replaced by a tryptophan residue 
at this location
142
. The satosporin acyltransferase AT
L
, had a predicted substrate specificity for 
methylmalonyl-CoA, as determined by the motif QQGHSQRSHANV, mostly consistent with 
the QQGHS[QMI]GRSHT[NS]V motif predicted for acyltransferases incorporating 
methylmalonate units
143
; the only difference was that the threonine (T) had been replaced by an 
alanine (A); a substitution observed in many acyltransferases of spirangiene PKSs
144
. These data 
suggest that satosporin biosynthesis begins with the loading of a methymalonyl unit onto the 
ACP phosphopantethienyl arm via a thioester bond followed by its decarboxylation by KS
Q
 to 
give rise to an ACP bound propionyl starter unit.  
The seven β-ketoacyl-ACP synthases (KS) within the sat cluster, responsible for seven 
chain elongations via decarboxylative condensations shared on average 80% amino acid 
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sequence identity; KSs of modules 4 and 7 were most similar, sharing 89% sequence identity. 
Alignment with other KS domains of PKSs within the SBSPKS database, satosporin KSs 
consistently showed highest sequence identities of 74 and 73% with KS domains from either 
avermectin or amphotericin PKSs, respectively
134
.  
Of the seven acyltransferase (AT) domains required to load and transfer the next extender 
units onto the module’s ACP, five had a substrate specificity sequence motif consistent with 
loading of a methyl-malonate unit as mentioned previously: AT
1
, AT
2
, AT
3
, AT
5
 and AT
6
. In 
contrast, the sequence motif QQGHSVGRFHTQV of AT
4
 and AT
7
 was consistent with that 
predicted for acyltransferases incorporating a malonate unit: 
QQGHS[LVIFAM]GR[FP]H[ANTGEDS][NHQ]V
143. Satosporin’s backbone formation thus 
involves 5 (2S)-methylmalonyl-CoA and 2 malonyl-CoA extender units in the order illustrated 
in Figure 4.7.  
All seven extender modules contained a β-ketoacyl-ACP reductase domain responsible for 
the stereospecific reduction of the β-carbonyl to a β-hydroxyl group using NADPH. All KR 
domains in satosporin biosynthesis appeared to be active as per the presence of the catalytic 
tyrosine (YAAAN motif) and NADPH binding site (TGGTGxLG motif) within each domain. 
Reducing KRs are divided into two main groups: B-type KRs contain an LDD motif ~57 amino 
acids (aa) before the catalytic tyrosine residue and result in hydroxyl groups with D-orientation, 
whereas A-type KRs do not contain the motif but instead have a tryptophan (W) 8 aa before the 
tyrosine residue and result in L-hydroxyl groups. Since the LDD motif and tryptophan residue 
are located on opposite sides of the active site, they are thought to guide the polyketide to enter 
at opposing sides of the active site, giving rise to the opposite stereochemistry following 
reduction. Domains KR
2
, KR
3
, KR
5
 and KR
6
 within the satosporin PKSs all had the LDD motif 
characteristic of B-type KRs whereas domains KR
4
 and KR
7
 had LAD and VDD motifs, 
respectively; these amino acid substitutions were previously reported for B-type KRs
145
. These 
KRs can be further subdivided into B2- and B1-type KRs, depending on whether or not the 
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enzyme carries out an epimerization reaction before reduction, resulting in L- and D-
stereochemistry of the α-substituent, respectively. The presence of a proline 2 aa past the 
catalytic tyrosine residue would indicate B2-type KRs; however, KRs
2-7
 did not contain this 
residue, resulting in B1-type and thus D-stereochemistry for both the β-hydroxyl group and the 
α-substituent when appropriate. These observations were consistent with previous reports where 
B1-type KRs were usually involved in modules containing further processing enzymes
145, 146
. 
The only KR in satosporin PKSs whose product did not undergo further processing was 
KR
1
; this enzyme did not contain the LDD motif but did have a tryptophan (W) 8 aa before the 
catalytic tyrosine, thus belonging to an A-type KR. Since no histidine was present 3 aa before 
the catalytic tyrosine, KR
1
 was classified as an A1-type KR and would result in L-
stereochemistry for both the β-hydroxyl group and the α-substituent since no epimerization of 
the α-substituent would occur previous to reduction initiated by the attack of the pro-4S hydride 
of NADPH to the carbonyl
145, 146
. A histidine residue was, however, present 4 aa before the 
catalytic tyrosine, it is possible that this residue may be capable of sterically selecting against the 
unepimerized polyketide and thus allowing only epimerized products to react with the 
tyrosine
145
. However, given the rectus (R) stereochemistry at carbons 14 and 15 in satosporins, 
L-configurations are required for both the α-substituent and the β-hydroxyl groups following 
reduction by KR
1 
suggesting that the first ketoreductase in satosporin PKS was more likely of 
A1-type. 
Modules 2 to 7 contained dehydratase domains to further reduce the β-hydroxyl group to a 
double bond between the α and β-carbons of the acyl-ACP. All appeared to be functionally 
active as they contained the motif HxxxGxxxxP containing the catalytic histidine. Although no 
sequence motif is capable of predicting whether the dehydratase produces the cis- or trans- 
alkene, cis- acting DH are usually preceded by A-type KR. Since KR
2-7
 are of B1-type, it is 
predicted that the catalytic aspartic acid will donate a hydrogen to the D-β-hydroxyl group and 
when the catalytic histidine extracts the L-α-hydrogen, resulting in syn elimination of water from 
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the β-carbon, giving rise to a trans-alkene146. Since modules 3, 4 and 7 did not contain further 
processing domains, the proposed satosporin polyketide backbone contained 3 trans-double 
bonds.  
Modules 2, 5 and 6 contained active enoylreductase domains, evidenced by the presence 
of the NADPH binding site GGVGMA, resulting in complete reduction of the initial β-keto 
groups
146
. Enoylreductases achieve this reduction via the formation of the enolate intermediate 
following the NADPH pro-4R hydride attack of the β-carbon followed by the α-carbon accepting 
a proton from a tyrosine or lysine residue
146
. Given the presence of the tyrosine ~94 aa before the 
NADPH binding site, satosporin ER domains were predicted to result in L-α-substituents, which 
is consistent with the observed L- stereochemistry at carbons 12, 6 and 4.  
The satosporin thioesterase domain was located at the C-terminus of the second PKS 
(SatC) and appeared to be active due to the presence of the histidine-aspartate-serine catalytic 
triad necessary for macrocyclization and polyketide release. The nucleophilic serine would 
presumably first attack the carbonyl of the thioester bound acyl-ACP, releasing it from the 
phosphopantetheinyl arm of ACP and resulting in an ester linkage to the serine residue of the 
thioesterase
146
. Secondly, the basic histidine residue would remove a hydrogen from the 
secondary alcohol created from the satosporin PKS module 1, which would then attack the ester 
carbonyl leading to macrocyclization and release from the serine residue of the PKS
146
, giving 
rise to the macrolactone (3) shown in Figure 4.7. 
Finally, interpolypeptide linker sequences, also known as docking domains, are short 
(~120 aa) but important sequences at the joining termini of two PKSs which allow crucial 
substrate channelling between the synthases
147
. The Dock_Dom_Anal interface of SBSPKS 
detected four helix bundle that are characteristic of the PKS docking domains, three from the C-
terminus of SatB and one from the N-terminus of SatC. Based on the DEBS2-3 docking domain, 
where two interacting ionic pairs are responsible for joining the two synthases, D64-K92 and 
R73-D105, only the aspartic acid-lysine interacting ionic pair was detected (D64-K92) in the 
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SatB-C docking domain
134
. The presence of this docking domain linking the C-terminus of SatB 
and the N-terminus of SatC supports the poposed order of polyketide assembly illustrated in 
Figure 4.7.  
Diels-Alder cyclization 
Following polyketide backbone assembly by the PKSs, SatB and SatC, satosporin 
biosynthesis is proposed to then undergo intramolecular cyclization via a Diels-Alder [4+2] 
cycloaddition between the electrophilic dienophile generated by module 7 and the diene 
generated by modules 3 and 4. The reactivity of this reaction is favored by the electron 
withdrawing ester functional group that activates the dienophile to this cycloaddition (Figure 4.8 
(A)). Many natural products such as terpenes, alkaloids, and polyketides have been proposed to 
include a biosynthetic Diels-Alder reaction
148
; examples include solanapyrones
149
, nargenicin
150
, 
betaenone B
151
, lovastatin
152
, macrophomic acid
153
 and spinosyn A
154
. 
Although few Diels-Alderase enzymes have been described, there was no genetic 
evidence to suggest that any gene within the sat cluster would encode an enzyme responsible for 
catalyzing a Diels-Alder reaction; there were no sequence similarities to the possible Diels-
Alderases lovastatin nonaketide synthase (LovB)
152
, macrophomate synhtase (MPS)
153
, spinosyn 
synthase (SpnF)
155
 or solanopyrone synthase (Sol5)
149
. The spontaneous nature of this reaction 
was further supported by the increased reactivity provided by the macrocyclization by SatC 
thioesterase which could provide structural rigidity towards the s-cis diene necessary for Diels-
Alder cyclization. Furthermore, the trans-decalin product was consistent with the endo transition 
state and product (Figure 4.8 (B)) that is often observed, thus supporting a spontaneous Diels-
Alder reaction. Knock-out experiments of individual genes within the sat cluster may provide 
further insights as to whether one may act as a Diels-Alderase or not. 
P450 oxidations 
The two main sources of oxygen in polyketides are either from the acetate/propionate-
derived extender units incorporated during assembly by PKSs or by enzymatic oxidation using  
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Figure 4.8. Diels-Alder cyclization reaction mechanism illustrating the trans-stereochemistry of 
the decalin moiety (rings fused at C3-C8) resulting from the s-cis-diene and trans-dienophile (A) 
and side views of the favoured endo product that led to the correct stereochemistry observed in 
satosporin (B).  
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cytochrome P450 monooxygenases. Based on the domain organization within each module of 
the sat PKSs and the necessity for the diene and dienophile to allow the Diels-Alder 
intramolecular cyclization, the oxygen atoms at C9 and C16 were predicted to have arisen from 
P450 mediated oxidations.  
Two putative cytochrome P450 monooxygenases were found within the sat cluster based 
on high amino acid sequence similarity to other CYP450. Sat A was found to share 66% 
sequence similarity with a cytochrome P450 from Amycolatopsis mediterranei, while the last 
400 aa of SatD shared 74% sequence similarity to a cytochrome P450 from Nocardia 
brasiliensis. Cytochrome P450 monoxygenases carry out a variety of reactions including 
hydroxylations, epoxidations, N-oxidation, deamination, dehalogenation and N-, O- and S-
dealkylation
156
. In order for the enzyme to oxidize the molecule, a heme cofactor must bind at a 
conserved cysteine residue while O2 binds to a tyrosine; other components such as a flavin-
dependent ferrodoxin reductase are also necessary to transfer electrons from NAD(P)H to heme. 
Both cytochrome P450 enzymes found within the sat cluster contained the conserved binding 
site residues tyrosine and cysteine as shown in the alignment of Figure 4.9, supporting their 
involvement in satosporin biosynthesis.  
In the proposed biosynthesis of satosporins, hydroxylation is necessary at C16 to provide 
the proper functional group for glycosylation; one of the two P450s must thus perform this 
reaction. Given the typical CYP450 structure of SatA and the unusual structure of SatD, SatA is 
probably responsible for this typical alkane hydroxylation at C16. Similar macrolide tailoring 
hydroxylations are common in natural products and have been observed in compounds such as 
erythromycin
157
, lankamycin
158
, pikromycin
91
, fostriecin
159
, fusarin
160
 and nargenicin
161
.  
The second oxidation at C9 is less straight forward as this location contains a C9-C10 
alkene as a result of the Diels-Alder cyclization. Two mechanisms for oxidation are thus 
suggested to convert the alkene to the ketone present in satosporins. The first, involves a 
mechanism where, following formation of the olefin addition intermediate (ii), a rearrangement  
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Figure 4.9. Partial alignment of the two cytochrome P450 sequences found in the sat cluster 
(satA and late portion of SatD) with other natural product P450s illustrating the presence of the 
necessary O2 and heme binding sites to confer activity as oxidative enzymes; LkmF: lankomycin 
C8 hydroxylase, EryF: EM C6 hydroxylase, OleP: oleandomycin C8 hydroxylase, ChmPI: 
probable chalcomycin C8-hydroxylase, ChmHI: probable chalcomycin C20-hydroxylase, EryK: 
EM C12 hydroxylase; modified from Arakawa et al.
158
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of the electrons and hydride shift to yield the ketone (iii), rather than the attack of the carbonium 
or radical to form the epoxide
162, 163
 (Figure 4.10). The second involves a mechanism where the 
P450 would hydroxylate the alkene at C9, forming the enol shown in Figure 4.11, which could 
then tautomerize to the ketone to provide structure (5) in Figure 4.7. Many P450 carryout 
unusual reactions such as ring expansion, isomerization via oxidation, halogen oxygenation, 
etc.
162
 and, thus, an unusual role for this structurally unique protein is proposed.  
Whichever mechanism is involved here, it is possible that betaenone B biosynthesis 
involves a similar pathway given that a ketone must also be formed from the octalin produced 
from a Diels-Alder cyclization (Figure 4.12). The origin of the ketone oxygen was proven to not 
arise from acetate or propionate via [1-
13
C, 
18
O2] labelling studies and was instead incorporated 
by P450 monoxygenase enzyme(s) since the non-oxygenated precursor, probetaenone I, was 
obtained when potent P450 inhibitors were included in the fermentation medium
151
. 
Unfortunately, no biosynthetic gene cluster has yet been described for betaenone.  
Although some CYP450 are known to carryout multiple oxidation reactions at different 
locations, such as PikC in pikromycin/methymycin biosynthesis
91
, most bacterial natural product 
P450s are highly specific and carryout a single reaction
164
, such as EryF and EryK for C6 and 
C12 hydroxylation, respectively
157, 165
. Although it was not possible to conclude whether SatA 
and/or SatD are involved in oxidation at C16 and C9, it may be proposed that the unique features 
of SatD may be responsible for the unique transformation at C9.  
SatD was unique in that it appeared to be a fused protein, where the first 323 aa showed 
sequence similarity to β-ketoacyl synthase III proteins, while the remaining 400 aa showed 
similarity to cytochrome P450 enzymes. No protein within the NCBI database showed similarity 
over the entire query, suggesting that such a fused KS/P450 protein has not been previously 
described. Although P450 enzymes have been reported as fusion proteins such as P450/ 
NADPH:p450 reductase
166
 and dioxygenase/P450
167
. Sequencing of PCR amplicons of the aa 
region 240-452 revealed no errors in which a stop codon could have been overlooked.  
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Figure 4.10. π-bond oxidation reactions by P450 monoxygenases, modified from Guengerich 
and Macdonald
163
 to explain ketone formation from the alkene generated during satosporin 
biosynthesis which involves electron rearrangement and a hydride shift.  
 
Figure 4.11. Second proposed mechanism to afford the satosporin ketone at C9, which involves 
hydroxylation of the alkene followed by tautomerization of the enol to the ketone. 
 
Figure 4.12. Betaenone B biosynthesis may also involves a P450 to mediate the oxidation of the 
alkene generated by a Diels-Alder cyclization to form a ketone; modified from Stocking and 
Williams
148
. 
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Although the P450 domain had residues supporting an active role in oxygenation, the KS-
like domain of the protein did not contain the conserved catalytic cysteine, but rather has a serine 
at this position instead. This has been observed in KS-like proteins such as CosE, DpsC, PksF, 
AknE2 and TaK, which are hypothesized to function either as fidelity factors towards the 
loading unit used by the PKS or involved in some tailoring reaction following PKS release of the 
polyketide 
168, 169
. Further investigation of this unique enzyme would yield a better prediction for 
its role in satosporin biosynthesis. 
To confirm the oxidative roles of SatA and SatD in satosporin biosynthesis, individual 
knock-out experiments or fermentations with potent P450 inhibitors are necessary to determine 
whether or not deoxygenated analogues would be produced; this may also reveal which P450 
acts at which site and in which order. It may also provide insights as to whether these 
oxygenation reactions occur before or after the Diels-Alder cyclization. The oxidations at C9 and 
C16 would thus provide the satosporin aglycone (5), described previously as satosporin C
129
.  
Sequential glucosylation via a single glycosyltransferase  
To convert satosporin C into the glycosylated natural products satosporin A and B, one 
and two glycosylation reactions must occur, respectively. The sat cluster contained an ORF, 
satE, with high protein sequence identity to macrolide glycosyltransferases; the closest match for 
SatE was the antibiotic resistance macrolide glycosyltransferase from Saccharopolyspora 
spinosa, sharing 63% sequence similarity.  
Most glycosylated bacterial natural products contain a large diversity of deoxygenated 
sugar moieties that often play an important role in biological activity
170
. Surprisingly, 
satosporins incorporate an unmodified sugar moiety, glucose. Vancomycin
115
 and pyralomycin 
2C
117
 are two examples of natural products that contain a glucose moiety and while the 
rebeccamycin and antibiotic AT2433 glycosyltransferases RebG and Atm incorporate a glucose 
molecule to the indocarbazole aglycone, it is then O-methylated to give the 4-O-methylglucose 
present in the natural products
171, 172
.  
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Other natural products may use glucosylation as a self-defense mechanism. Such is the 
case in oleandomycin and methymycin/pikromycin, where glucosyltransferases yielded 
inactivated glucosylated natural products that required β-glucosidases to cleave the sugar and 
yield the active natural products
111, 173
. Given the lack of the aglycone, satosporin C, in 
fermentations of K. griseola, the proposal of glucosylation to achieve self-resistance may be 
likely. However, until the biological activity of satosporins is discovered, the involvement of the 
glucose moieties for bioactivity remains unknown and thus it is difficult to predict the purpose of 
glycosylation. 
There is growing evidence that certain glycosyltransferases require the presence of an 
auxiliary protein usually adjacent within the biosynthetic gene cluster; these helper proteins 
resemble P450 enzymes, except that the active cysteine responsible for binding heme is not 
present. This enzyme has been characterized from the pikromycin/methymycin biosynthetic 
gene cluster as DesVIII which allows successful D-desosamine transfer by DesVII and 
analogous systems include AknT, EryCII, DnrQ and CosT in aclacinomycins, erythromycin, 
daunorubicin and cosmomycin, respectively
170, 174
. Given that there was a protein directly 
adjacent to the satosporin glycosyltransferase with C-terminal domain similar to a P450, it is 
possible that SatD may be an auxiliary protein to allow the glucosylation of the aglycone by 
SatE. Disruption of the P450 region of satD may identify whether this protein is involved in 
satosporin oxidation or glycosylation.  
Although the glycosyltransferase gene satE was found to be clustered with the other 
biosynthetic genes, no NDP-sugar biosynthetic genes were found. Satosporin probably utilizes 
dTDP-glucose from polysaccharide biosynthesis
170
. As only one glycosyltransferase was found 
within the sat cluster, it is predicted that this enzyme incorporates both glucose moieties 
sequentially to give rise to the monosaccharide and disaccharide molecules satosporin B and A.  
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Potential regulatory and self-resistance genes within the sat cluster  
Two genes within the sat cluster, ORF8 and ORF9 showed high protein sequence 
similarities to regulatory genes of other biosynthetic gene clusters and, thus, were considered to 
be putative cluster-situated regulators (or pathway specific regulatory proteins).  
ORF8 showed 51% sequence similarity to a Streptomyces antibiotic regulatory protein 
(SARP) from Catenulispora acidiphila. These proteins contain a helix-turn-helix motif which 
binds to a heptameric DNA repeat region (TCGAGxx) to initiate transcription
175
. The only 
potential repeated motif found was 94 bp upstream of the start codon for satB, where the motifs 
were detected, though in the complement strand, 50 and 48 bases apart. The large distances 
between the motifs as well as from the -10 region are in disagreement with the usual distances of 
11 nucleotide (nt) between motifs and 8 nt from the -10 region
175
 and thus the DNA binding 
location for the protein encoded by ORF8 remains unknown. Further evidence to support the 
regulatory function of ORF8 was that it contained the only in frame TTA codon of the entire 
cluster. This codon is very rare amongst the high GC content Actinobacteria but is usually found 
within secondary metabolite regulatory genes as the gene encoding this transfer RNA (tRNA), 
bldA, is only transcribed at the onset of differentiation during the stationary phase
176
.  
The second putative regulatory gene was ORF9, which showed high sequence similarity 
with numerous unspecific regulatory proteins, notably 80% identity to a putative regulatory gene 
from Streptomyces atroolivaceus. One specific BLAST
®
p hit was to TlmR3 (65% similarity), a 
tallysomycin regulatory protein with homology to SyrP, the syringomycin regulatory protein of 
Pseudomonas syringae
177
. A similar regulatory function is thus proposed for ORF9 and gene 
disruption experiments may provide evidence to support this role.   
Bacterial self-resistance is often accomplished via the export of the product through 
intracellular efflux protein. ORF2 showed 53% sequence similarity to a protein belonging to the 
major facilitator superfamily transporter of Stackebrandtia nassauensis. These membrane-bound 
proteins are further divided into 18 families and carryout the efflux of various compounds 
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including sugars, drugs, nitrate, phosphate, nucleoside, oxalate, etc.
178
 The protein encoded by 
ORF2 is thus proposed to serve as an efflux protein to export satosporins to the fermentation 
medium, where it may be non-toxic to the producing organism. This self-resistance mechanism 
may be used in combination with glucosylation as mentioned previously.  
Other sat genes 
No putative role in satosporin biosynthesis could be attributed to ORF2-ORF7 and 
ORF10, which showed sequence similarity to NRPS, PKS and genes of unknown function. Their 
involvement in satosporin biosynthesis should be assessed by gene disruption experiments.  
4.4 CONCLUSION 
The data generated from this research revealed that the sat cluster described here is 
involved in the production of satosporins in the actinomycete K. griseola MF730-N6. The entire 
set of genes necessary to propose a plausible biosynthesis of satosporin A and B are present 
within this cluster: two PKSs for the biosynthesis of the polyketide backbone, two putative P450 
monoxygenases to carry out oxidation reactions, a glycosyltransferase for the transfer of one or 
two glucose molecules to the macrolide, two putative regulatory genes to control the timing of 
secondary metabolite production and one putative self-resistance gene. The PKSs domain 
organization suggests that a spontaneous intramolecular cyclization via a Diels-Alder 
mechanism gives rise to the unique satosporin structure composed of an octalactone ring fused to 
an oxo-decalin moiety.  
As large amounts of bacterial genomes become available, the ability to detect (and thus 
“turn on”) cryptic secondary metabolite biosynthetic gene cluster relies on a detailed 
understanding of natural product biosynthesis
177
. It is thus important to keep increasing the pool 
of known biosynthetic genes and their products. This research represents the first step towards a 
functionally annotated satosporin biosynthetic gene cluster. Experiments are currently underway 
to confirm the involvement and possibly gain functional information of various genes within the 
sat cluster via gene deletion. 
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CHAPTER 5 - DRAFT GENOME SEQUENCE 
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AND INSIGHTS INTO THE POTENTIAL FOR 
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5.1 INTRODUCTION 
Until very recently, a single organism within the genus Kitasatospora, K. setae NBRC 
14216, had its genome sequence published
136
. Its genome was 8.7 Mb in length, shared 
numerous developmental genes with streptomycetes and contained 24 secondary metabolite 
biosynthetic gene clusters, most of which had unknown products
136
. Given the affordability of 
sequencing genomes with current technologies such as second (by Illumina
®
, Roche and Life 
Technologies) and third generation sequencing (by Pacific Biosciences
®
) and the plethora of 
information they provide
35, 36
, genome sequencing is becoming a feasible method to determine 
the nucleotide sequence of secondary metabolite biosynthetic genes clusters while 
simultaneously obtaining genome data for that organism.  
The presence of numerous secondary metabolite gene clusters within a single genome is a 
feature shared by actinomycetes and has prompted the sequencing of numerous streptomycetes 
and other natural product producing Actinobacteria. This past summer, Kitasatospora genomic 
data has grown as three new genomes were published: Kitasatospora spp. MBT63 and 
MBT66
179
 and K. cheerisanensis
180
 as well as other genomes which have not yet been annotated 
or published but are listed as assemblies in the NCBI database such as K. phosalacinea NRRL 
B-16230, K. setae NRRL-16185, K. phosalacinea NRRL-16228, K. arboriphila NRRL-24581, 
Kitasatospora sp. B-11411, K. mediocidica KCTC 9733 and K. azatica KCTC 9699.  
The discovery of novel natural products via genome mining is an alternative strategy to 
the isolation and structure elucidation of compounds and numerous bioinformatic tools now exist 
to rapidly annotate genomic data and predict which belong to secondary metabolite biosynthetic 
gene clusters
181
. Given the large number of secondary metabolite gene clusters within 
kitasatosporae and the low abundance of available genomic data, there is much to be gained 
from exploring the genome of members of the genus Kitasatospora.  
In order to locate and analyse the genes responsible for the production of the newly 
isolated polyketides, satosporins, (see Chapter 3), the entire genome of K. griseola MF730-N6 
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was sequenced and not only provided the sat cluster (see Chapter 4), but also enabled the 
analysis of the remainder of its genome. The objectives of this study were thus to analyse the 
genome of K. griseola MF730-N6 and assess whether it shared similar developmental and 
secondary metabolite genes as previously reported for other kitasatosporae.  
5.2 MATERIALS AND METHODS 
5.2.1 Strain information  
Kitasatospora griseola strain MF730-N6 was obtained from the International Patent 
Organism Depositary (IPOD) in Nashihara, Japan, under the accession number FERM BP-1045 
(transferred from FERM P-No. 8247)
88
. The strain had been isolated from soil near the 
Umawatashi Bridge across the Iwaiga River in Nara Prefecture, Japan, and was shown to 
produce the diterpene terpentecin
67, 88
 and, more recently, the polyketide satosporin (see Chapter 
3)
129
.  
5.2.2 Genome sequencing and assembly 
Genomic DNA was isolated from 10 mL K. griseola cultures grown overnight in seed 
medium containing 10 g/L glucose and 10 g/L yeast extract at 30°C and 200 rpm using the 
Qiagen genomic tip 100/G kit. The sample was kept at 4°C and sent the following day to the 
McGill University and Génome Québec Innovation Centre for library preparation and 
sequencing using the Pacific Biosciences
®
 RS II platform using 8 SMRT
®
 cells. DNA quality 
and concentration were assessed using a NanoDrop (Thermo Scientific™) spectrophotometer 
and the Quant-it™ PicoGreen® dsDNA assay kit in triplicate (Life Technologies), respectively. 
De novo assembly of corrected reads was performed by McGill University and Génome Québec 
Innovation Centre using the Hierarchical Genome Assembly Process 2 (HGAP2) analysis 
pipeline
182, 183
.  
Gap closure was achieved by first performing a de novo assembly using the 15 contigs 
generated from HGAP2 and the Geneious assembler. Primers (Table 5.1) were then generated to 
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amplify 3-9 kb overlapping regions between adjacent contigs using either KOD Hot Start DNA 
Polymerase (VWR) or EconoTaq
®
 plus green (Lucigen); cycling conditions were as follow: 
95°C for 2 min, 25 cycles of 95°C for 20 s, X°C for 10 s, 70°C for Y time and a final extension 
of 70°C for 5 min (see Table 5.1 for X and Y parameters). Amplicons were then sequenced 
using primers located ~1 kb apart (Table 5.2) to confirm the ends were consistent with the 
predicted assembly sequences.  
5.2.3 Genome annotation and analysis 
Annotation was performed by submitting the contigs generated during the assembly to the 
rapid annotation using subsystem technology (RAST) server and results were visualized within 
the SEED environment of the National Microbial Pathogen Data Resource (NMPDR) 
(http://rast.nmpdr.org/)
184
. Geneious was also used to visualise genome annotations
185
. Contigs 
were also submitted to antiSMASH to determine the biosynthetic gene clusters present within 
the draft genome
38
. At the time of writing, four kitasatosporae genomes were published; the 
genome sequences for Kitasatospora setae KM-6054 (AP010968)
136
, Kitasatospora 
cheerisanensis KCTC 2395 (JNBY01000000)
180
, Kitasatospora sp. MBT63 (JAIZ01000000)
179
 
and Kitasatospora sp. MBT66 (JAIY01000000)
179
 were thus also submitted to RAST and 
antiSMASH for direct genomic comparisons. Genome alignments were performed using the 
progressiveMauve algorithm within the Geneious plugin
186
 and dot plots were generated with the 
genome comparison tool within the SEED environment.  
5.2.4 Accession numbers 
This genome sequencing project has been deposited to GenBank under accession number 
JXZB00000000.  
5.3 RESULTS AND DISCUSSION 
5.3.1 Sequencing and assembly 
Genomic DNA was extracted using the Qiagen genomic tip since gravity, rather than 
centrifugation, was used to purify gDNA via column chromatography. Spectrophotometric 
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Table 5.1. Primers and polymerase chain reaction conditions used to generate amplicons confirming overlapping contigs generated during 
Geneious de novo assembly.  
Gap 
Amplicon 
size (bp) 
Primer name Sequence 5’3’ 
X 
(°C) 
Y  
(min:s) 
DNA 
polymerase 
1 7815 
Gap_40to44_F CTACCTGGCCGACTACCTCT 
62.1 3:45 KOD 
Gap_40to44_R TCAAGGTGATGGAGATGGGC 
2 8042 
Gap_44to45_F ATCCGGCAGTACGTCGTCCA 
64.4 3:45 KOD 
Gap_44to45_R AGTTGCTGGAGAGCCTGGAC 
3 9000 
Gap_34to42_F CGCACCAACTGGACGTCGTA 
60.4 3:45 KOD 
Gap_34to42_ R AGCTGGTGGTAACCCAATCA 
4 8715 
Gap_42to46_F GGAGGGTCGGTCGGAAGGCT 
68.6 9:00 EconoTaq
®
 
Gap_42to46_ R AGCTTCGCCAGCGTCGGCAC 
5 7403 
Gap_46to36_F GTCCGCCAGCCCGTCGACAT 
68.6 9:00 EconoTaq
®
 
Gap_46to36_ R AGCACCCGGTCGATCTCCGC 
6 7735 
Gap_36to39_F GCCTCGGCAAGCTCGATGAA 
64.4 3:45 KOD 
Gap_36to39_ R TGCCGAAGTACACGACCGTG 
7 3338 
Gap_39to38_F AACAACGCGTGGCTGACCCT 
64.5 1:30 KOD 
Gap_39to38_ R ACTGCCGGAGGCTCGGTGAC 
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Table 5.2. Sequencing primers used during gap closure experiments to confirm the identity of 
amplicons obtained from overlapping regions of adjacent contigs in the assembly.  
Primer Sequence 5’3’ Note
a
 
1_1_754378F CTACCTGGCCGACTACCTCT U 
1_2_755607R GGTCCGCATCCAGGTGTCGC O 
1_3_756582R ACTGGGTTGATAGGCCGGAT R 
1_4_759500F CCCCCGGATCAAAGCTCGGT R 
1_5_760606F AACACCTAGTTCCCAACGTT R 
1_6_761413F TGAATGCTTCCACGAAAGAG R 
1_7_762194R TCAAGGTGATGGAGATGGGC U 
  
 
2_1_1346919F ATCCGGCAGTACGTCGTCCA U 
2_2_1350218R CGGAGATGGTCGGTTGGCTG U 
2_3_1349440R GGCTTCGCCAACCCGCAGTC U 
2_4_1350731F TGTGGCCGTAGTTGAGGATC U 
2_5_1352060F CGCCGCCGAACTTCTCCGCC U 
2_6_1352930F TCCCACTTCGGCCACTCGGT U 
2_7_1354966R AGTTGCTGGAGAGCCTGGAC U 
  
 
3_1_3115313F CGCACCAACTGGACGTCGTA O 
3_2_3116207R GGCTTCCCTGTGGCCTTGTC O 
3_3_3123386F GAGTCCGAGGTTCAGCAGTG U 
3_4_3124029F ACCGCCTGGACTCCCGACAG U 
3_5_3124311R AGCTGGTGGTAACCCAATCA U 
  
 
5_1_5517645F GTCCGCCAGCCCGTCGACAT U 
5_2_5518516F CGGGTCGAGGTGGCCGGGGA R 
5_3_5519328F ATATGTTGACATCCCCGGCC R 
5_4_5523104F CGGGTGAACTGTGGTTAAGG R 
5_5_5523911F GGATAACAGGCTGATCTTCC R 
5_6_5524498F ACCCGGAAGCTAAGCCTCAC R 
5_7_5525048R AGCACCCGGTCGATCTCCGC U 
  
 
7_1_7918230F AACAACGCGTGGCTGACCCT U 
7_2_7919688F ATGGAGTGCGGGGAGACGGT U 
7_3_7919966R CCAGTCCATCCCCTGTTTGT U 
7_4_7920742F CCCGTCGATCTCGTGAACGT U 
7_5_7921568R ACTGCCGGAGGCTCGGTGAC U 
a
U:unique sequence, R:located within rRNA operon, O:present at other location(s) within the 
genome 
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measurements of the resulting gDNA were 1.89 and 1.80 for 260/280 and 260/230 ratio 
respectively, suggesting the DNA was of good quality and contained no protein contaminants. 
DNA concentration using PicoGreen
®
 was calculated to be 80.36 ±1.91 ng/µL (average ±1 
standard deviation).  
500 µL of the fresh K. griseola gDNA was sent to the McGill University and Génome 
Québec Innovation Centre to be sequenced using Pacific Biosciences
®
 technology. From the 
150,000 zero-mode waveguides within each of the eight SMRT
®
 cells, empty ZMWs ranged 
between 6.81 and 24.66% while those loaded with two enzyme complexes or other detrimental 
conditions ranged between 16.63 and 33.72%. ZMWs loaded with a single enzyme complex, 
giving rise to usable sequence reads, ranged between 57.70 and 61.91%. Average raw read 
quality was between 0.82 and 0.83.  
Each sequencing SMRT
®
 cell generated average raw read lengths of 4,331 bp which 
included sequence data from both insert and adapters. The sequencing facility processed and 
filtered these reads to remove the SMRTbell™ sequencing adapters, poor quality regions, and 
reads of insufficient length. Good quality, adapter-free sequence data were saved as continuous 
long reads (CLRs), also referred to as subreads. When the insert DNA between two SMRTbell™ 
adapters was sequenced at least twice in the zero-mode waveguide, the raw read was used to 
generate a high-accuracy circular consensus sequences (CCS) read.  
The HGAP2 analysis pipeline was then used to generate a highly accurate (>99.99%) 
polished assembly in three stages
182
. Since PacBio sequencing data are only ~86% accurate, the 
purpose of the first stage was to correct most of the sequencing errors. Subreads were first 
grouped into two categories based on read length: the 219,016 subreads longer than 3 kb were 
used as “seed subreads” to which all the remaining subreads were aligned. The resulting 
consensus sequences were saved as long corrected subreads. The second stage involved using 
only the corrected subreads generated in the first stage to construct an assembly using Celera 
Assembler. In the third stage, all of the initial subreads were aligned to the assembly generated 
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in stage 2 using Quiver, correcting the few errors that were still present in the first assembly.  
Sequencing of eight SMRT
®
 cells generated 1,377,430 subreads (2,920,331,552 bases) 
and 77,677 CCS (175,515,662 bases), totalling 3,095,847,214 bases and 324- and 18-fold 
coverage, respectively (assuming a 9 Mb genome). 219,016 subreads were greater than 3 kb, 
totalling 1,065,806,608 bases and a 118X coverage assuming a 9 Mb genome. A summary of the 
raw data is provided in Table 5.3. The polished assembly from K. griseola MF730-N6 
sequencing data contained 15 contigs (Quiver_34-48) ranging in size between 2.8 kb and 2.3 
Mb. BLAST
®
n results from the 16S rRNA gene from the genome confirmed that the gDNA 
originated from K. griseola as the sequence shared >99% nucleotide identity with 16S rRNA 
genes from various K. griseola strains such as NBRC 14371 and JCM 3339.  
Gap closure 
To reduce the number of contigs forming the K. griseola MF730-N6 draft genome, 
Geneious
 
was used to assemble the 15 contigs provided by the sequencing facility. The assembly 
was able to assemble 13 of the contigs (Quiver_37 and _43 were not part of the assembly) 
(Figure 5.1).   
Primers were designed to amplify 7 overlapping regions, but only amplicons for gaps 1, 2, 3, 5 
and 7 were obtained; the amplicon sizes were as expected. Sequences from gaps 1, 2, 5 and 7 
assembled with the reference sequences of the assembly and not only confirmed the close 
proximity of adjacent contigs, but also allowed the correction of errors located at the extremities 
of the contigs. Discrepancies between overlapping contigs were probably a result of poor error 
correction during HGAP2 assembly due to insufficient alignment overlap. The inability of 
HGAP2 to assemble adjacent contigs can also be explained for gaps 1 and 5 due to the presence 
of rRNA operons at these extremities. 
Although Geneious had predicted that the 3’ end of Quiver_34 was adjacent to the 3’end 
of Quiver_42 (Figure 5.1), sequencing of gap 3 amplicon revealed a complicated scenario. 
Quiver_43, which was not assembled by Geneious, had an identical 2 kb region to the 3’ 
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Table 5.3. Read data generated from each of the eight SMRT
®
 cells used to generate the data assembled into 15 contigs.  
 
Raw reads  Subreads  CCS  Longest >3 kb subreads 
Run 
average 
read 
quality 
average  
read length 
(bp) 
 count 
average   
read length 
(bp) 
 
count 
average  
read length 
(bp) 
 count 
average       
read length 
(bp) 
1 0.83 4,422  156,513 2,376  11,001 2,494  31,655 5,174 
2 0.82 3,883  169,239 1,982  6,433 2,138  25,415 4,612 
3 0.82 3,923  174,754 1,995  6,911 2,151  26,340 4,620 
4 0.83 5,066  190,130 2,216  13,054 2,279  30,717 5,063 
5 0.83 4,928  189,057 2,207  12,417 2,279  30,607 4,983 
6 0.82 4,136  162,358 2,065  8,917 2,189  24,704 4,797 
7 0.83 4,102  167,765 2,057  9,269 2,215  25,008 4,772 
8 0.83 4,191  167,614 2,062  9,675 2,209  24,570 4,772 
   
 
  
 
  
 
  
Average 0.83 4,331  
 
2,120  
 
2,244  4,849 4,849 
Sum 
  
 1,377,430 
 
 77,677 
 
 219,016 
 
Total bases 
  
 2,920,331,552  175,515,662  1,065,806,608 
 
 
 
 
Figure 5.1. Geneious assembly using 13 of the 15 contigs provided by the sequencing facility, contigs Quiver_37 and _44 we not used in the 
assembly and gaps for which primers could be designed are circled and numbered according to the amplicon number, *denotes contigs assembled 
using the complimentary strand.  
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extremities of both Quiver_34 and _42, encoding various tRNA genes and a phage integrase. 
Quiver_34 and _42 were however concluded to be adjacent without including Quiver_43 for two 
reasons. First, although Quiver_43 had a 2 kb region with high identity to the 3’ end of 
Quiver_34 and _42, the remaining 3 kb of this contig did not align with Quiver_34, suggesting 
that either quiver_43 was misassembled or represented another region within the genome 
containing the same tRNA genes along with the phage integrase (Figure 5.2). Secondly, node 
167, obtained from Illumina
®
 sequencing mentioned in Chapter 4 (Section 4.2.2), was large 
enough to cover the entire overlapping region between Quiver_34 and _42 while extending a 
further 3.3 kb onto Quiver_42 and 2.7 kb onto Quiver_34 (Figure 5.3), suggesting that these 
contigs were adjacent in the genome. Similarly, nodes 468 and 1430 from Illumina
®
 sequencing 
confirmed junctions between Quiver_44 to _45 and Quiver_46 to _36, respectively. Gap closure 
via PCR thus permitted the closure of 5 gaps, resulting in 8 contigs rather than 15 and ranged in 
size from 5.9 kb to 3.5 Mb with a contig N50 of 2,590,787.  
5.3.2 General features of the K. griseola MF730-N6 genome 
The K. griseola draft genome was composed of eight contigs covering 7,966,157 bp and had an 
overall G + C content of 72.7%, which is the shortest genome and lowest G + C content of the 
four other Kitasatospora genomes published (Table 5.4). Genome annotation by RAST revealed 
a total of 7225 protein coding sequences (PEGs), 100 tRNA genes and 40 rRNA genes forming 
9 complete and 5 incomplete rRNA operons
187
. As illustrated in Figure 5.4, the tRNA genes 
were located mostly within contig_4, while rRNA operons were distributed evenly throughout 
the contigs. 
Of the 7225 coding DNA sequences, 2540 were genes encoding hypothetical proteins 
while 4685 were assigned putative functions. 2170 (31%) were categorized into 425 subsystems 
and, when compared to those determined by RAST for K. setae, K. cheerisanensis, 
Kitasatospora spp. MBT63 and MBT66 (Figure 5.5), showed a comparable distribution of  
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Figure 5.2. Alignment of the 3' end of Quiver_34 with Quiver _43 illustrating how even though 
there was a 2 kb region with excellent nucleotide alignment, the remainder of quiver_43 failed to 
align to Quiver_34. 
 
 
 
 
 
 
Figure 5.3. Evidence suggesting that contigs Quiver_42 and Quiver_34 are adjacent on the 
genome of K. griseola includes node 167 (black bar) obtained from Illumina
®
 sequencing (see 
Section 4.2.2) which covered the entire overlapping region between the two contigs (grey) with 
high nucleotide identity; contig overlapping extremities are shown by dotted vertical lines and 
alignment with gap 3 amplicons is also shown.  
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Table 5.4. General features of K. griseola MF730-N6 genome compared to the other published kitasatosporae genomes. 
Strain 
K. griseola 
MF730-N6 
K. cheerisanensis KCTC 
2395 
Kitasatospora sp. 
MBT63 
Kitasatospora sp. 
MBT66 
K. setae KM-6054 
Total length (bp) 7,966,157 8,035,179 9,900,000 10,400,00 8,783,278 
Contigs (no.) 8 5 scaffolds (178 contigs) 849 45 1 
G + C content (%) 72.7 73.6 73.0 73.2 74.2 
# RNA genes  140
a
 NR 78 81 101
b
 
# tRNA genes 100 72 NR NR 74 
# rRNA operons 
9 complete + 5 
incomplete 
9 NR NR 9 
# Protein encoding 
sequences (PEG) 
7,226 7,810 8,651 8,827 7,569 
Accession number JXZB00000000 JNBY00000000 JAIZ00000000 JAIY00000000 AP010968 
Published  June 2014 June 2014 June 2014 November 2010 
Reference This study 
180
 
179
 
179
 
136
 
a 
probably an overestimation due to rRNA and tRNA genes at numerous contig boundaries, 
b
provided by RAST analysis rather than from 
publication; NR: not reported, no.: numbers. 
 
Figure 5.4. Distribution of rRNA operons (red) and tRNA genes (blue) within the genome of K. griseola illustrating that numerous incomplete 
rRNA operons (indicated by stars) were located at the extremities of contigs which probably interfered with the assembly.
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Figure 5.5. Number of coding sequences grouped into each subsystem category by RAST 
illustrating a comparable detection of genes between all published kitasatosporae genomes. 
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coding sequences (CDSs) into subsystem categories. Although other kitasatosporae have 
recently been sequenced according to NCBI, their genome sequence was not yet available and, 
thus, comparison with these organisms was not possible.  
For all kitasatosporae, the majority of coding sequences belonged to the amino acid and 
derivative subsystem category, involving functions related to amino acid biosynthesis and 
catabolism; K. griseola had 524 CDSs in this category. Genes related to carbohydrate catabolism 
were also abundant in K. griseola (394 CDSs), including genes in pathways such as glycolysis, 
pentose phosphate pathway, Entner-Doudoroff pathway, the tricarboxilic acid (TCA) cycle and 
various anabolic and catabolic processes of sugars such as lactose, galactose, mannose and 
glycogen. The third most prevalent subsystem category was protein metabolism with 351 coding 
sequences in K. griseola. This category included tRNAs and genes involved in their 
aminoacylation as well as genes for protein chaperones, ribosome biogenesis, ribosomal proteins 
and protein processing, modification and degradation.  
Alignment of the K. griseola genome with that of K. setae and K. cheerisanensis using 
both progressiveMauve and the SEED comparison tool to generate the dot plot in Figure 5.6 (A, 
C) and (B, D), respectively, revealed that there was a high level of synteny with both genomes as 
would be expected for closely related organisms. As gap closure for both K. griseola and K. 
cheerisanensis genome was not completed, the order and orientation of the 8 contigs and 5 
scaffolds, respectively, could not be determined. It is thus possible that genome rearrangements, 
which often occur at the terminal regions of the genome, were not detected here
188
. It can 
however be concluded that the core portion of the genome (contig_4 in K. griseola) is highly 
syntenic to that of K. setae. 
Since no telomere-associated proteins homologous to KSE_73020 and KSE_73030 
encoding Tap and Tpg, respectively, could be detected, it was not possible to identify the 
terminal sequences of the genome. Furthermore, no sequences at any contig extremities 
contained the conserved sequence CCCGCGGAGCGGG located at the start of many 
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Figure 5.6. Genome synteny between K. griseola and K. setae (A and B) and K. griseola and K. cheerisanensis (C and D) using 
progressiveMauve and the SEED illustrating that there was high synteny between the genome of the newly sequenced organism to that of 
previously sequenced members of the same genus; each coloured block represents a region without rearrangements and is connected with its 
orthologous block, K. griseola contigs were arranged in the order: 1, 4, 2, 3, 37, 41, 43 and 48 and K. cheerisanensis contigs were kept in 
ascending order in order to simplify visualization of the alignments, red vertical lines represent the contig boundaries in K. griseola. 
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Streptomyces terminal sequences as well as in that of K. setae
189
. Streptomyces and K. setae 
chromosomes are linear with large inverted repeat terminal regions. Kitasatospora setae has at 
its extremity a 127 kb sequence that is inverted and repeated at the other end
136
; these large 
repeated sequences are difficult to resolve during de novo assembly. Until the remainder of the 
gaps are closed, the features of the terminal sequences of K. griseola remain unknown. 
Interestingly, Tap and Tpg homologs were identified in Kitasatospora spp. MBT63 (PEG.8582, 
64% aa identity and PEG.8584, 57% aa identity) and MBT66 (PEG. 2870, 72% aa identity and 
PEG.2869, 69% aa identity), respectively but both were absent in the genome of K. 
cheerisanensis. 
The putative bidirectional origin of replication oriC was located at bases 2,313,299-
2,314,082 (784 bp) of contig_4 and shared 86% nucleotide identity with oriC of K. setae located 
at bases 4,370,854-4,372,117 (1,264 bp). G + C content of the putative oriC region was 62.2%. 
It was flanked by dnaA and dnaN which encode for the chromosomal replication initiator protein 
DnaA and DNA polymerase III beta subunit DnaN, respectively. OriC, spanning the dnaA-dnaN 
intergenic region, also featured numerous nonameric DnaA boxes to which the DnaA protein 
would bind and unwind the DNA to allow replication; some streptomycetes have been reported 
to have 19 DnaA box-like sequences, while 20 are reported for K. setae
136, 190
. Sixteen DnaA box 
sequences using the sequence (T/C/G)(T/C)(G/A/C)TCCAC(A/C/G) were located within the 
oriC region in K. griseola. Alignment with putative oriC regions from four other kitasatosporae 
revealed that most of the DnaA boxes were also present at the same locations (Figure 5.7). 
Furthermore, 36 of the 40 “strong” genomic DnaA box sequences (TT(A/G)TCCACA) were 
located within contig_4 (Figure 5.8), suggesting that, along with the presence of oriC, Contig_4 
contained the core portion of the genome
191
. Although Streptomyces and Kitasatospora are very 
similar genera, a phenotypic characteristic that distinguishes them is the presence of the meso 
isomer of diaminopimelic acid (DAP) in the substrate mycelial peptidoglycan layer
86
. 
Genetically, dapF encodes for the diaminopimelate epimerase required to convert the LL-DAP   
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Figure 5.7. Alignment of the putative oriC regions from five kitasatosporae genomes illustrating the presence of DnaA box-like sequences 
((T/C/G)(T/C)(G/A/C)TCCAC(A/C/G)) shown as black arrows at similar locations within oriC.  
 
 
 
Figure 5.8. Distribution of “strong” DnaA box sequences (TT(A/G)TCCACA) (black arrows) within the genome where most of them were located 
on contig_4, surrounding the labelled origin of replication oriC (light grey arrow)
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into meso-DAP. Although three dapF paralogs were identified from K. setae; this may be the 
exception rather than the rule for this genus as only one homolog was identified from 
Kitasatospora spp. MBT63 and MBT66
179
 as well as from the genomes of K. griseola and K. 
cheerisanensis where KGR_1687 shared 88% aa identity and KCH_5206 shared 89% aa identity 
with KSE_53750 (dapF), respectively. The protein responsible for adding DAP to N-
acetylmuramyl-L-alanyl-D-glutamate during peptidoglycan biosynthesis is MurE, a UDP-N-
acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase was also located within the 
genome of K. griseola (KGR_4366) and shared 88% aa similarity to KSE_21280 and conserved 
gene synteny. All genes within the dcw cluster required for division and cell wall were present in 
K. griseola (KGR_4354-4375) as was reported for K. setae and Kitasatospora MBT63 and 
MBT66
136, 179
.  
Genetic classification of organism to either Streptomyces or Kitasatospora relies on muti-
locus genotyping of 16S rRNA gene, RpoB, RecA and more recently SsgB gene products
97
. In 
2013, Girard et al.
97
 reported that SsgB aa sequences differed by only 1 aa within streptomycetes 
and by 3 aa between the two genera; DNA sequences varied by ~50 nt between genera. At that 
time, only the genome of K. setae was available for comparison. Since then, the same authors 
confirmed that the SsgB protein from two new kitasatosporae (Kitasatospora spp. MBT63 and 
MBT66) followed the same trend
179
. The data generated here was consistent with previous 
conclusions as the SsgB aa sequences (Figure 5.9) were extremely conserved between members 
of the genus Kitasatospora where K. griseola, K. cheerisanensis and Kitasatospora spp. MBT63 
and MBT66 shared almost the same SsgB protein sequence, differing in only the last residue to 
that of K. setae. SsgB nucleotide sequences varied by as much as 29 nt between kitasatosporae 
but varied by 56 to 61 nt to that of S. coelicolor. Using two additional kitasatosporae sequences, 
it appears that the paradigm holds true and that SsgB remains an appropriate taxonomic marker 
to distinguish streptomycetes from kitasatosporae.  
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Figure 5.9. Amino acid (A) and nucleotide (B) alignment showing how highly conserved the amino acid sequence of the SsgB protein sequence is 
between members of the genus Kitasatospora compared to Streptomyces coelicolor; 1: K. griseola, 2: K. cheerisanensis, 3: Kitasatospora sp. 
MBT63, 4: Kitasatospora sp. MBT66, 5: K. setae and 6: S. coelicolor; discrepancies are highlighted in the protein sequences and bolded in the 
DNA sequences.  
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5.3.3 Genes involved in developmental regulation  
Streptomycetes have an elaborate life cycle, beginning with germination of a unigenomic 
spore. Chromosomal replication, cell wall growth and branching result in a dense substrate 
mycelium which, in response to nutrient limitation and cell density, develops into aerial hyphae, 
each containing multiple copies of the chromosome
71
. The onset of aerial hyphae formation is 
controlled by numerous bld genes and also involves a protein encoded by ram genes (SapB) as 
well as amphipathic surface-active proteins (chaplins and rodlins)
192
. Growth and septation of 
aerial mycelia, controlled by whi genes and SsgA-like proteins (SALPs) result in long chains of 
spores, each containing a single copy of the chromosome
71
.  
Genes involved in aerial hyphae formation  
Orthologs of almost all aerial mycelia regulatory genes (bld) were identified in K. griseola as 
was previously reported for K. setae and Kitasatospora spp. MBT63 and MBT66
136, 179
 and are 
listed in Table 5.5. In agreement with other kitasatosporae sequenced to date, no true ortholog of 
bldB could be identified by BLAST
®
p in K. griseola. Gene synteny revealed that the genomic 
region (KSE_53190-KSE_53240) of all five kitasatosporae was identical except that no 
Kitasatospora genes homologous to the S. coelicolor bldB (SCO_5723) were present in this 
genomic region. BldB has been reported to be essential for production of aerial mycelia and 
secondary metabolites in S. coelicolor in glucose–containing media193; the same appears to be 
untrue for Kitasatospora as they are still capable of producing both aerial hyphae and secondary 
metabolites. In S. coelicolor, SCO_7246 has been described as a paralog of bldB
136
 and although 
orthologs were located in all kitasatosporae, it is not known what function this gene has and 
whether it is involved in similar processes as bldB.  
SapB, encoded by the ram cluster in S. lividans, and the other lanthionine-containing 
peptides within class 3 lantibiotics have been shown (SapT, AmfS) and suggested 
(labyrinthopeptins A1 and A2) to be involved in aerial mycelia formation in streptomycetes
194
.  
In contrast to K. setae where no such genes could be located
136
, orthologs of the ram gene cluster 
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Table 5.5. Aerial mycelia orthologs identified in K. griseola, number in parentheses represent percent amino acid identity to K. setae homolog.  
  
K. griseola MF730-N6 K. setae KM-6054 S. coelicolor A3(2) 
Aerial mycelium  
 bldA KGR_rna_116 (98) KSE_t0069 SCO_t24 
 bldB (KGR_1513)
a
 (87) (KSE_16220)
a
 SCO_5723 (SCO_7246) 
 bldC KGR_6221 (100) KSE_41620 SCO_4091 
 bldD KGR_1201 (98) KSE_13950 SCO_1489 
 bldG (=rsbV) KGR_5723 (98) KSE_35840 SCO_3549 
 bldH (=adpA) KGR_4894 (78) KSE_26930 SCO_2792 
 bldKA-bldKE KGR_6785-KGR_6789 (86-89) KSE_48250-KSE_48290 SCO_5112- SCO_5116 
 bldM (=whiK) KGR_5305 (100) KSE_31060 SCO_4768 
 bldN (=adsA) KGR_5487 (88) KSE_33690 SCO_3323 
 amfC KGR_6370 (91) KSE_43740 SCO_4184 
Lantibiotic-like surfactant (SapB)  
 ramC KGR_3869 (46) KSE_63000 SCO_6685 
 ramS  KGR_3868 (36)
b
 ND SCO_6682 
 ramA KGR_3867 (42)
b
 ND SCO_6683 
 ramB KGR_3865 (41)
b
 ND SCO_6684 
 ramR ND ND SCO_6681 
ND: not detected, 
a
represents the kitasatosporae orthologs of the bldB S. coelicolor paralog SCO_7246, 
b
aa identity to S. coelicolor homolog
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 (ramC, S, A and B) were located in both K. griseola and K. cheerisanensis but not in 
Kitasatospora spp. MBT63 and MBT66. As shown in Figure 5.10 (A), the clusters contained the 
usual lanthionine synthetase gene (KGR_3869), the precursor peptide gene (KGR_3868) and the 
ATP-binding cassette (ABC) transporter system genes (KGR_3867, KGR_3865). The presence 
of the synthetase upstream of the precursor peptide was a characteristic feature of type 3 
lantipeptides. The predicted leader and core peptide sequences are shown in Figure 5.10 (B) 
where dehydrated serine and threonine are shown as dehydroalanine (Dha) and dehydrobutyrine 
(Dhb), respectively, with two cysteine residues available for cyclization. No ramR ortholog was 
located in either kitasatosporae and, although present in both S. coelicolor and S. griseus, it was 
not present within the LabA1/A2 clusters of Actinomaduras namibiensis
194
. Since the peptide 
predicted to result from the orthologous genes in K. griseola was different from previously 
reported class 3 lantipeptide, the resulting peptide would require a different name.  
Nine chaplin genes (KGR_5470-5473, KGR_3094-3095, KGR_3635, KGR_1661 and 
KGR_4395) and two rodling genes (KGR_5476-5477) were located within the genome of K. 
griseola. These amphipathic proteins are believed to assist in breaking the surface tension of the 
water at the surface of the colony to allow the hyphae to grow vertically
192
.  
Differentiation into spores (whi and SALPs) 
Following the formation of multigenomic aerial hyphae, unigenomic spores are formed 
following glycogen deposition, septation, prespore rounding, cell wall thickening and spore 
pigment deposition
71, 192, 195
 (Figure 5.11). The differentiation of aerial hyphae into spore chains 
is regulated by numerous whi genes and involves many SALPs. As was reported for K. setae, 
orthologs of all whi genes, except whiJ, were located in K. griseola suggesting that 
kitasatosporae seem to regulate sporulation in a similar manner (Table 5.6). WhiJ (SCO4543) 
has recently been described as a sporulation repressor that is inactivated by a signal provided by 
adjacent genes encoding for an acidic protein related to bldB (SCO4542)
196
. This may provide an 
explanation why whiJ and bldB seem to be the only two genes within the whi and bld clusters to 
 196 
 
 
Figure 5.10. Gene synteny of the ram cluster between various streptomycetes and 
kitasatosporae, where orthologs are identified using the same numbers, highlighting similar gene 
organization: lanthionine synthethase (ramC, black, 1), precursor peptide (ramS, white, star), 
ABC transporter (ramA/B, grey, 2) and regulatory (ramR, grey, 5) genes. K. griseola 
orthologous genes are identified and ramR ortholog was absent (A) and predicted leader peptide 
and lantipeptide sequence following dehydration of serine and threonine residues by KGR_3869 
to result in Dha and Dhb, respectively with possible cyclization between Dha/Dhb and two 
cysteine residues (shown with arrows) (B). 
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Figure 5.11. Sporulation in streptomycetes involves various whi and SsgA-like protein (SALP) genes, where ssgG is involved in controlling the 
site of septation, ssgA initiates septum formation, ssgD is involved in peptidoglycan synthesis while ssgF and ssgE are involved in autolysis of the 
mature spore chain. Reproduced, with permission, from Noens et al.
195
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Table 5.6. Whi and SsgA-like protein (SALP) orthologs located in the genome of Kitasatospora griseola along with the corresponding genes in K. 
setae and S. coelicolor. Number in parentheses represents percent amino acid identity to the orthologous gene in K. setae. 
 
K. griseola MF730-N6 K. setae KM-6054 S. coelicolor A3(2) 
Sporulation   
 whiA KGR_1863 (99) KSE_55390 SCO1950 
 whiB KGR_5109 (100) KSE_29410 SCO3034 
 whiD (=wblB) KGR_5307 (95) KSE_31070 SCO4767 
 whiE KGR_3688-KGR_3695 (82-94) KSE_72410-KSE_72480 SCO5314-SCO5321 
 whiG KGR_7183 (93) KSE_52540 SCO5621 
 whiH KGR_1723 (95) KSE_54050 SCO5819 
 whiI KGR_1834 (95) KSE_55090 SCO6029 
 whiJ ND ND SCO4543 
 sigF KGR_5912 (88) KSE_37310 SCO4035 
 sigN KGR_5913 (89) KSE_37320 SCO4034 
 crgA (=whiP) KGR_6090 (90) KSE_39340 SCO3854 
SsgA-like proteins (SALPs)   
 ssgR KGR_6125 (80) KSE_39760 SCO3925 
 ssgA ND KSE_39770/KSE_12250 SCO3926 
 ssgB KGR_1264 (99) KSE_14600 SCO1541 
 ssgC ND KSE_1860 SCO7289 
 ssgD KGR_5035 (71) KSE_28620 SCO6722 
 ssgE ND ND SCO3158 
 ssgF ND KSE_5120 SCO7175 
 ssgG KGR_5020 (97) KSE_28490/KSE_11930 SCO2924 
 Other SALPs ND KSE_6570 
  
 
KGR_1906 (76) KSE_55820 
  
 
KGR_2498 (69) KSE_60010 
  ND KSE_68960 
  KGR_561 ND  
  KGR_873 ND  
  KGR_2403 ND  
ND: not detected
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be absent from kitasatosporae.  
Besides the ssgB gene mentioned earlier, eight other putative SsgA-like protein (SALP) 
genes were found within the genome of K. griseola (Table 5.6) and include putative orthologs of 
ssgD and ssgG. Although SsgA has been shown to be required for sporulation in 
streptomycetes
197
, no ssgA ortholog was found in K. griseola. Comparison of genomic regions at 
this locus(Figure 5.12) showed that although ssgR, which encoded an IclR family regulator, was 
present in K. griseola, ssgA was not; Kitasatospora sp. MBT66 did not have ssgA nor ssgR 
orthologs, while Kitasatospora sp. MBT63 had a ssgA ortholog but no ssgR ortholog. K. 
griseola had three SsgA-like protein genes to which no K. setae ortholog could be assigned; this 
may suggest that one of these genes may function as SsgA or that septation is initiated 
differently in members of this genus. Knock-out experiments of each SALP would be necessary 
to assign their function in K. griseola as has been done in S. coelicolor
195
.    
5.3.4 Genes involved in secondary metabolism  
Analysis of the K. griseola MF730-N6 genome by antiSMASH 
(http://antismash.secondarymetabolites.org/) revealed 24 putative secondary metabolite 
biosynthetic gene clusters. Cluster 2 was discarded as it contained a single predicted biosynthetic 
gene, which following further analysis by BLAST
®
p and synteny search with other 
kitasatosporae, indicated that the genomic region was well conserved and did not encode for 
secondary metabolite biosynthesis; the predicted biosynthetic gene was similar to an 
endonuclease (91% aa identity with endonuclease from Streptomyces sp. NRRL S-384). A total 
of 23 biosynthetic genes clusters were thus present in the genome of K. griseola MF730-N6. 
Similarly, 24 and 38 secondary metabolite biosynthetic gene clusters are predicted for K. setae
136
 
and Kitasatospora sp. BMT66
179
, respectively. 
As listed in Table 5.7 and Table 5.8, the analysis predicted seven lantipeptide, six 
polyketide (PK), three terpene, two siderophore, two nonribosomal peptide-polyketide hybrid
 200 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12. Evidence of gene synteny between kitasatosporae for ssgR (number 9) and ssgA 
(number 8) where a ssgR ortholog is present in K. griseola, while the ssgA ortholog is absent. 
Genes in K. setae are labelled for reference and orthologs are represented by the same number.  
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Table 5.7. Secondary metabolite biosynthetic gene clusters predicted by antiSMASH that are present and absent in the genome of K. setae for 
which the biosynthetic products are known. 
Cluster
a 
 Contig
b
  Location
c
 Class  ORF ID in K. setae 
(KSE_XXXXX) 
 Metabolite and/or propeptide prediction 
Present in K. setae     
 11 contig_4 74,391-
100,828 
Terpene  17490-17710  Hopanoids  
 19 contig_4 2,852,268-
2,874,460 
Terpene  46170-46000  Germacradienol/geosmin  
 21 contig_1 454,424-
551,853 
PKS (type 1)  73580-73410  Bafilomycin (setamycin) 
 20 contig_4 2,974,386-
3,015,348 
Unclassified 27320-27430  Similar to valanimycin biosynthetic genes  
 9 contig_2 2,333,740-
2,376,204 
PKS (type 2)  72290-72660  Spore pigment (encoded by whiE genes) 
Absent in K. setae     
 8 contig_2 1,881,136-
1,902,071 
Terpene  N/A Terpentecin  
 24 contig_1 1,221,976-
1,321,691 
PKS (type 1)  N/A Satosporin  
 10 contig_2 2,516,932-
2,539,439 
Lantipeptide
d
 
(class 3) 
N/A Spore-associated protein (SapB-like)
  
(encoded by ram cluster)  
a
cluster number as per antiSMASH analysis 
b
contig number following gap closure as mentioned previously 
c
nucleotide of the entire cluster predicted by antiSMASH within the specified contig  
d
prepropeptide prediction: MAILDLQALETPEETTEYR-SVLSSLSVVNCTNSTVSTLLCL 
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Table 5.8. Secondary metabolite biosynthetic gene clusters predicted by antiSMASH that are present and absent in the genome of K. setae for 
which the biosynthetic products are not known. 
Cluster
a 
 Contig
b
  Location
c
 Class  ORF ID in K. setae (KSE_XXXXX) 
Present in K. setae   
 13 contig_4 223,839-234,639 Bacteriocin  19150-19400  
 14 contig_4 569,839-584,444 Siderophore  12610-12700  
 12 contig_4 117,317,158,363 PKS (type 3)  17920-18180 
 18 contig_4 2,522,507-2,544,849 Lantipeptide  42430-42240  
 1 contig_2 130,850-146,294 Siderophore  53760-53870  
Absent in K. setae   
 17 contig_4 1,856,553-1,908,288 PKS (type 1)  N/A 
 3 contig_2 720,683-777,863 PKS  
(type 1 & 2)  
N/A 
 5 contig_2 871,577-920,858 NRPS/PKS (type 1)  N/A 
 4 contig_2 772,034-849,908 NRPS/PKS (type 1 & 2)  N/A 
 7 contig_2 1,673,073-1,742,609 NRPS  N/A 
 6 contig_2 1,221,534-1,267,236 Lantipeptide (class 2)
d
 N/A 
 16 contig_4 1,743,904-1,768,710 Lantipeptide (class 1)
e
 N/A 
 15 contig_4 681,081-703,789 Lantipeptide  N/A 
 22 contig_1 991,487-1,015,146 Lantipeptide  N/A 
 23 contig_1 1,160,634-1,183,213 Lantipeptide  N/A 
a
cluster number as per antiSMASH analysis 
b
contig number following gap closure as mentioned previously 
c
nucleotide of the entire cluster predicted by antiSMASH within the specified contig  
d
prepropeptide prediction: MSKVLELQKMVTVEGS-PIDQEAISVSSCDSHSC or MPTVVHRSDVHGA-ESATGHCRRRLRSGLGAVSERPLM 
e
prepropeptide prediction: MRNEILVQQDTDLDLDLRIAEVAEETQAFGQ-GTFTSPSSYAIGTRCPVCC 
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(NRP-PK), one nonribosomal peptide (NRP), one bacteriocin and one unclassified biosynthetic 
gene clusters. They are distributed throughout the genome (Figure 5.13). Of the 23 biosynthetic 
gene clusters predicted in K. griseola, eight had known products and ten were present in K. 
setae, indicating that although the two organisms were closely related, over half of the secondary 
metabolite gene clusters were unique to K. griseola MF730-N6. AntiSMASH results are 
available at http:antismash.secondarymetabolites.org/upload/689503c5-e552-414b-b32b-
2e128b54e624/index.html. 
Lantipeptides 
Lantipeptides are lanthionine and methyl-lanthionine containing ribosomally synthesized 
peptides which often exhibit antibacterial activities (except class 3 lantipeptides)
194
. Seven 
lantipeptide biosynthetic gene clusters were predicted to be present within the genome of K. 
griseola. Only one had a known product, a peptide similar to the spore-associated protein SapB 
which was mentioned in Section 5.3.3, which was predicted to be involved in aerial hyphae 
formation and was encoded by ram orthologous genes within cluster 10 (KGR_3865-3869). The 
lantipeptide encoded by genes within cluster 18 (KGR_6257-6265) did not have a known 
metabolite but was found to have orthologs in both K. setae and K. cheerisanensis with 
conserved gene synteny. The five remaining lantipeptide gene clusters (clusters 6, 15, 16, 22 and 
23) had unknown products and only two prepropeptide sequences could be predicted by 
antiSMASH, as noted in Table 5.8. Othologs in K. cheerisanensis were identified for all gene 
clusters but #6, which instead had orthology and gene synteny to a cluster in S. griseus. Possible 
K. setae orthologs were also detected by RAST but not by antiSMASH for lantipeptide clusters 
15 and 22 (Figure 5.14). These genes were however not previously highlighted as secondary 
metabolite genes from K. setae
136
.  
Polyketides, nonribosomal peptides and hybrids thereof  
Polyketides represent a clinically important class of natural products biosynthesized via 
the condensation of simple units, usually malonyl- and methylmalonyl-CoA, to starter units such
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Figure 5.13. Genomic distribution of K. griseola secondary metabolite biosynthetic gene clusters as predicted by antiSMASH where 23 
biosynthetic genes clusters were predicted within contigs 1, 2 and 4; natural product classes are colour-coded as follow: terpene (pink), polyketide 
(blue), nonribosomal peptide (red), polyketide-nonribosomal peptide hybrid (purple), lantipeptide (yellow), siderophore (orange), bacteriocin 
(green) and unclassified (black).  
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Figure 5.14. Synteny surrounding lantipepide synthetases (labelled as1) illustrating that similar lantibiotic biosynthetic genes to those of cluster 15 
and 22 of K. griseola were also found in K. cheerisanensis and K. setae.  
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as acetyl-, propionyl- and benzoyl-CoA
10
. Six polyketide biosynthetic gene clusters were 
detected by antiSMASH, three of which had known products.  
The bafilomycin biosynthetic gene cluster was identified in K. griseola (cluster 21; 
KGR_431-449) as was expected given the isolation of the compound in previous chapters of this 
thesis and reports of the compound (also known as setamycin) by K. griseola NRRL-16229
86
. 
Orthologs of this type 1 PK cluster were present in K. setae and K. cheerisanensis, as well as 
numerous streptomycetes including those previously reported to produce bafilomycins such as S. 
lohii
77
. A portion of the cluster was found at the end of a contig in Kitasatospora sp. MBT66 and 
was not located in strain MBT63; completing the genomes of these strains would reveal whether 
all kitasatospora sequenced to date are capable of producing bafilomycins. Given the high 
incidence of isolating bafilomycins from streptomycetes
28
, it is not surprising that kitasatosporae 
would also have the biosynthetic machinery leading to their production. 
The second type 1 polyketide biosynthetic gene cluster with known metabolite was cluster 
24 (KGR_1149-1168) and contained genes involved in satosporin biosynthesis as described in 
Chapter 4,Section 4.3.4. AntiSMASH had categorized cluster 24 as a mixed NRP-PK (type 1) 
due to the presence of NRPS genes to which a function in satosporin biosynthesis could not be 
attributed. No orthologous gene cluster could be identified from any other organism. Finally, 
gene cluster 9 (KGR_3688-3695) contained the type 2 polyketide whiE genes involved in the 
production of the aromatic spore pigment described previously (Section 5.3.2). Orthologous 
gene clusters were located in all kitasatosporae and numerous streptomycetes, as was expected 
given the common production of this pigment during sporulation
198
.  
The remaining three PKs, one NRP and two NRP-PK hybrids had unknown products. 
Cluster 12 (type 3 PK) had orthologs in all kitasatosporae except Kitasatospora sp. MBT66, 
Cluster 7 had orthologs in K. cheerisanensis and the other unknown biosynthetic gene clusters 
had no orthologs. Further analysis of these unknown biosynthetic gene clusters may provide 
promising new polyketide and nonribosomal peptide natural products.   
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Terpenes 
Terpenes are structurally diverse, clinically relevant natural products biosynthesized from 
repeating units of two simple precursors: isopentenyl diphosphate (IPP) and dimethylallyl 
diphosphate (DMAPP).  
All three K. griseola terpene biosynthetic gene clusters had known metabolites. The first, 
cluster 8, encoded genes for the biosynthesis of the diterpene terpentecin as previously reported 
from this strain
64, 67
. This included mevalonate pathway (KGR_3233-3239) and terpentecin 
specific genes (KGR_3241-3247); no orthologs of the terpentecin genes were found in any other 
organism.  
Cluster 11 (KGR_4014-4032) encoded genes for hopanoid biosynthesis (pentacyclic 
triterpenes) such as the squalene hopene synthase gene (shc/hpnF), a gene encoding a protein 
required for the addition of adenosine to the hopane skeleton (hpnH) and the aminotransferase 
gene required for aminobacteriohopanetriol synthesis (hpnO)
199
. Orthologous clusters were 
identified from all kitasatosporae with exact gene synteny and from numerous Streptomyces 
which shared similar clusters.  
The last terpene cluster identified by antiSMASH, cluster 19, included the 
germacradienol-geosmin synthase gene (KGR_6572) responsible for germacradienol and 
geosmin biosynthesis from farnesyl diphosphate
200
. Geosmin is the main compound, produced 
by numerous Streptomyces and other actinomycetes, which gives soil its earthy smell
201
. 
Orthologs to KGR_6572 were identified from all kitasatosporae, though synteny of adjacent 
genes was not always observed.  
Siderophores 
Siderophores are small molecules responsible for iron uptake in bacteria, fungi and 
graminaceous plants due to their high affinity for iron
202
. Genes encoding for both the 
biosynthesis of the compound and transport of the (siderophore+iron) complex are usually 
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present. Although siderophores do not usually display antimicrobial properties, prodrugs can be 
designed to take advantage of the siderophore iron uptake system as an entry route
202
.  
The siderophore biosynthetic genes of cluster 1 (KSE_1692-1695) contained two 
siderophore synthetases (Type A and C) with similarity to IucA_IucC and RhbC family of 
proteins, a siderophore synthase with similarity to AlcB (N-acetyltransferase) and a 
lysine/ornithine N-monoxygenase gene. Although the biosynthesis of many siderophores 
involves a protein of the nonribosomal synthetase family to form a polypeptide, this siderophore 
involved a nonribosomal synthetase-independent pathway that is also found in siderophores such 
as aerobactin (iucABCD), rhizobactin (rhbABCDEF), desferrioxamines (desABCD), alcaligin 
(alcABCDE), and others. A similar pathway has now been shown to be widely distributed in 
over 40 species of bacteria
203
. Orthologs of this gene cluster were located in all kitasatosporae as 
well as in S. coelicolor (SCO5799-SCO5801) and other streptomycetes with conserved gene 
synteny (Figure 5.15). Although the product of cluster 1 remains unknown, it is clear that its 
production is widespread amongst both streptomycetes and kitasatosporae.   
The second gene cluster predicted encoding a siderophore was cluster 14 (KSE_4489-
4498). Similarly, the biosynthesis of this unknown compound does not involve a nonribosomal 
synthethase, but rather a siderophore synthetase (type B), three other biosynthetic genes and 5 
transport genes. Orthologous clusters existed in all kitasatosporae except Kitasatospora sp. 
MBT63 (Figure 5.15(B)) and did not seem to be present in any Streptomyces, though 
antiSMASH and SEED predicted orthologous clusters in Renibacterium salmonarium, 
Polaromonas sp. JS666, Streptosporangium roseum, etc. As previously stated for K. setae, no 
desferrioxamine biosynthetic genes were located in K. griseola or any of the other kitasatosporae 
even though they are often present in streptomycetes
136
.  
Bacteriocin and unclassified natural products 
Bacteriocins are ribosomally synthesized antibacterial peptides produced by bacteria that 
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Figure 5.15. Unknown siderophore biosynthetic gene clusters 1 (A) and 14 (B) in K. griseola 
were found to have orthologous clusters in numerous kitasatosporae and in the case of cluster 1, 
orthologs were also present in numerous streptomycetes. Orthologous genes are represented by 
the same number.  
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are believed to be implicated in colonization, competition and signalling within complex 
microbial communities
204
. Some have also been shown to be useful pharmaceuticals against 
pathogenic microorganisms such as methicillin-resistant Staphylococcus aureus (MRSA) and 
Clostridium difficile
204
. Cluster 13 (KGR_4156-4164) was predicted by antiSMASH to 
biosynthesize a bacteriocin that was present in both K. setae and K. cheerisanensis. Genes 
within this cluster had homology to linocin M18 bacteriocin structural gene (KGR_4163), 
putative membrane protein gene (KGR_4158) and a gene encoding a cytochrome P450 
hydroxylase (KGR_4161). AntiSMASH predicted orthologous genes in K. setae (KSE_19150-
19230), while RAST predicted orthologous genes in K. cheerisanensis. It is possible that the  
bacteriocin produced by K. griseola and encoded by KGR_4163 (267 aa) may be similar to 
linocin M18 which is encoded by lin and results in a protein of 266 aa in Brevibacterium linens 
M18
205
.   
AntiSMASH predicted a compound in the unclassified category of secondary metabolites 
(KGR_6679-6694) with orthology to KSE_27320-27430, which had been previously identified 
as genes similar to those involved in valanimycin biosynthesis
136
. BLAST
®
p revealed protein 
similarities to vlmA, vlmB and vlmH and orthologous genes were also detected in Kitasatospora 
sp. MBT63. Valanimycin was shown to have antibacterial activity against Gram-negative and 
Gram-positive bacteria as well as anticancer activities
206
.  
5.4 CONCLUSION 
The analysis of the K. griseola MF730-N6 draft genome has provided a wealth of 
information pertaining to general features such as genome length, tRNA genes and rRNA 
operons, DNA replication genes and genes involved in cell wall biosynthesis that are shared with 
the kitasatosporae currently available and with streptomycetes. Kitasatosporae also seem to have 
orthologs of almost all developmental regulatory genes (bld and whi genes) usually involved in 
the complex life cycle of streptomycetes with the exception of bldB and whiJ. In contrast to 
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other Kitasatospora genome reports, an ortholog of the ram cluster, encoding a protein similar to 
sapB, was located in both K. griseola and K. cheerisanensis suggesting that some kitasatosporae 
may use this protein to facilitate aerial hyphae formation while others may not. This research 
also illustrates the efficiency of the PacBio sequencing technology to provide high quality 
genome data in few contigs at a reasonable cost.   
This research highlights the usefulness of studying kitasatosporae as sources of novel 
natural products in a drug discovery program as 15 of the 23 secondary metabolite biosynthetic 
gene clusters predicted by antiSMASH in K. griseola had unknown products. This large number 
of gene clusters supports previous suggestions that non-streptomycete Actinobacteria are a 
prolific source of novel natural products
207
. Since Kitasatospora genomic data consistently 
exceeds the number of experimentally isolated compounds, it can be concluded that numerous 
natural products remain to be isolated from members of this underexplored genus. Further 
analyses into the metabolomes of kitasatosporae may thus provide previously uncharacterized 
compounds; this will be the subject of the next chapter. 
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CHAPTER 6 - DISCOVERY OF NEW 
NATURAL PRODUCTS FROM MEMBERS OF 
THE GENUS KITASATOSPORA BY 
METABOLOMIC PROFILING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collaborators and their contributions to this chapter: 
Chemical characterizations (Sections 6.2.4, 6.3.2 and 6.3.3) were carried out by Krista Gill, PhD 
candidate, Molecular and Macromolecular Sciences (MMS), UPEI.  
 
 
 
Part of this chapter contains material previously published as:  
 
Gill, K.A., F. Berrue, J.C. Arens, and R.G. Kerr, Isolation and structure elucidation of 
cystargamide, a lipopeptide from Kitasatospora cystarginea. J. Nat. Prod., 2014. 77(6): 1372-6. 
 
Gill, Krista; Berrue, Fabrice; Arens, Jennifer; Carr, Gavin and R.G. Kerr, Cystargolides, 20S 
proteasome inhibitors isolated from Kitasatospora cystarginea. J. Nat. Prod., 2015. 78(4): 822-6  
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6.1 INTRODUCTION 
Successful drug discovery programs now require a more strategic plan than simply 
fermenting as many microbes as possible and, ideally, involve innovative sampling and 
cultivation techniques to uncover underexplored taxa, the development of new assays targeting 
drugable biological targets and the use of automated analytic techniques to rapidly identify new 
compounds
19, 28
. This dereplication step is essential to avoid wasting time and financial resources 
towards the isolation and structure elucidation of known compounds
19
. In a study carried out by 
the Fundación Medina in Spain, 42% of the 5,530 streptomycetes fermented produced known 
compounds, whereas only 19% of the 3,140 non-Streptomyces actinomycetes produced known 
compounds
28
, illustrating the necessity for both early compound dereplication and selective 
isolation for the investigation of underexplored genera.   
The objective of this study was to use the metabolomic analysis method developed in our 
research group by Forner et al.
24
 to rapidly identify putatively new natural products from a large 
set of LC-HRMS data from crude extracts of numerous members of non-Streptomyces 
actinomycetes of the genus Kitasatospora.  
6.2 MATERIALS AND METHODS 
6.2.1 Fermentation and extraction of 12 kitasatosporae  
Kitasatospora griseola MF730-N6 was obtained from the International Patent Organism 
Depositary in Japan and eleven strains labelled as Kitasatospora spp. were obtained from the 
ARS culture collection (Table 3.1). Following growth on solid lean medium (Table 2.3), two 
seeds were grown in 10 mL seed medium (Table 2.3) in 25 X 150 mm glass culture tubes for 48 
h each at 30°C and 200 rpm using a scraping from the agar plate for seed 1 and a 7.5% inoculum 
of seed 1 for seed 2. Each organism was then grown in 10 mL of both lean and ISP2 media (see 
Table 2.3) in triplicate culture tubes, each inoculated using 500 µL of seed 2 and grown for 48 h 
at 30°C and 200 rpm. Media blanks were included as negative controls.  
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All 78 culture tubes were then extracted by adding an equal volume (10 mL) EtOAc 
directly to the fermentation, allowing 1 h for the extraction at 200 rpm, removing the organic 
layer and repeating the process a second time. The EtOAc layers were then combined and dried 
under air and analysed by LC-HRMS (0.5 mg/mL in MeOH) over three runs (26 samples per 
run) using Thermo Scientific™ LTQ Exactive equipment with a Core Shell Kinetex 1.7 µm C18, 
50 X 2.1 mm, 100 Å column, photodiode array detector, SEDEX 80 Sedere LT-ELSD and a 
Finnigan LXQ ion trap mass spectrometer (MS) in positive mode equipped with an electrospray 
ionization source (ESI) detecting m/z between 190 and 2000. Chromatographic separation was 
achieved with a 4.8 min gradient of 95:5 water:ACN to 100% ACN, 3.2 min of 100% ACN and 
finally a return to starting conditions over 3 min; solvents contained 0.1% formic acid and a flow 
rate of 500 µL/min was used. Methanol blanks were included as negative controls and reserpine 
(1 µg/mL final concentration) was added to each sample as an internal control.  
6.2.2 Data processing and statistical analysis 
High resolution mass spectral data for all samples and methanol blanks were processed as 
described by Forner et al.
24
 with a few modifications. Briefly, the .RAW files generated by the 
instrument were first converted to .CDF files using the Xcalibur™ software to enable import 
into MZmine. MZmine 2
208
 was then used to carry out mass detection, chromatogram building, 
de-isotoping, alignment and export to Excel
®
 as described previously
24
. Peak intensity threshold 
during mass detection was set to 1E4 while mass to charge ratio (m/z) and retention rime (tR) 
tolerances during bucket generation were set to 0.005 and 0.1 min, respectively; other 
parameters were set to default.  
Within Excel
®
, replicate buckets were first condensed and those also present in the solvent 
(MeOH) and media samples were removed by selecting and deleting buckets that were present in 
the appropriate media and any of the methanol blanks. This process was performed separately 
for each medium due to their different compositions. Unlike the method of Forner et al.
24
, the 
area under the curve for each bucket was not converted to a binary format. Statistical analysis 
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was then performed using the principal component analysis tool within the program The 
Unscrambler
®
 X (Camo, Woodbridge, USA) using crude extract as the samples and buckets as 
the variables.  
6.2.3 Biological assay 
Crude extracts were tested following the clinical laboratory standards institute testing 
standards (2003) in a microplate broth assay, at a concentration of 75 µg/mL, against the 
following microorganisms: methicillin-resistant Staphylococcus aureus ATCC 33591, 
vancomycin-resistant Enterococcus faecalis EF 379, Candida albicans ATCC 14035, 
Pseudomonas aeruginosa ATCC 14210, Proteus vulgaris ATCC 12454 and Staphylococcus 
warneri ATCC 17917. Media blanks and solvent containing 1 µg/mL reserpine were also tested.  
6.2.4 Purification of compounds of interest and structure elucidation 
To follow up hits, the appropriate organism was re-fermented as mentioned previously 
except using Fernbach flasks containing each 500 to 750 mL of the appropriate medium. The 
fermentation was extracted as described and the resulting crude extracts were then given to a 
PhD candidate in our laboratory (Krista Gill, Molecular and Macromolecular Sciences) in order 
to purify the desired compound using various chromatographic separation techniques and to 
carry out the structure elucidation using one- and two-dimensional nuclear magnetic resonance 
(NMR) experiments and (LC-HRMS).  
6.3 RESULTS AND DISCUSSION 
6.3.1 General results 
Following LC-HRMS analysis of crude extracts from 12 kitasatosporae grown in two 
media, the 81 files generated by the instrument were used for the metabolomic analysis. This 
included data from kitasatosporae fermentations, media blanks and methanol samples.  
To analyse this large amount of data, the metabolomic analysis method described by 
Forner et al.
24
 was used. The data was processed using MZmine 2 which first generated a list of 
all masses present at each scan of each data file above the threshold chosen (1E4). This threshold 
was based on inspecting methanol blank mass spectra and choosing the lowest intensity above 
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most background peaks and also depended on the computational capabilities of the computer 
used for the analysis. The list of exact masses generated was then used by the chromatogram 
builder module to detect the same masses (within 0.005 atomic mass units) in adjacent scans; 
only masses which were present in all scans within a 0.1 min period were used to build the 
chromatogram. De-isotoping was then performed to keep only the most intense isotope. Finally 
the Alignment module allowed the formation of the buckets, combining the m/z and retention 
time values for each peak in the chromatograms and aligning all of the buckets throughout all 
samples into one document that was then exported into Excel
®
.    
Inspection of this Excel
®
 file revealed that the internal standard, reserpine (predicted 
pseudomolecular ion [M+H]
+
 m/z of 609.2812), which had been added to every sample was 
detected as a single bucket (m/z 609.2812, tR 3.11 min) in all samples (excluding the MeOH 
blanks ran by technician) and confirmed there was no shift in mass detection or retention time 
between the three LC-HRMS analyses conducted over eight days.  
From the crude extract of 12 kitasatosporae fermented in two media and in triplicate, 
MZmine 2 generated a total of 633 buckets. Visual inspection of the Excel
®
 file revealed that 
numerous buckets were sometimes generated for the same m/z with retention times throughout 
the analysis (Figure 6.1 (A)). Condensing these replicates into a single bucket was essential for 
the proper removal of media components and artefacts and resulted in 527 buckets.  
A total of 34 buckets were present in at least one of the MeOH blanks and were thus 
removed from the list. Fifty-seven buckets were detected from at least one the the lean medium 
control fermentation extracts and those peak areas were thus replaced by zero for fermentations 
carried out in lean medium. Similarly, data from 39 buckets were “zeroed” in samples from 
cultures grown in ISP2 due to their presence in the media blanks. Artefact and media component 
suppresion resulted in a total of 444 buckets which represented ions of compounds produced as a 
result of bacterial metabolism. 
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Figure 6.1. Example of buckets (highlighted in grey) which required being condensed into one 
bucket in order to properly carry out the artefact suppression step (A). Matrix generated during 
metabolomic analysis of LC-HRMS data collected from the crude extracts of 12 kitasatosporae 
cultured in two media and in triplicate (rows) giving rise to 444 different buckets (columns) 
illustrating the overwhelming amount of information generated during this experiment. Black 
boxes represent the presence of that bucket in the sample (B).  
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The matrix generated (Figure 6.1 (B)) contained 72 rows, each representing a single crude 
extract, and 444 columns, each representing a single bucket containing information pertaining to 
both the m/z and tR of the ions detected by the mass spectrometer. Each black square represents 
the presence of the particular bucket within the sample. Although it is possible to draw a few 
general conclusions such as some crude extracts contained more metabolites than others and 
some metabolites were produced by numerous bacteria while others appeared to be produced by 
a single organism, it was not possible to analyse this overwhelming amount of data set in any 
detail.  
The principal component analysis allowed the rapid visualization of the metabolomes 
which differed most within the dataset. Kitasatospora cystarginea (NRRL B-16505) and K. 
mediocidica (NRRL B-16109) had the most unique metabolomes (Figure 6.2) as their 
metabolites, represented here as buckets, contributed to most of the variation within the data set 
(56% and 17%, respectively). The loadings plot (Figure 6.3) indicated that the variable (bucket) 
causing K. mediocidica to separate from the remainder of the data had a m/z 686.4711(tR 3.08), 
while ions with m/z 672.4557 and 708.4526 also contributed, but to a lesser extent. Similarly, the 
buckets causing K. cystarginea to separate from the remainder of the data had m/z 371.2177 (tR 
3.09) and 357.2022 (tR 2.88).   
The strength of this analysis lies in its rapid detection of metabolites that are unique to a 
particular organism, thus increasing the chances that the compounds have not previously been 
described. Furthermore, this technique provides information on the potential novelty of the 
compound based on a rapid database search in AntiBase
 
2012 using the m/z. The use of 
chromatographic separation (LC) in combination with UV, MS, MS/MS or NMR is regarded as 
a very sensitive and powerful dereplication tool for the identification of new natural products
23
. 
In contrast, a disadvantage of this technique is that it does not provide any information as to the 
potential biological activity of the compound in treating various human and animal diseases.  
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Figure 6.2. Scores plot of principal components 1 and 2 illustrating that the metabolomes of K. 
mediocidica (B-16109) and K. cystarginea (B-16505) were the largest contributors of variability 
within this data set. Circles represent extracts obtained from lean medium fermentations while 
squares represent extracts obtained from ISP2 medium fermentations.  
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Figure 6.3. Loadings plot of principal components 1 and 2 illustrating which buckets 
(represented by the m/z) were causing K. mediocidica and K. cystarginea to separate from the 
remainder of the data.  
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As one of the objectives in the laboratory is to find novel secondary metabolites that could 
be developed into human or animal pharmaceutical products, knowledge of the activity of the 
crude extracts against numerous microorganisms can aid in prioritizing compound purification 
and structure elucidation. Of the 79 samples submitted for antibacterial assay (sample 
concentration = 75 µg/mL) against methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant Enterococcus faecalis (VRE), Candida albicans, Pseudomonas 
aeruginosa, Proteus vulgaris and Staphylococcus warneri, crude extracts from three organisms 
showed moderate or good antimicrobial activity. All three replicate extracts of K. kifunensis 
NRRL B-24284 grown in lean medium showed 89, 92 and 95% growth inhibition of C. 
albicans, while all three replicates of K. streptosporus NRRL B-16228 grown in ISP2 showed 
62, 79 and 83% growth inhibition of VRE. Finally, replicates 1 and 2 of K. griseola NRRL B-
16229 grown in lean medium showed 94% growth inhibition of S. warneri and replicate 2 also 
showed 72% growth inhibition of MRSA.  
Since there appeared to be only minute quantities of the bioactive compound in the 
extracts of K. streptosporus (the ELSD chromatograms were devoid of any significant peaks), 
this extract was not investigated further as the scale necessary to purify and elucidate the 
structure of the compound exceeded the time and resources available at this point. Other samples 
highlighted by the principal component analysis or by the antibacterial assay were investigated 
further by Krista Gill (PhD candidate MMS).  
6.3.2 Hits based on chemical novelty 
Ions with m/z 371.2177 and 357.2022 from K. cystarginea extracts 
The two variables (buckets) contributing to most of the variability in the data set were 
those with m/z 371.2177 (tR 3.09 min) and 357.2022 (tR 2.88 min) in extracts of K. cystarginea 
grown in both ISP2 and lean media. The only compound previously reported by K. cystarginea 
was cystargin (C20H42N8O6S, [M+H]
+
 523.3021)
209
, suggesting that neither of the highlighted 
ions was cystargin. Searches for known compounds within AntiBase
 
with [M+H]
+
 mass within 5 
 222 
 
ppm of both m/z did not generate any hits, though numerous compounds had masses consistent 
with [M+Na]
+
; all had molecular formula C21H32O4 and C20H30O4 for m/z 371.2177 (14 hits) and 
357.2022 (47 hits), respectively. Since, the sodium adducts were also present within the same 
mass spectra ([M+Na]
+
 m/z 379.1839 and 393.1997), it could be concluded that the ions initially 
observed belonged to the pseudomolecular ion [M+H]
+
 and, thus, were not present within 
AntiBase. Given the lack of hits and the fact that these two compounds seemed to be the major 
constituents of the crude extracts from K. cystarginea (Figure 6.4 (A)), crude extract from a 5 L 
fermentation was given to Krista Gill for purification and structure elucidation.  
She was able to elucidate the structure of the compounds with ions of m/z 357 and 371 and 
confirmed that they corresponded to two novel depsipeptides, cystargolide A and B, with 
molecular formula C17H28N2O6 and C18H28N2O6, respectively; their structures were recently 
published in the Journal of Natural Products
210
. The purification procedure also allowed her to 
identify that the compound at 3.60 min of the ELSD (Figure 6.4 (A)) was yet another unknown 
secondary metabolite produced by K. cystarginea with molecular formula C49H59N7O13 and 
pseudomolecular ion [M+H]
+
 m/z of 954.4287. The structure elucidation paper of this new 
lipopeptide, cystargamide, was published in the Journal of Natural Products
211
 and its structure is 
illustrated in Figure 6.4 (C). The metabolomic analysis was, thus, very effective at determining 
ions which were both unique and abundant.  
Ions with m/z 686.4711, 672.4557 and 708.4526 from K. mediocidica extracts 
The main variable (bucket) responsible for pulling K. mediocidica away from the 
remainder of the data set had an m/z 686.4711 and tR 3.07 min and constituted a major portion of 
the crude extract (Figure 6.5 (A)). This observed ion represented the pseudomolecular ion 
[M+H]
+
 of the compound since the sodium adduct (m/z 708.4526) was also detected at 3.07 min. 
AntiBase revealed a single hit consistent with this mass, the peptide pepstatin A (produced by 
Streptomyces sp.
212
) with molecular formula C34H63O9N5. The ion with m/z 672.4557 (tR 2.94 
min) was consistent with an analogue of the main compound containing one less methylene  
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Figure 6.4. Evaporative light scattering detector chromatogram (A) and mass spectrum at 2.88 
min (B) illustrating that compounds with m/z 371.2177 (tR 3.09) and 357.2022 (tR 2.88) 
constituted the major compounds within the crude extracts of K. cystarginea. Structure of a third 
new secondary metabolite from K. cystarginea extract, the new lipopeptide cystargamide (C).  
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Figure 6.5. Evaporative light scattering detector chromatogram from the crude extract of K. 
mediocidica NNRL B-16109 where pepstatin A was identified as the likely compound detected 
at 3.03 min (A) and structure of the peptide pepstatin A (B).  
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group (-CH2-) and had two AntiBase
 
hits: pepstatin BU and pepsidin A, both with molecular 
formula C33H61O9N5. Given the high production of the compound in K. mediocidica and the few 
possible hits for the detected ions, the samples were given to Krista Gill for further analysis.  
NMR experiments revealed signals with characteristic peptide chemical shifts such as the 
presence of signals around 7.5 ppm (consistent with the amide protons) as well as methine and 
methylene signals at approximately 4 and 3 ppm, respectively (consistent with branched 
aliphatic amino acid side chains), all of which was consistent with the compound pepstatin. 
Given the high probability that the compound with m/z 686.4711 was the known peptide 
pepstatin A (Figure 6.5 (B)), the extract was not investigated further.  
A limitation of this technique is its dependence on compound ionization within the mass 
spectrometer, where potentially novel compounds may not be detected if they do not ionize well. 
Using this technique in combination with others which do not rely on compound ionization, such 
as UV, NMR and biological assays, could result in a more comprehensive understanding of the 
metabolomes under study.  
Since more time and resources are necessary to isolate and elucidate the structure of minor 
components of the crude extracts, identifying unique and highly abundant compounds first was 
advantageous. However, since novel chemical entities may be present as minor components of 
the crude extracts, the data can be easily converted to a binary format in order to search through 
numerous principal components and identify putatively novel compounds. 
6.3.3 Hits based on biological activity  
Kitasatospora kifunensis NRRL B-24284 extract is active against Candida albicans 
Since the crude extracts of K. kifunensis NRRL B-24284 grown in lean media exhibited 
strong inhibitory activities against C. albicans, it was re-fermented in 750 mL lean medium, 
extracted as mentioned previously and given to Krista Gill for purification and structure 
elucidation of the bioactive compound. 
 226 
 
NMR analyses revealed that the structure of the compound detected at 3.85 min (Figure 
6.6 (A)) was the known compound naphthomycin A, an ansamycin antibiotic. Given that 
naphthomycin A was reported to have antifungal activity
213
, the growth inhibition observed in C. 
albicans was probably a result of the presence of this compound in the crude extracts of K. 
kifunensis grown in lean medium.  
Furthermore, the metabolomic analysis revealed that extracts from the lean medium 
contained ions with m/z 720.2948 and 742.2769, consistent with the pseudomolecular ion and 
sodium adduct, respectively, of that expected for naphthomycin A, that were also absent from 
fermentations of the same organism grown in ISP2 medium. Unfortunately, the ELSD 
chromatograms of the crude extracts originating from ISP2 medium suggest that very few 
metabolites were produced in this medium. It is thus possible that another compound was 
responsible for the antifungal activity. Talosin A and B are compounds known to have inhibitory 
activity against C. albicans (MIC 15 and 7 µg/mL, respectively) that were previously isolated 
from another strain of the same species
214
, though no ions with m/z consistent with the predicted 
talosin pseudomolecular ions (417.1180 and 563.1759) or the sodium adducts (439.1000 and 
585.1579) were detected in any of the crude extracts. Given the high probability that the 
antifungal activity of these extracts was caused by a known compound, this extract was not 
investigated further for novel metabolites.   
Kitasatospora griseola NRRL B-16229 extract is active against S. warneri 
Although this organism was known to produce setamycin (bafilomycin B1), which is 
active against S. aureus (MIC 25 µg/mL)
90
, ions with m/z consistent with the pseudomolecular 
ion ([M+H]
+
 816.4528) and the sodium adduct ([M+Na]
+
 838.4383) were not detected in the 
extracts. Compounds were, however, present in the ELSD chromatograms at ~5.5 min 
(setamycin was previously determined to be detected by the ELSD at 5.50 min in Section 2.3.4), 
but did not ionize well in the mass spectrometer. It is thus difficult to assess whether the 
inhibitory activity against S. warneri and MRSA of the extract were caused by the presence of 
 227 
 
 
 
 
 
 
 
Figure 6.6. Evaporative light scattering detector chromatogram of the crude extract of K. 
kifunensis NRRL B-24284 grown in lean medium (A) illustrating that the structure of the 
compound detected at 3.85 min was the known compound naphthomycin A (B).  
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setamycin or not. It is also possible that another compound within the extract was responsible for 
the antibacterial activity. In fact, extracts from K. griseola NRRL B-16229 grown in lean 
medium contained major compounds with m/z 542.3229 (tR 3.79) and 556.3389 (tR 3.93). These 
were also highlighted by the principal component 3 as buckets responsible for pulling K. 
griseola extracts from the remainder of the data set (Figure 6.7). Since the sodium adducts were 
also identified (m/z 564.3047 (tR 3.79) and 578.3203 (tR 3.93)), an AntiBase search using the 
mass of the pseudomolecular ions [M+H]
+
 revealed that no compounds within the database 
shared the same molecular formula. Furthermore, these compounds appeared to be produced 
mostly in cultures from lean medium as the ELSD chromatogram from ISP2 extracts of the same 
organism were devoid of any significant peaks at 3.74 and 3.90 min (Figure 6.8). The two new 
compounds are most likely analogues of each other, differing by one methylene group (CH2) as 
the two compounds have mass to charge ratios 14 atomic mass units apart. Krista Gill is 
currently working on purifying and elucidating the structure of these putatively new compounds.  
Gill was also able to identify the compound 3-methyl-lumichrome from the same extracts (m/z 
257.1033, tR 2.60), which also appeared to be produced by K. griseola MF730-N6 and K. setae 
(presence of same bucket, data not shown). No activity was reported for this compound in 
AntiBase
 
but lumichrome is a derivative of riboflavin (vitamin B2) that is commonly secreted by 
bacteria, plants and algae and has been proposed to be involved in quorum sensing
215
 and as a 
root respiration enhancer in plant associated microbes
216
. Though the bioactivity against 
staphylococci is probably not caused by the presence of this compound, it is beneficial to 
associate ELSD chromatogram peaks within the extracts with known compounds. The isolation, 
structure elucidation and bioactivity screening of the purified compounds with mass spectral ions 
of m/z 542 and 556 will reveal whether they constitute novel chemical entities and whether these 
compounds were responsible for the bioactivity observed in the crude extracts against 
staphylococci.   
  
 
2
2
9
 
 
Figure 6.7. Scores and loadings plots of principal components 3 and 4 illustrating that the metabolites responsible for pulling the extracts of K. 
griseola NRRL B-16229 (grown in lean medium) away from the remainder of the data had m/z 556.3385 and 542.3229. Circles in the scores plot 
represent extracts obtained from lean medium fermentations and squares represent extracts obtained from ISP2 medium fermentations. 
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Figure 6.8. Evaporative light scattering detector chromatograms of the crude extracts from 
triplicate cultures of K. griseola NRRL B-16229 grown in lean medium (A) and ISP2 medium 
(B), illustrating the different chemical profile obtained from each medium, where the major 
compounds produced in lean medium are putatively new compounds with a mass to charge ratio 
of 542.3229 and 556.3389.  
 
 
 
 
 
 231 
 
6.4 CONCLUSION 
The use of LC-HRMS metabolomics in combination with antimicrobial assays has 
enabled the discovery of at least three novel natural products, cystargamide and cystargolides A 
and B from K. cystarginea and two putatively new compounds from K. griseola (compounds 
with [M+H]
+
 m/z 542 and 556) with possible biological activity against MRSA and S. warneri.  
Although compound rediscovery was inevitable for both techniques, time and resource 
investments was considerably lower for hits based on chemical novelty as a simple proton NMR 
was sometimes able to address the likelihood that the compound was known as was the case for 
pepstatin A in extracts of K. mediocidica. This research supports the use of LC-HRMS based 
metabolic profiling to rapidly identify new compounds and the use of kitasatosporae as a prolific 
source of novel natural products in a drug discovery program.  
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CHAPTER 7 - GENERAL CONCLUSIONS 
AND FUTURE DIRECTIONS 
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7.1 Development of a metabolically simplified strain of Streptomyces lividans TK24 unable 
to heterologously produce the antibacterial terpene terpentecin. 
In order to provide a practical, renewable and economically relevant source of terpenes, 
the first objective of this thesis was to develop a bacterial host platform for the heterologous 
production of bioactive terpenes. Streptomyces lividans TK24 was first genetically engineered to 
eliminate competing pathways leading to the production of actinorhodin and undecylprodigiosin. 
Genotypic and phenotypic evidence was presented that confirmed S. lividans no longer produced 
ACT and RED.  
To generate a recombinant host capable of producing an antibacterial terpene, the 
terpentecin biosynthetic gene cluster was successfully cloned from Kitasatospora griseola 
MF730-N6 in three fragments and was expressed in S. lividans TK24 ∆act∆red via a new 
integrating vector (pJC003) under the control of the constitutive promoter PErmE*_actII-
ORF4_JC to drive the transcription of downstream genes. Although genetic studies confirmed 
that exogenous terpentecin and promoter genes were present in S. lividans TK24 
∆act∆red::pTERP1 and RT-PCR confirmed that transcripts of terpentecin gene were present, 
metabolomic PCA analysis did not suggest any terpentecin production in the heterologous host.  
Since terpentecin and antibacterial activity were not detected in the developed 
heterologous host, the recombinant strain would not, at this moment, provide a rapid method of 
assessing terpene yields in mutant strains. Future studies attempting to isolate the elusive 
compound terpentecin from the native producer may provide amounts of pure terpentecin which 
could be used to develop more sensitive analytical techniques. Alternatively, other antibacterial 
terpene genes, such as those for phenalinolactone or platencin biosynthesis, could be introduced 
in the developed host as they have already proven to be produced heterologously in 
Streptomyces hosts
50, 55
.  
Since the molecular tools generated during this study (pJC003, PErmE*_actII-ORF4_JC 
and S. lividans ∆act∆red ) were not commercially available, their development during this study 
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has made them accessible to other members of the Kerr laboratory and to collaborators for future 
genetic studies involving microorganisms of the genera Streptomyces and Kitasatospora. As 
new gene clusters are described, whether from the Kerr laboratory or other research groups, this 
bacterial host can be used to confirm the products of these pathways and may also act as a 
reliable source cryptic natural products or compounds in short supply.  
7.2 Satosporin A and B are new polyketide natural products from K. griseola MF730-N6 
with an unprecedented tricyclic ring system and unusual sugar moieties. 
In attempting to isolate terpentecin from a large scale (12 L) fermentation of K. griseola 
MF730-N6, two new compounds were detected in the crude extracts. LC-HRMS analysis 
revealed the presence of ions with m/z 711.3558 and 549.3021, corresponding to the sodium 
adduct pseudomolecular ion [M+Na]
+
 of satosporin A (C34H56O14) and B (C28H46O9), 
respectively. The compounds were purified using liquid partitioning, normal- and reversed-phase 
silica-based chromatography and HPLC, and their structures were elucidated using MS and 
NMR experiments such as 
1
H, 
13
C, COSY, HSQC, HMBC, NOESY and ROESY. Satosporin A 
contained a unique oxo-decalin moiety fused to an eight-membered lactone ring and a 
disaccharide attached at C16 composed of two β-glucose molecules; satosporin B corresponded 
to the monosaccharide analogue. Interestingly, these compounds were not produced by any other 
kitasatosporae studied including a member of the same species, K. griseola NRRL B-16229. 
The aglycone analogue of the isolated satosporins, though not detected in K. griseola 
fermentations, was desired to assign the absolute stereochemistry at C16. It was obtained via 
enzymatic deglucosylation by incubation of pure satosporin A with β-glucosidase from almonds 
and the reaction was monitored by LC-HRMS. The compound was converted to satosporin B 
within 1 h and fully converted to the aglycone, satosporin C, after 8 d. 
The relative configuration of the oxo-decalin moiety of satosporins was determined using 
NOESY correlations, whereas computational methods were used to compare experimental and 
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theoretical interatomic distances of the eight-membered lactone ring. The absolute 
stereochemistry of satosporins was determined using circular dichroism. The modified Mosher’s 
reaction was used to determine the absolute stereochemistry at C16 and the modified Tanaka’s 
derivatization determined that the sugar moieties of satosporin A were both D-glucose. The 
absolute stereochemistry of satosporins was determined to be 2R, 3R, 4S, 6R, 8R, 10S, 11R, 12S, 
14R, 15R, 16R.  
Although satosporin A did not exhibit any significant biological activity against the 
pathogens and cancer cell lines tested, it was also non-toxic to healthy cells at a concentration of 
128 µg/mL. This provides a promising perspective for future applications of this natural product; 
further investigations regarding their possible biological activities are currently ongoing.  
As resistance to current drugs becomes more widely spread and current drugs become 
ineffective, it is crucial that new chemical entities enter the drug discovery pipeline to be the 
source of tomorrow’s medicines18. This research supports previous findings that members of the 
genus Kitasatospora are prolific producers of secondary metabolites and that further 
investigations of their metabolome may provide additional novel natural products.  
7.3 The satosporin biosynthetic gene cluster involves genes encoding multimodular type I 
polyketide synthases, a cytochrome P450, a glycosyltransferase, a unique fused KS-P450 as 
well as regulatory and self-resistance genes.  
To identify the genetic origin of satosporins in K. griseola, data from a degenerate primer 
PCR-based method was combined with Illumina
®
 and PacBio genome sequencing data. DNA 
sequences were analysed by antiSMASH, which revealed a 99.7 kb region containing two large 
PKSs containing one loading and 7 extender modules, consistent with the predicted assembly of 
the satosporin polyketide backbone. An insertional inactivation of module 1 was generated by 
homologous recombination and the integration of the apramycin resistance gene was confirmed 
by PCR and the metabolic profiles from recombinant strains were compared to that from the 
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wild-type organism. HPLC analysis revealed that the satosporins were no longer present in the 
crude extracts from recombinant strains, confirming the involvement of the selected genetic 
region in satosporin biosynthesis.  
Sequence analysis, performed using antiSMASH, FramePlot and BLAST
®
, revealed that 
the satosporin biosynthetic genes (ORF1 to ORF10) spanned 67 kb and, based on sequence 
similarities, probably encoded a cytochrome P450 monoxygenase, two large multimodular 
PKSs, a unique fused ketosynthase-cytochrome P450 monoxygenase, a glycosyltransferase as 
well as regulatory and self-resistance genes.  
A biosynthetic scheme was proposed based on the genetic organization of the sat cluster, 
where the unique tricyclic ring system of satosporins was proposed to originate from a Diels-
Alder cyclization following polyketide backbone assembly by the PKSs (SatB and SatC). Two 
P450 hydroxylations were then proposed to occur (by SatA and/or SatD) to give rise to the 
aglycone, satosporin C. Finally SatE was proposed to carry out the two glucosylations required 
to biosynthesize satosporin B and A. Putative pathway specific regulatory genes (ORF8 and 
ORF9) had high aa sequence homology to other regulatory genes (SARP and unspecific 
regulatory protein), while ORF2 had aa sequence homology to efflux proteins and may therefore 
be involved in regulation and self-resistance to satosporins, respectively.  
The inactivation of each biosynthetic gene within the described cluster is essential to 
confirm the encoding enzymes and the biosynthetic steps they carry out; this is currently being 
investigated by other members of the laboratory. This research also provided the DNA sequence 
to allow heterologous production of satosporins. This would confirm that all the necessary genes 
have been included here, would determine the minimal satosporin biosynthetic gene cluster and 
could also provide other analogs via combinatorial biosynthesis. As the annotation of secondary 
metabolite biosynthetic genes relies on nucleotide and amino acid sequence similarities to 
previously described genes, reporting and characterizing both usual and unusual biosynthetic 
genes is crucial to developing the most precise gene annotations prediction software. The 
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characterization of the unique KS-P450 gene (satD) will thus be important as it may be the first 
member of a new enzyme class, whereas characterization of the substrate specificities of the 
glycosyltransferase may provide a new enzymatic tool for the generation of new non-natural 
natural products via glycodiversification
170
.  
7.4 The genome of K. griseola MF730-N6 has similar developmental regulatory genes to 
other kitasatosporae and contains 23 putative secondary metabolite biosynthetic gene 
clusters.  
The genome of K. griseola MF730-N6 was sequenced using the Pacific Bioscience RS II 
platform and, following PCR-based gap closure, resulted in eight contigs covering 7,966,157 bp. 
The genome was similar to that of other kitasatosporae in its overall G + C content (72.7%), 
rRNA operons (9 complete + 5 incomplete) and number of protein encoding sequences (7,226).  
Kitasatopora griseola has orthologs of almost all developmental regulatory genes (bld and 
whi genes) that are usually involved in the complex life cycle of streptomycetes with the 
exception of bldB and whiJ. Given the high relatedness of kitasatosporae and streptomycetes, it 
is not surprising that orthologous genes for important functions are present in members of both 
genera. In contrast to the K. setae genome, orthologs of the ram cluster were identified in K. 
griseola, suggesting that some kitasatosporae may use a protein similar to SapB to facilitate 
aerial hyphae formation
194
.  
AntiSMASH analysis revealed 23 putative secondary metabolite biosynthetic gene 
clusters in the genome of K. griseola MF730-N6. The analysis predicted biosynthetic genes 
leading to the production of seven lantipeptides, six polyketides, three terpenes, two 
siderophores, two nonribosomal peptide-polyketide hybrids, one nonribosomal peptide, one 
bacteriocin and one unclassified. Only ten were also present in K. setae, suggesting that most 
natural products produced by kitasatosporae are not distributed throughout members of the 
genus. As only eight gene clusters could be attributed to known compounds, including 
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bafilomycin, satosporin and terpentecin, there is the potential to isolate other secondary 
metabolites from this organism; this could give rise to the isolation of new natural products or it 
could provide the genetic information for compounds that have already been discovered. 
Culturing or genetic methods should be employed to induce or increase the production of these 
numerous cryptic metabolites. The heterologous host developed in Chapter 2 would provide an 
ideal host as its background metabolite production is minimal and therefore, small amounts of 
heterologous product may be easily detected by LC-HRMS. The publication of the annotated 
genome will also allow a more comprehensive comparison to be made between kitasatosporae 
and streptomycetes.  
This research also offers significant advantages for future research involving K. griseola. 
For example, this genome data could quickly provide the biosynthetic origins of two putatively 
new compounds produced by this organism; performing knock-out experiments would then be 
necessary to confirm their involvement in the natural product’s biosynthesis, saving considerable 
time and effort. 
7.5 Principal component analysis of the metabolomes of twelve kitasatosporae allowed the 
rapid detection of novel natural products  
In order to discover new natural products from “rare” actinomycetes, twelve members of 
the genus Kitasatospora were cultured in two media and extracted with EtOAc. Following LC-
HRMS analysis of the crude extracts, the metabolomes were analysed and subjected to principal 
component analysis according to methods previously developed by members of our lab
24
. The 
analysis revealed that the metabolomes of Kitasatospora cystarginea was unique amongst the 
kitasatosporae studied. The loadings plot revealed that the ions responsible for this 
differentiation had m/z of 357.2022 and 371.2177. Following structure elucidation by Krista Gill 
(PhD candidate in Kerr laboratory), the compounds highlighted by PCA were confirmed to be 
new β-lactone containing peptides, cystargolides A and B (manuscript submitted to the Journal 
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of Natural Products). The same crude extract also resulted in Gill purifying an additional new 
product, cystargamide, whose structure elucidation was recently published
211
. The PCA also 
highlighted ions with m/z 686.4711 to be unique in the crude extract of K. mediocidica; 
AntiBase and preliminary NMR experiments confirmed that this compound was the peptide 
pepstain A and, thus, was not investigated further. 
Although the extracts containing the new compounds (cystargolides and cystargamide) 
showed no antimicrobial activity against the organisms tested, the crude extracts of 
Kitasatospora kifunensis showed activity against Candida albicans. Based on LC-HRMS and 
NMR data, this activity was probably caused by the known compound naphthomycin A, which 
was isolated from the crude extract and has reported antifungal activity
213
. This study, however, 
provided two putatively new compounds from K. griseola (compounds with [M+H]
+
 m/z 
542.3229 and 556.3389) with possible biological activity against MRSA and S. warneri. Gill is 
currently working towards purifying sufficient amounts to elucidate their structure.  
This research supports the use of LC-HRMS based metabolic profiling and PCA to rapidly 
identify new compounds and confirms the use of studying “rare” actinomycetes such as 
kitasatosporae for the discovery of novel natural products. Future studies involving “rare” 
actinomycetes for the discovery of new natural products could include a more comprehensive 
collection of kitasatosporae from both culture collections and from unique environments as 
strain-specific natural products can evolve in members of the same species, evidenced here by 
terpentecin and satosporin production in K. griseola MF730-N6. Genera to incorporate in future 
analyses could include Salinispora, Actinosynnema, Kibdelosporangium, Microellobosporia, 
Chainia, etc.
217
 and the use of various fermentation conditions could be used to trigger the 
production of as many natural products as possible.  
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7.6 Concluding remarks 
This thesis work has provided advancements in various disciplines within natural product 
research in the form of new/accessible molecular tools, new natural products with unique 
chemical structures and genetic and metabolomic information from kitasatosporae. Other studies 
have already stemed from research within this thesis and, hopefully, natural products drug 
discovery from kitasatosporae will continue beyond the work that I have accomplished.  
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Figure A.1. HRMS of satosporin A.  
 
 
 
Figure A.2. HRMS of satosporin B. 
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Figure A.3. HRMS of satosporin C.  
 
 
 
Figure A.4. 
1
H NMR spectrum (600 MHz, CD3OD) of satosporin A. 
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Figure A.5.
 13
C NMR spectrum (150 MHz, CD3OD) of satosporin A. 
 
Figure A.6. COSY spectrum of satosporin A. 
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Figure A.7. HSQC spectrum of satosporin A. 
 
Figure A.8. HMBC spectrum (600 MHz, CD3OD) of satosporin A. 
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Figure A.9. ROESY spectrum (600 MHz, CD3OD) of satosporin A. 
 
Figure A.10. 
1
H NMR spectrum (600 MHz, CD3OD) of satosporin B. 
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Figure A.11. COSY spectrum of satosporin B. 
 
Figure A.12. HSQC spectrum (600 MHz, CD3OD) of satosporin B. 
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Figure A.13. HMBC spectrum (600 MHz, CD3OD) of satosporin B. 
 
Figure A.14. ROESY spectrum of satosporin B. 
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Figure A.15. 
1
H NMR spectrum (600 MHz, CD3OD) of satosporin C. 
 
Figure A.16. COSY spectrum of satosporin C. 
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Figure A.17. HSQC spectrum of satosporin C. 
 
Figure A.18. HMBC spectrum of satosporin C. 
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Figure A.19. NOESY spectrum of satosporin C. 
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Figure A.20. Infrared spectra (IR) recorded at 25°C in methanol for satosporin A (A), satosporin 
B (B) and satosporin C (C). 
 
 
 
